WO2018181710A1 - 歯科材料用多官能モノマーおよび歯科材料用水酸基含有モノマー - Google Patents
歯科材料用多官能モノマーおよび歯科材料用水酸基含有モノマー Download PDFInfo
- Publication number
- WO2018181710A1 WO2018181710A1 PCT/JP2018/013236 JP2018013236W WO2018181710A1 WO 2018181710 A1 WO2018181710 A1 WO 2018181710A1 JP 2018013236 W JP2018013236 W JP 2018013236W WO 2018181710 A1 WO2018181710 A1 WO 2018181710A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- general formula
- monomer
- bonded
- meth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
- A61K6/887—Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/30—Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/40—Primers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C265/00—Derivatives of isocyanic acid
- C07C265/02—Derivatives of isocyanic acid having isocyanate groups bound to acyclic carbon atoms
- C07C265/04—Derivatives of isocyanic acid having isocyanate groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/10—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Definitions
- the present invention relates to a polyfunctional monomer for dental material, a dental material containing the monomer, a cured product of the dental material, and a kit containing the dental material.
- the present invention also relates to a hydroxyl group-containing monomer for dental materials, a dental material containing the monomer, a cured product of the dental material, and a kit containing the dental material.
- resin-based dental materials contain a monomer having a (meth) acrylate group in the molecular structure.
- Typical monomers for dental materials are bisphenol A diglycidyl methacrylate (Bis-GMA), 2,2,4-trimethylhexamethylenebis (2-carbamoyloxyethyl) dimethacrylate (UDMA), triethylene glycol dimethacrylate (TEGDMA) and other dimethacrylates having methacrylic groups at both ends.
- HEMA 2-Hydroxyethyl methacrylate
- a hydroxyl group and a polymerizable group in the molecule and the hydrophilicity of the molecule derived from the hydroxyl group is thought to be effective for dentine affinity and modification of the tooth surface.
- the polymerizability is effective for integration with the resin matrix.
- Such a property of HEMA is useful as a primer, and in the dental material field, it is blended in a wide range particularly in a dental primer and a dental bonding material (for example, see Non-Patent Document 2).
- An object of the present invention is to provide monomers, compositions, dental materials, kits and the like useful for dental materials.
- the objects of the first aspect and the second aspect of the present invention are as follows.
- an object of the first aspect of the present invention is to provide a polyfunctional monomer for a dental material that gives a cured product having high strength, and a cured product thereof.
- Another object of the first aspect of the present invention is to provide a dental material containing the above-mentioned polyfunctional monomer for dental material, which has a low residual ratio of unreacted polymerizable terminals after curing.
- the second aspect of the present invention aims to provide a hydroxyl group-containing monomer for dental materials having a function of improving the adhesive strength with a tooth during dental treatment.
- the present inventors have produced a (meth) acryloyl group-containing polyfunctional monomer from a reaction between a polyhydric alcohol or polyol and a (meth) acryloyl group-containing isocyanate compound.
- the cured product of the composition containing the (meth) acryloyl group-containing polyfunctional monomer exhibits high strength, and the composition containing the (meth) acryloyl group-containing polyfunctional monomer was found to show a high polymerization rate, and the first aspect of the present invention was completed.
- the present inventor has found that a monomer containing a hydroxyl group and a (meth) acryloyl group is obtained by a reaction between a polyhydric alcohol or polyol and a (meth) acryloyl group-containing isocyanate compound.
- the second aspect of the present invention was completed by finding that it can be produced, and that the adhesiveness of dental materials containing a hydroxyl group and a monomer containing the (meth) acryloyl group to the tooth is improved.
- the first aspect of the present invention includes the matters described in [1A] to [23A] below.
- [1A] A polyfunctional monomer for dental materials containing a compound represented by the following general formula (8A) in which the following core (X) and the following end group (Y2A) are bonded directly or via the following linking group (Z).
- n 8aA represents the number of end groups (Y2A) directly bonded to the nucleus (X), and n 8bA represents a linking group (Z ), And the sum of n 8aA and n 8bA is equal to the valence of the core (X),
- the core part (X) contains an oxygen atom or a nitrogen atom, and the atom bonded to the terminal group (Y2A) or the linking group (Z) is an oxygen atom or a nitrogen atom.
- the terminal group (Y2A) is a (meth) acryloyl group-containing group (Y3), a (meth) acryloyl group, or a hydrocarbon group having 1 to 20 carbon atoms represented by the following general formula (9), and a plurality of terminal groups (Y2A) may be the same or different.
- a plurality of terminal groups (Y2A) may be the same or different.
- three or more are (meth) acryloyl group-containing groups (Y3) or ( A (meth) acryloyl group and one or more is a (meth) acryloyl group-containing group (Y3);
- the linking group (Z) is a divalent group represented by the following general formula (2).
- the linking group (Z Z) may be the same or different.
- R 9a represents a hydrogen atom or a methyl group
- R 9b represents a linear alkylene group having 2 to 6 carbon atoms, or a linear oxyalkylene group having 2 to 6 carbon atoms
- the hydrogen atom contained in the linear alkylene group or the linear oxyalkylene group may be substituted with an alkyl group having 1 to 6 carbon atoms or a (meth) acryloyloxymethylene group.
- n 2a , n 2b , n 2c , and n 2d represent the number of units of each repeating unit, and are each 0 to 100, n 2a , n 2b , n 2c , and n 2
- the total of 2d is 1 to 100, and the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the terminal group (Y2A).
- [2A] The polyfunctional monomer for dental materials according to [1A], wherein the terminal group (Y2A) is a (meth) acryloyl group-containing group (Y3) or a (meth) acryloyl group.
- [3A] The polyfunctional monomer for dental materials according to [1A] or [2A], wherein the terminal group (Y2A) is a (meth) acryloyl group-containing group (Y3).
- n 2a , n 2b , n 2c , and n 2d in the linking group (Z) are each 0 to 20, and the sum of n 2a , n 2b , n 2c , and n 2d is 1 to 20
- n 4a , n 4b and n 4c represent the number of units of each repeating unit, and are each 0 to 20, and the total of n 4a , n 4b and n 4c is 1 to 20
- the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y2A).
- n 5a and n 5b represent the number of units of each repeating unit, and are each 0 to 20, and the total of n 5a and n 5b is 1 to 20, (The left end is bonded to the nucleus (X), and the right end of the above group is bonded to the end group (Y2A).)
- [7A] The polyfunctional monomer for dental materials according to any one of [1A] to [6A], wherein the core (X) is a trivalent to valent organic group.
- the core part (X) is at least one selected from the group consisting of groups represented by the following general formulas (6a) to (6j): [1A] to [7A] Multifunctional monomer for dental materials.
- the above (meth) acryloyl group-containing group (Y3) is at least one selected from the group consisting of groups represented by the following general formulas (9a) to (9f): [1A] to [8A]
- the polyfunctional monomer for dental materials according to any one of the above.
- [10A] A compound represented by the following general formula (1A) in which the following core (X) and the following end group (Y1A) are bonded directly or via the following linking group (Z), and the following general formula (3 ) And (meth) acryloyl group-containing isocyanate compound (number of isocyanate groups contained in the compound represented by the following general formula (3)) / (oxygen contained in the compound represented by the following general formula (1A))
- n 1aA represents the number of end groups (Y1A) directly bonded to the core (X), and n 1bA is connected to the core (X) via the linking group (Z)).
- the number of terminal groups (Y1A) bonded , the sum of n 1aA and n 1bA is equal to the valence of the core (X),
- the core part (X) contains an oxygen atom or a nitrogen atom, and a trivalent or higher polyvalent number of 1 to 200 carbon atoms in which the atom bonded to the terminal group (Y1A) or the linking group (Z) is an oxygen atom or a nitrogen atom.
- the terminal group (Y1A) is a (meth) acryloyl group, a monovalent hydrocarbon group having 1 to 20 carbon atoms, or a hydrogen atom, and a plurality of Y1A may be the same or different, provided that the general formula ( 3 or more of the terminal groups (Y1A) contained in the compound represented by 1A) are hydrogen atoms or (meth) acryloyl groups, and 1 or more are hydrogen atoms,
- the linking group (Z) is a divalent group represented by the following general formula (2). When the compound represented by the general formula (1A) includes a plurality of linking groups (Z), the linking group (Z Z) may be the same or different.
- n 2a , n 2b , n 2c , and n 2d represent the number of units of each repeating unit, and are each 0 to 100, n 2a , n 2b , n 2c , and n 2 2d total is 1 to 100, the left end of the base is bonded to core portion (X), the right end of the group is attached to end group (Y1A).
- R 3a represents a hydrogen atom or a methyl group
- R 3b represents a linear alkylene group having 2 to 6 carbon atoms, or a linear oxyalkylene group having 2 to 6 carbon atoms
- the hydrogen atom contained in the linear alkylene group or the linear oxyalkylene group may be substituted with an alkyl group having 1 to 6 carbon atoms or a (meth) acryloyloxymethylene group.
- [11A] The polyfunctional monomer for dental materials according to [10A], wherein the terminal group (Y1A) is a hydrogen atom.
- n 2a , n 2b , n 2c , and n 2d are each 0 to 20, and the sum of n 2a , n 2b , n 2c , and n 2d is 1 to 20
- [13A] The polyfunctional monomer for dental materials according to any one of [10A] to [12A], wherein the linking group (Z) is a divalent group represented by the following general formula (4).
- n 4a , n 4b and n 4c represent the number of units of each repeating unit, and are each 0 to 20, and the total of n 4a , n 4b and n 4c is 1 to 20 And the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y1A).
- n 5a and n 5b represent the number of units of each repeating unit, and are each 0 to 20, and the total of n 5a and n 5b is 1 to 20, The left end is bonded to the nucleus (X), and the right end of the above group is bonded to the terminal group (Y1A).
- [15A] The polyfunctional monomer for dental materials according to any one of [10A] to [14A], wherein the core (X) is a tri- to 12-valent organic group.
- [16A] Any of [10A] to [15A], wherein the compound (1A) is at least one selected from the group consisting of compounds represented by the following general formulas (6′a) to (6′k) The polyfunctional monomer for dental materials described in 1.
- n 6′ia , n 6′ja , and n 6′ka bind to the core (X).
- the number of arms of the polyol an integer greater than or equal to 3
- n 6′ib and n 6′jb represent the number of oxyethylene and oxypropylene units, respectively, and range from 1 to 100, The number of units for each arm may be the same or different.
- n 6′kb and n 6′kc represent the number of oxyethylene and oxypropylene units, respectively, Is in the range of 1 to 100, and the sum of the number of units for each arm may be the same or different.
- the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) is at least one selected from the group consisting of compounds represented by the following general formulas (3a) to (3f) [10A] -The polyfunctional monomer for dental materials according to any one of [16A].
- [18A] A monomer composition for dental materials containing the polyfunctional monomer for dental materials according to any one of [1A] to [17A].
- [19A] The monomer composition for dental materials according to [18A], which shows negative in a reverse mutation test.
- [20A] A dental material containing the polyfunctional monomer for dental materials according to any one of [1A] to [17A].
- [21A] The dental material according to [20A], which is negative in the reverse mutation test.
- [22A] A cured product obtained by curing the dental material according to [20A] or [21A].
- [23A] A kit comprising the dental material according to [20A] or [21A].
- the second aspect of the present invention includes the matters described in [1B] to [21B] below.
- [1B] A hydroxyl group-containing monomer for dental materials containing a compound represented by the following general formula (8B) in which the following core (X) and the following end group (Y2B) are bonded directly or via the following linking group (Z).
- n 8aB represents the number of end groups (Y2B) directly bonded to the nucleus (X), and n 8bB represents a linking group (Z ), And the sum of n 8aB and n 8bB is equal to the valence of the core (X),
- the core part (X) contains an oxygen atom or a nitrogen atom, and a trivalent or higher polyvalent number of 1 to 200 carbon atoms in which the atom bonded to the terminal group (Y2B) or the linking group (Z) is an oxygen atom or a nitrogen atom.
- the terminal group (Y2B) is a (meth) acryloyl group-containing group (Y3) represented by the following general formula (9), a (meth) acryloyl group, a hydrocarbon group having 1 to 20 carbon atoms, or a hydrogen atom.
- One end group (Y2B) may be the same or different, provided that one or more of all end groups (Y2B) in the compound represented by formula (8B) is a (meth) acryloyl group-containing group (Y3 And one or more is a hydrogen atom
- the linking group (Z) is a divalent group represented by the following general formula (2). When the compound represented by the general formula (8B) includes a plurality of linking groups (Z), the linking group (Z Z) may be the same or different. )
- R 9a represents a hydrogen atom or a methyl group
- R 9b represents a linear alkylene group having 2 to 6 carbon atoms, or a linear oxyalkylene group having 2 to 6 carbon atoms
- the hydrogen atom contained in the linear alkylene group or the linear oxyalkylene group may be substituted with an alkyl group having 1 to 6 carbon atoms or a (meth) acryloyloxymethylene group.
- n 2a , n 2b , n 2c , and n 2d represent the number of units of each repeating unit, and are each 0 to 100, n 2a , n 2b , n 2c , and n 2
- the total of 2d is 1 to 100, and the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the terminal group (Y2B).
- [2B] The hydroxyl group-containing monomer for dental materials according to [1B], wherein the terminal group (Y2B) is a (meth) acryloyl group-containing group (Y3) or a hydrogen atom.
- n 2a , n 2b , n 2c , and n 2d in the linking group (Z) are each 0 to 20, and the sum of n 2a , n 2b , n 2c , and n 2d is 1 to 20
- [4B] The hydroxyl group-containing monomer for dental materials according to any one of [1B] to [3B], wherein the linking group (Z) is a divalent group represented by the following general formula (4).
- n 4a , n 4b and n 4c represent the number of units of each repeating unit, and are each 0 to 20, and the total of n 4a , n 4b and n 4c is 1 to 20
- the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y2B).
- n 5a and n 5b represent the number of units of each repeating unit, and are each 0 to 20, and the total of n 5a and n 5b is 1 to 20, (The left end is bonded to the nucleus (X), and the right end of the above group is bonded to the terminal group (Y2B).)
- [6B] The hydroxyl group-containing monomer for dental materials according to any one of [1B] to [5B], wherein the core (X) is a trivalent to valent organic group.
- the core part (X) is at least one selected from the group consisting of groups represented by the following general formulas (6a) to (6j): [1B] to [6B] Hydroxyl-containing monomer for dental materials.
- the (meth) acryloyl group-containing group (Y3) is at least one selected from the group consisting of groups represented by the following general formulas (9a) to (9f): The hydroxyl-containing monomer for dental materials as described in any one.
- [9B] A compound represented by the following general formula (1B) in which the following core (X) and the following end group (Y1B) are bonded directly or via the following linking group (Z), and the following general formula (3 ) / (The number of active protons bonded to oxygen and nitrogen atoms contained in the compound represented by the following general formula (1B)) ⁇ (the following general formula (3) ) The number of isocyanate groups contained in the compound represented by the formula (1) / (Number of active protons bonded to the oxygen atom and nitrogen atom contained in the compound represented by the following general formula (1B)) ⁇ 1 A hydroxyl group-containing monomer for dental materials.
- n 1aB represents the number of terminal groups (Y1B) directly bonded to the nucleus (X), and n 1bB represents the nucleus (X) via the linking group (Z).
- the core part (X) contains an oxygen atom or a nitrogen atom, and the trivalent or higher polyvalent number of 1 to 200 carbon atoms in which the atom bonded to the terminal group (YI) or the linking group (Z) is an oxygen atom or a nitrogen atom.
- the terminal group (Y1B) is a (meth) acryloyl group, a monovalent hydrocarbon group having 1 to 20 carbon atoms, or a hydrogen atom, and a plurality of Y1Bs may be the same or different, provided that the above general formula ( 2 or more of the terminal groups (Y1B) contained in the compound represented by 1B) are hydrogen atoms,
- the linking group (Z) is a divalent group represented by the following general formula (2). When the compound represented by the general formula (1B) includes a plurality of linking groups (Z), the linking group (Z Z) may be the same or different.
- n 2a , n 2b , n 2c , and n 2d represent the number of units of each repeating unit, and are each 0 to 100, n 2a , n 2b , n 2c , and n 2
- the total of 2d is 1 to 100, and the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the terminal group (Y1B).
- R 3a represents a hydrogen atom or a methyl group
- R 3b represents a linear alkylene group having 2 to 6 carbon atoms, or a linear oxyalkylene group having 2 to 6 carbon atoms
- the hydrogen atom contained in the linear alkylene group or the linear oxyalkylene group may be substituted with an alkyl group having 1 to 6 carbon atoms or a (meth) acryloyloxymethylene group.
- [10B] The hydroxyl group-containing monomer for dental materials according to [9B], wherein the terminal group (Y1B) is a hydrogen atom.
- n 2a , n 2b , n 2c , and n 2d in the linking group (Z) are each 0 to 20, and the sum of n 2a , n 2b , n 2c , and n 2d is 1 to 20
- [12B] The hydroxyl group-containing monomer for dental materials according to any one of [9B] to [11B], wherein the linking group (Z) is a divalent group represented by the following general formula (4).
- n 4a , n 4b and n 4c represent the number of units of each repeating unit, and are each 0 to 20, and the total of n 4a , n 4b and n 4c is 1 to 20 And the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y1B).
- n 5a and n 5b represent the number of units of each repeating unit, and are each 0 to 20, and the total of n 5a and n 5b is 1 to 20, (The left end is bonded to the nucleus (X), and the right end of the above group is bonded to the terminal group (Y1B).)
- n 6′ia , n 6′ja , and n 6′ka are the polyols bonded to the core X).
- Indicates the number of arms, an integer greater than or equal to 3, N 6'Ib and n 6'Jb in the general formula (6'i) and (6'j), respectively oxyethylene represents the number of oxypropylene units in the range of 1 to 100, respectively The number of units for each arm may be the same or different.
- n 6′kb and n 6′kc represent the number of oxyethylene and oxypropylene units, respectively, Is in the range of 1 to 100, and the sum of the number of units for each arm may be the same or different.
- the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) is at least one selected from the group consisting of compounds represented by the following general formulas (3a) to (3f) [9B]
- [17B] A monomer composition for dental material containing the hydroxyl group-containing monomer for dental material according to any one of [1B] to [16B].
- [18B] The monomer composition for dental materials according to [17B], which is negative in the reverse mutation test.
- [19B] A dental material containing the hydroxyl group-containing monomer for dental materials according to any one of [1B] to [16B].
- [20B] The dental material according to [19B], which shows negative in a reverse mutation test.
- [21B] A kit comprising the dental material according to [19B] or [20B].
- the monomer obtained in the present invention is useful as a dental material.
- strength is obtained by hardening the composition containing the polyfunctional monomer for dental materials which is the 1st aspect of this invention.
- the dental material containing the polyfunctional monomer for dental materials has a low residual ratio of unreacted polymerizable terminals after curing.
- the hydroxyl group-containing monomer for dental materials according to the second aspect of the present invention has a function of improving the adhesive strength with the tooth during the dental treatment.
- (meth) acryl means acryl or methacryl
- (meth) acrylic acid means methacrylic acid or acrylic acid
- (meth) acryloyl means “acryloyl” or “methacryloyl”
- (meth) acrylate means “acrylate” or “methacrylate”.
- the polyfunctional monomer for dental materials according to the first aspect of the present invention has the following general formula (8A) in which the following core (X) and the following end group (Y2A) are bonded directly or through the following linking group (Z). It is a compound shown by these.
- n 8aA represents the number of terminal groups (Y2A) directly bonded to the nucleus (X), and n 8bA represents a linking group (Z) to the nucleus (X). through the number of bonds to that terminal group (Y2A), the sum of n 8aA and n 8bA is equal to the valence of core portion (X).
- n 8aA and n 8bA are integers of 0 or more, and the combination is not particularly limited as long as the sum is 3 or more.
- n 8aA is 0, n 8bA is an integer of 3 or more. In this case, all end groups (Y2A) are bonded to the core X via a linking group (Z). Yes.
- n 8bA is 0, n 8aA is an integer of 3 or more. In this case, all end groups (Y2A) are directly bonded to the nucleus X.
- the core (X) is a trivalent or higher polyvalent organic group containing an oxygen atom or a nitrogen atom, and an atom bonded to the terminal group (Y2A) or the linking group (Z) being an oxygen atom or a nitrogen atom. .
- the oxygen atom or nitrogen atom bonded to the terminal group (Y2A) or linking group (Z) is a group other than the terminal group (Y2A) or linking group (Z) other than a methylene group or a divalent aromatic carbon group.
- Any hydrogen atom contained in the methylene group or divalent aromatic carbon group may be replaced with a monovalent hydrocarbon group having 1 to 12 carbon atoms.
- the number of carbon atoms in the core part (X) is usually in the range of 1 to 200, preferably 1 to 100, more preferably 1 to 30, and further preferably 2 to 20.
- the valence of the core part (X) is 3 or more as described above, but it is preferably 3 to 12 valence, more preferably 3 to 8 valence.
- the atom bonded to the terminal group (Y2A) or the linking group (Z) is selected from an oxygen atom or a nitrogen atom as described above, and is preferably an oxygen atom.
- Examples of the core (X) include groups represented by the following general formulas (6a) to (6j).
- n 6g is an integer of 1 to 40, preferably 1 to 20, more preferably 1 to 10, and further preferably 1 to 5. .
- the terminal group (Y2A) is a (meth) acryloyl group-containing group (Y3), a (meth) acryloyl group, or a hydrocarbon group having 1 to 20 carbon atoms represented by the following general formula (9), and a plurality of terminal groups (Y2A) may be the same or different. However, among all the terminal groups (Y2A) in the compound represented by the general formula (8A), three or more are (meth) acryloyl group-containing groups (Y3) or ( It is a (meth) acryloyl group, and one or more is a (meth) acryloyl group-containing group (Y3).
- R 9a represents a hydrogen atom or a methyl group
- R 9b represents a linear alkylene group having 2 to 6 carbon atoms, or a linear oxyalkylene group having 2 to 6 carbon atoms
- the straight chain alkylene group or the hydrogen atom contained in the straight chain oxyalkylene group may be substituted with an alkyl group having 1 to 6 carbon atoms or a (meth) acryloyloxymethylene group.
- Examples of the (meth) acryloyl group-containing group (Y3) represented by the general formula (9) include groups represented by the following general formulas (9a) to (9f).
- the terminal group (Y2A) is a (meth) acryloyl group-containing group (Y3), a (meth) acryloyl group, or a hydrocarbon group having 1 to 20 carbon atoms represented by the general formula (9) as described above.
- the (meth) acryloyl group-containing group (Y3) or the (meth) acryloyl group is preferable, and the (meth) acryloyl group-containing group (Y3) is more preferable.
- linking group (Z) is a divalent group represented by the following general formula (2).
- the linking group (Z Z) may be the same or different.
- n 2a , n 2b , n 2c , and n 2d represent the number of units of each repeating unit, and are each 0 to 100, preferably 0 to 20.
- the total of n 2a , n 2b , n 2c and n 2d is 1 to 100, preferably 1 to 20.
- the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y2A).
- the repeating unit represented by —C 2 H 4 O— in the general formula (2) is an oxyethylene unit.
- the oxyethylene unit include —CH 2 CH 2 O— and —CH (CH 3 ) O—.
- —CH 2 CH 2 O— is preferable.
- These oxyethylene units may be contained singly or in combination of two or more.
- the repeating unit represented by —C 3 H 6 O— in the general formula (2) is an oxypropylene unit.
- the oxypropylene units e.g., -CH 2 CH 2 CH 2 O -, - CH (CH 3) CH 2 O-, and -CH 2 CH (CH 3) groups such as O- and the like.
- oxypropylene units —CH (CH 3 ) CH 2 O— and —CH 2 CH (CH 3 ) O— are preferable.
- These oxypropylene units may be contained singly or in combination of two or more.
- the repeating unit represented by —C 4 H 8 O— in the general formula (2) is an oxybutylene unit.
- the oxybutylene unit include —CH 2 CH 2 CH 2 CH 2 O—, —CH (CH 3 ) CH 2 CH 2 O—, —CH 2 CH (CH 3 ) CH 2 O—, —CH 2 CH 2 CH (CH 3 ) O—, —CH (CH 2 CH 3 ) CH 2 O—, —CH 2 CH (CH 2 CH 3 ) O—, —CH (CH 3 ) CH (CH 3 ) O—, And groups such as —C (CH 3 ) 2 CH 2 O— and —CH 2 C (CH 3 ) 2 O—.
- —CH 2 CH 2 CH 2 CH 2 O— is preferable.
- These oxybutylene units may be included singly or in combination of two or more.
- the repeating unit represented by —CO (CH 2 ) 5 O— in the general formula (2) is one unit of a polycaprolactone chain.
- Said repeating unit may be comprised by 1 type, and may be comprised by 2 or more types.
- the form in which these repeating units are included is not particularly limited.
- each repeating unit may be included at random, or a certain number of repeating units are fixed in a certain number. That is, each repeating unit may be included in blocks. Further, the order of these repeating units is not limited at all.
- the linking group (Z) is preferably a divalent group represented by the following general formula (4).
- the linking groups (Z) may be the same or different.
- n 4a , n 4b, and n 4c represent the number of units of each repeating unit, and are each 0-100, preferably 0-20.
- the sum of n 4a , n 4b and n 4c is 1 to 100, preferably 1 to 20.
- the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y2A).
- the description about each repeating unit in the said General formula (4) is the same as the description of each repeating unit in the said General formula (2).
- the linking group (Z) is more preferably a divalent group represented by the following general formula (5).
- the linking groups (Z) may be the same or different.
- n 5a and n 5b represent the number of units of each repeating unit, and are each 0-100, preferably 0-20.
- the total of n 5a and n 5b is 1 to 100, preferably 1 to 20.
- the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y2A).
- the description about each repeating unit in the said General formula (5) is the same as the description of each repeating unit in the said General formula (2).
- linking group (Z) include those in which the repeating unit is composed only of oxyethylene units (in the general formula (5), n 5b is 0 and n 5a is 1 to 100, preferably Is composed of only oxypropylene units (in formula (5), n 5a is 0, n 5b is 1 to 100, preferably 1 to 20), oxy Polymer block composed of propylene units-polymer block composed of oxyethylene units-polymer block composed of oxypropylene units (in general formula (5), linked in the following structure (5 ') And the like).
- n 5a1 , n 5a2 and n 5b represent the number of units of each repeating unit, and are each 1 to 100, preferably 1 to 20.
- the sum of n 5a1 , n 5a2 and n 5b is 1 to 100, preferably 1 to 20.
- the left end of the group is bonded to the core (X), the right end of the group is bonded to the end group (Y2A), and the oxypropylene polymer block and the oxyethylene polymer block in parentheses are bonded in this order. is doing.
- the description about each repeating unit in the said General formula (5 ') is the same as the description of each repeating unit in the said General formula (2).
- the polyfunctional monomer for dental materials of the present invention has, for example, the following general formula (1A) in which the following core (X) and the following end group (Y1A) are bonded directly or through the following linking group (Z). It is obtained by reacting all active protons in the indicated compound with the isocyanate group in the (meth) acryloyl group-containing isocyanate compound represented by the following general formula (3) to produce a corresponding carbamate group or urea group.
- an active proton refers to a hydrogen atom that binds to alcoholic oxygen and amine nitrogen and has reactivity at a practical rate with isocyanate.
- the production conditions of the polyfunctional monomer for dental materials of the present invention are, for example, the following general formula (the following general formula (X) and the following end group (Y1A) are bonded directly or through the following linking group (Z) ( 1A) and a raw material containing a (meth) acryloyl group-containing isocyanate compound represented by the following general formula (3) and an isocyanate group contained in the compound represented by the following general formula (3)
- reaction ratio there is a reaction under the condition of the above reaction ratio> 1.
- the (meth) acryloyl group-containing isocyanate compound represented by the following general formula (3) remains, but all the activities in the compound represented by the following general formula (1A) Protons can react with isocyanate groups to obtain a mixture containing the polyfunctional monomer for dental materials of the present invention.
- the reaction ratio during the production is preferably close to 1, but is, for example, 2 or less, preferably 1.5 or less, and more preferably 1.2 or less.
- Such a mixture can also be blended with the dental material of the present invention directly as it is or through a further known reaction or treatment.
- the reaction ratio during the production is preferably close to 1, but for example, ((average number of active protons in one molecule minus 1 ) / (Average number of active protons in one molecule)) or more.
- Such a mixture can also be blended with the dental material of the present invention directly as it is or through a further known reaction or treatment.
- the number of moles of active protons in the raw material containing the compound represented by the following general formula (1A) is determined by a known analysis method, for example, measurement of hydroxyl value, specifically, JIS K 0070-1992, JIS K 1557-1-2007. , ISO 14900-2001 and methods based on these standards can be obtained by calculation.
- the number of moles of isocyanate groups contained in the compound represented by the following general formula (3) is determined by a known analysis method, for example, NCO value measurement, specifically JIS K-7301-1995, JIS K 1603-2007, JIS It can be calculated by K ⁇ ⁇ 1556-2006, ISO 14896-2006, and methods based on these.
- n 1aA represents the number of end groups (Y1A) directly bonded to the nucleus (X), and n 1bA is bonded to the nucleus (X) via a linking group (Z).
- the sum of n 1aA and n 1bA is equal to the valence of the core part (X).
- n 1aA and n 1bA are integers of 0 or more, and the combination is not particularly limited as long as the sum is 3 or more. As an example of the combination, if n 1aA is 0, n 1bA is an integer of 3 or more. In this case, all end groups (Y1A) are bonded to the core X via a linking group (Z). Yes.
- n 1bA is 0, n 1aA is an integer of 3 or more.
- all the end groups (Y2A) are directly bonded to the nucleus part X.
- the explanation of the core (X) and the linking group (Z) is as described for the general formula (8A).
- the terminal group (Y1A) is a (meth) acryloyl group, a monovalent hydrocarbon group having 1 to 20 carbon atoms, or a hydrogen atom, and a plurality of Y1A may be the same or different. However, 3 or more of the terminal groups (Y1A) contained in the compound represented by the general formula (1A) are hydrogen atoms or (meth) acryloyl groups, and 1 or more are hydrogen atoms.
- the terminal group (Y1A) is preferably a (meth) acryloyl group or a hydrogen atom, and more preferably composed of only a hydrogen atom.
- Examples of the compound of the general formula (1A) include polyols represented by the following general formulas (6′a) to (6′h).
- n 6′g is an integer of 1 to 40, preferably 1 to 20, more preferably 1 to 10, and more preferably 1 to 5. More preferably.
- Another example of the compound of the general formula (1A) includes, for example, polyols represented by the following general formulas (6′i) to (6′k).
- N 6′ia , n 6′ja , and n 6′ka in the general formulas (6′i), (6′j), and (6′k) are polyols bonded to the core (X). In the present invention, it is an integer of 3 or more, preferably from 3 to 12, more preferably from 3 to 8, and even more preferably from 3 to 6.
- n 6′ib and n 6′jb represent the number of oxyethylene units and oxypropylene units, respectively, and range from 1 to 100.
- the number of repeating units for each arm may be the same or different.
- n 6′kb and n 6′kc represent the number of oxyethylene units and oxypropylene units, respectively, and the sum thereof is in the range of 1 to 100 and is 1 to 20. Preferably, the sum of the number of repeating units for each arm may be the same or different.
- X in the above general formulas (6′i), (6′j), and (6′k) is the nucleus (X), and examples thereof include those represented by the above general formulas (6a) to (6h). At least one group selected from the group consisting of
- polyols having repeating units such as oxyethylene units and oxypropylene units in the molecule are already widely used in the industry as materials such as polyurethane.
- the production method is not particularly limited, but it can be obtained by adding ethylene oxide, propylene oxide or the like to a polyol as represented by the general formulas (6'a) to (6'h) by a known method.
- R 3a represents a hydrogen atom or a methyl group
- R 3b represents a linear alkylene group having 2 to 6 carbon atoms, or a linear oxyalkylene group having 2 to 6 carbon atoms
- the straight chain alkylene group or the hydrogen atom contained in the straight chain oxyalkylene group may be substituted with an alkyl group having 1 to 6 carbon atoms or a (meth) acryloyloxymethylene group.
- (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) include at least one selected from the group consisting of compounds represented by the following general formulas (3a) to (3f). Can be mentioned.
- These (meth) acryloyl group-containing isocyanate compounds may be used alone or in combination of two or more.
- the polyfunctional monomer for dental material of the present invention is obtained by reacting the compound represented by the general formula (1A) with the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) as described above.
- the reaction can be carried out by a known method or a method according to the known method.
- the polyfunctional monomer for dental materials of the present invention can be obtained by mixing the compound represented by the general formula (1A) and the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3). it can. At this time, a hydroxyl group or an amino group in the compound represented by the general formula (1A) reacts with an isocyanate group in the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3), whereby a carbamoyl group is obtained. Or a urea group is formed. Such a reaction is sometimes called a urethanization reaction.
- a catalyst may or may not be added, but it is preferable to add a catalyst in order to improve the reaction rate.
- a catalyst a known catalyst that accelerates the urethanization reaction can be used.
- urethanization catalysts include organic tin compounds such as dibutyltin dilaurate, dibutyltin dioctate and tin octoate, copper naphthenate, cobalt naphthenate, zinc naphthenate, acetylacetonatozirconium, acetylacetonatoiron and acetylacetonato.
- organic tin compounds such as dibutyltin dilaurate, dibutyltin dioctate and tin octoate, copper naphthenate, cobalt naphthenate, zinc naphthenate, acetylacetonatozirconium, acetylacetonatoiron and acetylacetonato.
- organometallic compounds other than tin such as germanium, triethylamine, 1,4-diazabicyclo [2.2.2] octane, 2,6,7-trimethyl-1-diazabicyclo [2.2.2] octane, 1, 8-diazabicyclo [5.4.0] undecene, N, N-dimethylcyclohexylamine, pyridine, N-methylmorpholine, N, N, N ′, N′-tetramethylethylenediamine, N, N, N ′, N ′ -Tetramethyl-1,3-butanediamine, N, N, N ', Amine compounds such as '-pentamethyldiethylenetriamine, N, N, N', N'-tetra (3-dimethylaminopropyl) -methanediamine, N, N'-dimethylpiperazine and 1,2-dimethylimidazole and their salts And trialkylphosphine compounds such as tri-n
- the total weight of the compound represented by the general formula (1A) and the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) is 100 parts by weight. It is preferable to add 001 to 0.5 parts by weight, more preferably 0.002 to 0.3 parts by weight, still more preferably 0.01 to 0.3 parts by weight. It is more preferable to add 01 to 0.2 parts by weight, and it is more preferable to add 0.05 to 0.2 parts by weight.
- the addition amount is less than the above lower limit value, the effect of the catalyst may be reduced, and the reaction time may be remarkably increased. If the addition amount exceeds the above upper limit value, the catalyst effect becomes excessive and a large amount of reaction heat is generated, resulting in a temperature. Control can be difficult.
- the entire amount of the catalyst may be added at the start of the reaction, or may be added to the reaction system sequentially or divided as necessary. Such sequential or divided introduction of the catalyst suppresses the generation of a large amount of reaction heat at the initial stage of the reaction, so that the reaction temperature can be controlled more easily.
- the reaction temperature is not particularly limited, but is preferably 0 to 120 ° C., more preferably 20 to 100 ° C., and further preferably 40 to 80 ° C.
- the reaction rate When the reaction is carried out at a temperature lower than the lower limit, the reaction rate extremely decreases, so that a very long time is required until the reaction is completed, and in some cases, the reaction may not be completed.
- impurities may be generated due to side reactions. Such impurities may cause coloring of the manufactured polyfunctional monomer for dental materials.
- the reaction temperature is preferably controlled from the viewpoint of stable production in the above-mentioned preferable temperature range.
- the urethanization reaction is an exothermic reaction
- cooling may be performed when the exothermic amount is large and the temperature of the reaction product may rise beyond the preferable reaction temperature range.
- heating may be performed when the reaction is almost completed and the temperature of the reaction product may fall beyond the preferable reaction temperature range.
- the polyfunctional monomer for dental materials of the present invention has polymerization activity. Therefore, an unintended polymerization reaction may proceed during the production when exposed to a high temperature.
- a known polymerization inhibitor can be added before starting the reaction or during the reaction.
- the polymerization inhibitor is not particularly limited as long as unintentional polymerization of the (meth) acryloyl group can be suppressed when the polyfunctional monomer for dental material of the present invention is produced.
- BHT dibutylhydroxytoluene
- HQ hydroquinone
- MEHQ Hydroquinone monomethyl ether
- PTZ phenothiazine
- BHT is less consumed by reacting with isocyanate groups than other phenolic polymerization inhibitors and is less colored as seen with amine-based polymerization inhibitors.
- the amount of the polymerization inhibitor to be added is not particularly limited, but with respect to 100 parts by weight of the total weight of the compound represented by the general formula (1A) and the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3). 0.001 to 0.5 parts by weight is preferably added, 0.002 to 0.3 parts by weight is more preferably added, and 0.005 to 0.3 parts by weight is more preferably added.
- the addition amount is lower than the lower limit value, the ability may not be exhibited as a polymerization inhibitor, and if the addition amount exceeds the upper limit value, it is hardened when used as a dental material that is an application of a polyfunctional monomer for dental materials.
- the speed may be extremely slow, and practicality may be limited.
- a solvent may be used.
- the solvent has practically no reactivity with the compound represented by the general formula (1A) and the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3), does not inhibit the reaction, If it can dissolve a thing, it will not specifically limit. Moreover, you may react without using a solvent. Since the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) is usually a low-viscosity liquid, it can be mixed with the compound represented by the general formula (1A) without using a solvent. The reaction can be carried out.
- the method of mixing the compound represented by the general formula (1A) and the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) is not particularly limited.
- a method of adding and mixing the compound represented by the above general formula (1A) in the reaction vessel while controlling the amount of the (meth) acryloyl group-containing isocyanate compound represented by the above general formula (3) is not particularly limited.
- the urethanization reaction is carried out by raising the temperature after putting the total amount of the compound represented by the general formula (1A) and the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) into a reaction vessel.
- the method can also be adopted.
- the reaction temperature may increase suddenly due to the heat of reaction, so temperature control by cooling may be necessary as appropriate.
- Oxygen is effective as a polymerization inhibitor for compounds containing a (meth) acryloyl group. For this reason, oxygen may be introduced into the reactor during the reaction in order to prevent unintended polymerization of (meth) acryloyl groups.
- Oxygen can be introduced into the reactor in the form of, for example, dry air or oxygen gas, but is preferably introduced into the reactor in the form of dry air. Dry air can be obtained by, for example, drying by a known method including use of a condensing type air dryer and removing water.
- a mixed gas of an inert gas such as nitrogen and oxygen can be introduced into the reactor. The aspect of the mixed gas of an inert gas such as nitrogen and oxygen is also preferable as in the case of the dry air.
- a mixed gas of an inert gas such as nitrogen and oxygen can be obtained by mixing nitrogen in a predetermined ratio with the above-described dry air containing oxygen gas or oxygen.
- the nitrogen is preferably dried by a known method to remove water.
- the introduction method is not particularly limited, for example, it can be introduced in the form of bubbles continuously or intermittently from the bottom of the reaction vessel. Moreover, you may introduce
- the (meth) acryloyl group-containing isocyanate compound represented by the above general formula (3) may react with water to cause unintended impurities. Therefore, it is preferable that water is not present in the reaction system as much as possible when the urethanization reaction is performed.
- the amount of water contained in the compound represented by the general formula (1A) is as small as possible. Specifically, the amount of water is 0.5% relative to the compound represented by the general formula (1A). It is preferably no greater than wt%, more preferably no greater than 0.3 wt%, and even more preferably no greater than 0.1 wt%.
- the amount of water contained in the compound represented by the general formula (1A) exceeds the above value, it is preferably used as a raw material for the polyfunctional monomer for dental materials of the present invention after removing water by a known method. .
- the polyfunctional monomer for dental materials which is the first aspect of the present invention can be used as a monomer composition for dental materials by blending other components, for example, components other than the polyfunctional monomer suitable for dental materials.
- the monomer composition for dental material is, for example, a polymerizable monomer other than the polyfunctional monomer for dental material which is the first aspect of the present invention which can be blended in the dental material described later (for example, other than the polyfunctional monomer of the present invention). (Meth) acrylate group-containing monomer) may be contained.
- the content of the polyfunctional monomer for dental materials according to the first aspect of the present invention is 1.0 mass with respect to the whole monomer composition for dental materials.
- % Or more (10% by mass or more, 50% by mass or more, 80% by mass or more, 90% by mass or more, etc.) and 100% by mass or less (99% by mass or less, 90% by mass or less, 80% by mass or less, 50% by mass).
- the reverse mutation test (Ames test) means a test for examining the mutagenicity of a composition using a microorganism.
- the reverse mutation test in the present invention is performed by the following method.
- the following procedure is performed under a fluorescent lamp with an ultraviolet absorbing film and / or under an LED.
- DMSO dimethyl sulfoxide
- pH 7.4 0.1 M phosphate buffer
- top agar described later is added and mixed, and overlaid on a minimum glucose agar plate medium (more than 5 doses) described later.
- a minimum glucose agar plate medium more than 5 doses described later.
- the top and bottom of the minimal glucose agar plate is inverted and cultured at 37 ° C. for 48 hours. The plate after culture is judged as negative or positive.
- DMSO is used as a negative control substance, and 0.1 mL of medium is added instead of the test composition liquid in the above step.
- test composition is in all strains and all doses, and both in the case of non-metabolic activation and in the case of metabolic activation, compared to the case of only the negative target substance, A composition is judged negative when the average number of colonies is within 2 times.
- the test substance contained in the test composition liquid (specifically, the dental material polyfunctional monomer contained in the monomer composition for dental material) has a maximum dose of 5000 ⁇ g / plate, Prepare at least 5 doses divided by a common ratio of 2-4.
- Salmonella typhimurium TA100, TA1535, Escherichia coli WP2uvrA, or frameshift mutant Salmonella typhimurium TA98 or TA1537, which is a base pair substitution mutant, is used.
- Tesmedia AN medium manufactured by Oriental Yeast Co., Ltd., for mutagenicity test
- the minimum glucose agar plate per dose should be 2 or more for the negative control substance and 2 or more for the test composition.
- the case of metabolic activation means the case where S9mix (a rat liver microsome fraction added with a coenzyme) is added together with the test substance, and the case of no metabolic activation means the case where S9mix is not added.
- the composition of S9mix is as follows: S9 (supernatant part when the homogenate of the liver is centrifuged at 9000 ⁇ g): 0.1 mL, MgCl2: 8 ⁇ mol, KCl: 33 ⁇ mol, glucose-6-phosphate: 5 ⁇ mol NADPH: 4 ⁇ mol, NAPH: 4 ⁇ mol, sodium phosphate buffer (pH 7.4): 100 ⁇ mol.
- the top agar is prepared by sterilizing an amino acid solution (0.5 mmol / L L-histidine, 0.5 mmol / L D-biotin, 0.5 mmol / L L-tryptophan) while soft agar solution (0.6% ( W / v) Agar (Bacto-Agar, 0.5% (w / v) sodium chloride) was autoclaved at 121 ° C. for 20 minutes, and the amino acid solution and the dissolved soft agar solution were in a volume ratio of 1:10. Use a mixture of. Regarding the preparation of each bacterial suspension, those prepared with the bacterial cell concentration (1 ⁇ 10 9 bacteria / mL or more) are used for each bacterial cell.
- Nutrient broth culture solution is used for culturing each cell.
- Nutrient broth culture solution is Nutrient broth no. 2 (Oxoid, Nutrient Broth No. 2) is dissolved in purified water to 2.5 wt% and autoclaved at 121 ° C. for 20 minutes for preparation.
- the monomer composition for dental materials according to the first aspect of the present invention may have a relative cell viability within a certain range in a cytotoxicity test by the NRU method using Balb / 3T3 cells described later.
- the cytotoxicity test is performed by the following method.
- Balb / 3T3 cells (Balb / 3T3 clone A31 cells (mouse skin-derived fibroblasts)) seeded in a 96-well plate at 10,000 cells / well and pre-cultured for 25 hours, the medium in each well was removed, and the test composition was Add 0.1 mL of the test solution or negative control solution, and incubate in a CO 2 incubator for 24 hours. At this time, 12 wells are used for the negative control solution and 6 wells are used for the test solution. After culturing, each well is observed under a microscope, and after confirming cell growth, the culture solution in each well is removed and washed with 0.15 mL of PBS.
- NR culture solution After washing, 0.1 mL of NR culture solution is added and cultured for 3 hours in a CO 2 incubator for staining. After culturing, the culture solution in each well is removed and washed with 0.15 mL of PBS. Add 0.15 ml of NR redissolved solution to each well and shake for 10 minutes on a plate shaker. Neutral red (NR) is dissolved in the NR redissolved solution, the absorbance at 540 nm of the solution in each well after dissolution is measured, and the average value is obtained.
- NR Neutral red
- the absorbance of the solution in the well to which the negative control solution is added is 100
- the absorbance of the solution in the well to which the test solution is added relative to the absorbance is the test composition containing the test substance (including the polyfunctional monomer for dental materials)
- the relative cell viability (%) of the monomer composition for dental material is 100
- the test solution containing the test composition is prepared by first adding the test composition to DMSO and then diluting with DMSO to prepare a DMSO solution. Thereafter, 10 ⁇ L of the above-mentioned DMSO solution is added per 2 mL of D05 culture solution described below, and mixed by stirring to prepare a test solution. The test solution is adjusted so that the test substance contained in the test composition solution (specifically, the polyfunctional monomer for dental materials contained in the monomer composition for dental materials) has a predetermined concentration.
- the negative control solution is prepared by adding DMSO to 0.5 V / v% to the D05 culture solution.
- D05 culture medium refers to D-MEM (Dulbecco's Modified Eagle's Medium 9, Cat No. 048-30275) containing calf serum 5 vol%, 1 mmol / L sodium pyruvate and penicillin-streptomycin-amphotericin B suspension 1 vol%. , Glutamine 584 mg / L and HEPES 5.958 g / L).
- the D10 culture medium refers to D-MEM containing calf serum 10 vol%, penicillin-streptomycin-amphotericin B suspension 1 vol%, 100 mmol / L sodium pyruvate solution 1 vol%.
- the NR culture solution refers to a mixture obtained by mixing NR (neutral red) stock solution and D10 culture solution at 1:79, leaving at 37 ° C. overnight, and then removing NR crystals by filter filtration.
- the NR (neutral red) stock solution refers to a 0.4% (w / v) aqueous solution of neutral red (NR) (manufactured by Wako Pure Chemical Industries, Ltd.).
- the NR redissolved solution refers to a mixture of acetic acid, ethanol and water at 1:50:49. Prepare within 1 hour before use.
- the concentration of the test substance contained in the test composition in the test solution is, for example, 0.00164 mg / mL, 0.00410 mg / mL, 0.0102 mg / mL, 0.0256 mg / mL, 0.0640 mg / mL, It may be 0.160 mg / mL, 0.400 mg / mL, or 1.00 mg / mL.
- the concentration of the test substance contained in the test composition in the test solution is 0.00164 mg / mL, 0.00410 mg / mL, 0.0102 mg / mL, 0.0256 mg / mL, 0.0640 mg / mL, 0.160 mg / mL , 0.400 mg / mL or 1.00 mg / mL
- the relative cell viability by the NRU method using the BALB / 3T3 cells is 0.01% or more (0.05% or more, 0.1% or more 0.5% or more, 1.0% or more, 5.0% or more, 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more 90% or more, 95% or more, 99% or more, etc.) and 100% or less (99% or less, 95% or less, 90% or less, 80% or less, 70% or less, 60% or less, 50% or less) 40% or less, 30% Lower than 20%, 10% or less, 5.0% or less, 1.0% or less, 0.
- the relative cell growth rate may be within a certain range in the cell test by the WST method using Balb / 3T3 cells.
- the cell test is performed by the following method.
- Balb / 3T3 cells (Balb / 3T3 clone A31 cells (mouse skin-derived fibroblasts)) seeded in a 96-well plate at 2000 cells / well and pre-cultured for 24 hours, the culture solution in each well was removed, and the test composition Add 0.1 mL of the test solution or negative control solution, and incubate in a CO 2 incubator for 48 hours. At this time, 6 wells are used for the negative control solution and 3 wells are used for the test solution.
- the test solution or negative control solution is discarded, washed with PBS, 0.2 mL of DMEM culture solution containing 10% WST-8 reagent is added to each well, and a color reaction is performed in a CO 2 incubator for 2 hours. .
- the absorbance at 450 nm and 650 nm was measured with a microplate reader, and the value obtained by subtracting the 650 nm absorbance from the 450 nm absorbance of the liquid in each well was defined as the absorbance of each well, and the value was negative. If this is the case, the average absorbance is determined as 0.
- the test solution containing the test composition is prepared by first adding the test composition to DMSO and then diluting with DMSO to prepare a DMSO solution. Thereafter, 5 ⁇ L of DMSO diluted solution per 1 mL of DMEM culture solution is added to prepare a test solution. The test solution is adjusted so that the test substance contained in the test composition solution (specifically, the polyfunctional monomer for dental materials contained in the monomer composition for dental materials) has a predetermined concentration.
- the negative control solution is prepared by adding DMSO to 0.5 vol% with the DMEM culture solution.
- the DMEM culture medium refers to Dulbecco's Modified Eagle's Medium (D-MEM) containing 10 vol% calf serum and 1 vol% penicillin-streptomycin-amphotericin B suspension (x100).
- D-MEM Dulbecco's Modified Eagle's Medium
- x100 penicillin-streptomycin-amphotericin B suspension
- the concentration of the test substance contained in the test composition in the test solution is, for example, 0.00164 mg / mL, 0.00410 mg / mL, 0.0102 mg / mL, 0.0256 mg / mL, 0.0640 mg / mL, It may be 0.160 mg / mL, 0.400 mg / mL, or 1.00 mg / mL.
- the concentration of the test substance contained in the test composition in the test solution is 0.00164 mg / mL, 0.00410 mg / mL, 0.0102 mg / mL, 0.0256 mg / mL, 0.0640 mg / mL, 0.160 mg / mL , 0.400 mg / mL or 1.00 mg / mL
- the relative cell growth inhibition rate by the WST method using the BALB / 3T3 cells is 0.001% or more (0.01% or more, 0.05% Or more, 0.1% or more, 0.5% or more, 1.0% or more, 5.0% or more, 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 95% or more, 99% or more, etc.) and 100% or less (99% or less, 95% or less, 90% or less, 80% or less, 70% or less, 60% or less, 50% or less 40% or less, 30% or less, 20% or less, 10% or less,
- the polyfunctional monomer for dental materials which is the first aspect of the present invention is suitable as a raw material for dental materials.
- Components other than the polyfunctional monomer for dental materials of the present invention for example, polymerizable monomers other than the polyfunctional monomer for dental materials (other than the polyfunctional monomer of the present invention ( (Meth) acrylate group-containing monomer, epoxy group-containing monomer, etc.) can be blended to produce a dental material containing the polyfunctional monomer for dental material of the present invention.
- (Meth) acrylate group-containing monomer other than the polyfunctional monomer of the present invention As an example of components other than the polyfunctional monomer for dental materials which is the 1st aspect of this invention, (meth) acrylate group containing monomers other than the polyfunctional monomer of this invention can be mentioned.
- the (meth) acrylate group-containing monomer other than the polyfunctional monomer of the present invention includes one or more (meth) acrylate groups in the molecule.
- the number of polymerizable groups contained may be one, or two or more.
- the (meth) acrylate group-containing monomer other than the above-described polyfunctional monomer of the present invention may be composed of one compound or a mixture of two or more compounds.
- Examples of the (meth) acrylate group-containing monomer other than the polyfunctional monomer having only one polymerizable group include a monomer represented by the following general formula (21).
- R 21a represents hydrogen or a methyl group
- R 21b represents a monovalent organic group having 1 to 20 carbon atoms which may contain oxygen or nitrogen.
- Examples of the monovalent organic group include carbon atoms such as an acyclic hydrocarbon group having 1 to 20 carbon atoms such as an alkyl group, an alkenyl group, and an alkynyl group, a cycloalkyl group, a cycloalkenyl group, a cycloalkynyl group, and an aryl group.
- Hydrocarbon groups such as cyclic hydrocarbon groups of 1 to 20; oxygen is inserted between at least some carbon-carbon bonds of the above hydrocarbon groups such as alkoxyalkyl groups, alkoxyalkylene glycol groups, and tetrahydrofurfuryl groups.
- an oxygen-containing hydrocarbon group having 1 to 20 carbon atoms such as a group formed (provided that oxygen is not continuously inserted).
- the cyclic hydrocarbon group having 1 to 20 carbon atoms may have an acyclic hydrocarbon portion. Further, the acyclic hydrocarbon moiety contained in these groups may be either linear or branched.
- the hydrocarbon group having 1 to 20 carbon atoms or the oxygen-containing hydrocarbon group having 1 to 20 carbon atoms contains a linear alkylene moiety
- at least one methylene group is an ester bond, an amide
- the bond, carbonate bond, urethane bond (carbamoyl group), or urea bond may be substituted (however, the methylene group is not continuously replaced).
- a hydrogen atom contained in the organic group such as a hydrocarbon group having 1 to 20 carbon atoms or an oxygen-containing hydrocarbon group having 1 to 20 carbon atoms is an acid group such as a carboxyl group or a phosphate group, a hydroxyl group, or an amino group. , May be replaced with a functional group such as an epoxy group.
- Examples of the compound having a methacryloyl group represented by the general formula (21) include methyl methacrylate, ethyl methacrylate, propyl methacrylate, butyl methacrylate, hexyl methacrylate, cyclohexyl methacrylate, ethoxydiethylene glycol methacrylate, methoxytriethylene glycol methacrylate, and phenoxyethyl.
- Examples include methacrylate, 2-hydroxyethyl methacrylate, 2-hydroxypropyl methacrylate, 2-hydroxybutyl methacrylate, 2-hydroxy-3-phenoxypropyl methacrylate, 4-hydroxybutyl methacrylate, and 1,4-cyclohexanedimethanol monomethacrylate.
- Examples of the compound having an acryloyl group represented by the general formula (21) include methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate, hexyl acrylate, cyclohexyl acrylate, ethoxydiethylene glycol acrylate, methoxytriethylene glycol acrylate, and phenoxyethyl.
- Examples include acrylate, 2-hydroxyethyl acrylate, 2-hydroxypropyl acrylate, 2-hydroxybutyl acrylate, 2-hydroxy-3-phenoxypropyl acrylate, 4-hydroxybutyl acrylate, and 1,4-cyclohexanedimethanol monoacrylate.
- Examples of the (meth) acrylate group-containing monomer other than the polyfunctional monomer of the present invention having two or more polymerizable groups include monomers represented by the following general formula (22).
- R 22a and R 22b represent hydrogen or a methyl group, which may be the same or different, and R 22c may contain oxygen or nitrogen.
- a valent organic group In the general formula (22), R 22a and R 22b represent hydrogen or a methyl group, which may be the same or different, and R 22c may contain oxygen or nitrogen.
- a valent organic group In the general formula (22), R 22a and R 22b represent hydrogen or a methyl group, which may be the same or different, and R 22c may contain oxygen or nitrogen.
- a valent organic group may be used in the general formula (22).
- Examples of the divalent organic group include an acyclic hydrocarbon group having 1 to 40 carbon atoms such as an alkylene group, an alkenylene group and an alkynylene group, a cycloalkylene group, a cycloalkenylene group, a cycloalkynylene group and an arylene group.
- a hydrocarbon group such as a cyclic hydrocarbon group having 1 to 40 carbon atoms; a group in which oxygen is inserted between at least some carbon-carbon bonds of the hydrocarbon group such as an oxyalkylene group (provided that oxygen is continuous) Or an oxygen-containing hydrocarbon group having 1 to 40 carbon atoms.
- the cyclic hydrocarbon group having 1 to 40 carbon atoms may have an acyclic hydrocarbon portion. Further, the acyclic hydrocarbon moiety contained in these groups may be either linear or branched.
- the hydrocarbon group having 1 to 40 carbon atoms or the oxygen-containing hydrocarbon group having 1 to 40 carbon atoms contains a linear alkylene moiety
- at least one methylene group is an ester bond, an amide
- the bond, carbonate bond, urethane bond (carbamoyl group), or urea bond may be substituted (however, the methylene group is not continuously replaced).
- a hydrogen atom contained in the organic group such as a hydrocarbon group having 1 to 40 carbon atoms or an oxygen-containing hydrocarbon group having 1 to 40 carbon atoms is an acid group such as a carboxyl group or a phosphate group, a hydroxyl group, an amino group.
- a functional group such as an epoxy group, or a polymerizable group such as an acryloyl group or a methacryloyl group.
- an example of a suitable monomer is a monomer in which R 22c is a linear alkylene group having 2 to 20 carbon atoms, preferably 4 to 12 carbon atoms.
- Examples of the suitable monomer having a methacryloyl group include 1,4-butanediol dimethacrylate, 1,6-hexanediol dimethacrylate, 1,8-octanediol dimethacrylate, and 1,9-nonanediol. Examples include dimethacrylate and 1,10-decanediol dimethacrylate.
- Examples of the compound having an acryloyl group as the preferred monomer include 1,4-butanediol diacrylate, 1,6-hexanediol diacrylate, 1,8-octanediol diacrylate, and 1,9-nonanediol. Examples include diacrylate and 1,10-decanediol diacrylate.
- R 22C is a linear oxyalkylene group having 2 to 20 carbon atoms, preferably 4 to 12 carbon atoms. Monomer.
- Examples of the compound having a methacryloyl group as the above preferred monomer include ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, polyethylene glycol dimethacrylate, tripropylene glycol dimethacrylate, tetra Examples include propylene glycol dimethacrylate and polypropylene glycol dimethacrylate.
- Examples of the compound having an acryloyl group as the above preferred monomer include ethylene glycol diacrylate, diethylene glycol diacrylate, triethylene glycol diacrylate, tetraethylene glycol diacrylate, polyethylene glycol diacrylate, tripropylene glycol diacrylate, tetra Examples include propylene glycol diacrylate and polypropylene glycol diacrylate.
- Suitable monomers include monomers having a carbamoyl group represented by the following general formula (23).
- R 23a and R 23b are hydrogen or a methyl group, which may be the same or different, and R 23c and R 23d may contain oxygen and have 1 to 12 carbon atoms. These are divalent organic groups, and these may be the same or different.
- Examples of the divalent organic group include hydrocarbon groups such as an acyclic hydrocarbon group having 1 to 12 carbon atoms such as an alkylene group, a cyclic hydrocarbon group having 1 to 12 carbon atoms such as a cycloalkylene group and an arylene group.
- the cyclic hydrocarbon group having 1 to 12 carbon atoms may have an acyclic hydrocarbon portion. Further, the acyclic hydrocarbon moiety contained in these groups may be either linear or branched.
- a hydrogen atom contained in the organic group such as the hydrocarbon group having 1 to 12 carbon atoms or the oxygen-containing hydrocarbon group having 1 to 12 carbon atoms is an acid group such as a carboxyl group or a phosphate group, a hydroxyl group, an amino group.
- a functional group such as an epoxy group, or a polymerizable group such as an acryloyl group or a methacryloyl group.
- R 23e represents a divalent organic group having 1 to 20 carbon atoms which may contain oxygen.
- the divalent organic group include hydrocarbon groups such as an acyclic hydrocarbon group having 1 to 20 carbon atoms such as an alkylene group, a cyclic hydrocarbon group having 1 to 20 carbon atoms such as a cycloalkylene group and an arylene group.
- a group in which oxygen is inserted between at least some carbon-carbon bonds of the hydrocarbon group such as an oxyalkylene group (however, oxygen is not continuously inserted) 1 to Examples include 20 oxygen-containing hydrocarbon groups.
- the cyclic hydrocarbon group having 1 to 20 carbon atoms may have an acyclic hydrocarbon portion. Further, the acyclic hydrocarbon moiety contained in these groups may be either linear or branched.
- a hydrogen atom contained in the organic group such as the hydrocarbon group having 1 to 20 carbon atoms or the oxygen-containing hydrocarbon group having 1 to 20 carbon atoms is an acid group such as a carboxyl group or a phosphoric acid group, a hydroxyl group, or an amino group. , May be replaced with a functional group such as an epoxy group.
- Examples of the compound having an acryloyl group represented by the general formula (23) include 2-hydroxyethyl acrylate, 2-hydroxypropyl acrylate, 2-hydroxybutyl acrylate, 2-hydroxy-3-phenoxypropyl acrylate, 4-hydroxy Hydroxy acrylate such as butyl acrylate or 1,4-cyclohexanedimethanol monoacrylate and 2,4- or 2,6-toluene diisocyanate, 4,4'-, 2,4'- or 2,2'-diphenylmethane And urethane acrylate which is a reaction product with diisocyanate such as diisocyanate, 1,6-hexamethylene diisocyanate, 2,2,4- or 2,4,4-trimethyl-1,6-hexamethylene diisocyanate, and the like. Examples of such urethane acrylates, such as 2,2,4-trimethylhexamethylene bis (2-carbamoyloxy-ethyl) diacrylate.
- Another preferred example of the compound having a (meth) acryloyl group represented by the general formula (23) is at least one selected from the group consisting of compounds represented by the following general formulas (24a) to (24e) One can mention.
- Another example of the monomer represented by the general formula (22) is preferably a monomer represented by the following general formula (25).
- R 25a and R 25b represent hydrogen or a methyl group, which may be the same or different, and R 25c and R 25d may contain oxygen and have 1 to 12 carbon atoms.
- a divalent organic group which may be the same or different; Examples of the divalent organic group include hydrocarbon groups such as an acyclic hydrocarbon group having 1 to 12 carbon atoms such as an alkylene group, a cyclic hydrocarbon group having 1 to 12 carbon atoms such as a cycloalkylene group and an arylene group.
- a group in which oxygen is inserted between at least some carbon-carbon bonds of the hydrocarbon group such as an oxyalkylene group (however, oxygen is not continuously inserted) 1 to And 12 oxygen-containing hydrocarbon groups.
- the cyclic hydrocarbon group having 1 to 12 carbon atoms may have an acyclic hydrocarbon portion. Further, the acyclic hydrocarbon moiety contained in these groups may be either linear or branched.
- a hydrogen atom contained in the organic group such as the hydrocarbon group having 1 to 12 carbon atoms or the oxygen-containing hydrocarbon group having 1 to 12 carbon atoms is an acid group such as a carboxyl group or a phosphate group, a hydroxyl group, an amino group.
- a functional group such as an epoxy group, or a polymerizable group such as an acryloyl group or a methacryloyl group.
- R 25e represents a divalent organic group having 1 to 20 carbon atoms which may contain oxygen.
- the divalent organic group include a hydrocarbon group having 1 to 20 carbon atoms such as an alkylene group, a cycloalkylene group, and an arylene group; a carbon-carbon bond of at least a part of the hydrocarbon group such as an oxyalkylene group.
- an oxygen-containing hydrocarbon group having 1 to 20 carbon atoms such as a group in which oxygen is inserted (however, oxygen is not continuously inserted).
- the cyclic hydrocarbon group having 1 to 20 carbon atoms may have an acyclic hydrocarbon portion.
- a hydrogen atom contained in the organic group such as a hydrocarbon group having 1 to 20 carbon atoms or an oxygen-containing hydrocarbon group having 1 to 20 carbon atoms is an acid group such as a carboxyl group or a phosphate group, a hydroxyl group, or an amino group. , May be replaced with a functional group such as an epoxy group.
- Examples of the compound having a methacryloyl group represented by the general formula (25) include 2,2-bis [4- (3-methacryloyloxy-2-hydroxypropoxy) phenyl] propane (Bis-GMA), ethylene oxide modified Examples thereof include bisphenol A dimethacrylate and propylene oxide-modified bisphenol A dimethacrylate.
- Examples of the compound having an acryloyl group represented by the general formula (25) include 2,2-bis [4- (3-acryloyloxy-2-hydroxypropoxy) phenyl] propane, ethylene oxide-modified bisphenol A diacrylate, Examples include propylene oxide-modified bisphenol A diacrylate.
- the (meth) acrylate group-containing monomer other than the polyfunctional monomer of the present invention is used as an adhesive. It is preferable that the monomer which exhibits a function is contained.
- the (meth) acrylate group-containing monomer other than the polyfunctional monomer of the present invention that exhibits such an adhesion function include, for example, a monomer having at least one polymerizable group selected from a methacryloyl group and an acryloyl group and an acidic group. It is done.
- the acidic group include a phosphoric acid residue, a pyrophosphoric acid residue, a thiophosphoric acid residue, a carboxylic acid residue, and a sulfonic acid residue.
- Examples of the monomer having a methacryloyl group and a phosphate residue include 2-methacryloyloxyethyl dihydrogen phosphate, 9-methacryloyloxynonyl dihydrogen phosphate, 10-methacryloyloxydecyl dihydrogen phosphate, 11-methacryloyloxy.
- Undecyl dihydrogen phosphate 20-methacryloyloxyeicosyl dihydrogen phosphate, 1,3-dimethacryloyloxypropyl-2-dihydrogen phosphate, 2-methacryloyloxyethylphenyl phosphate, 2-methacryloyloxyethyl 2 ' -Bromoethyl phosphoric acid, methacryloyloxyethyl phenyl phosphonate, and acid chlorides thereof.
- Examples of the monomer having an acryloyl group and a phosphate residue include 2-acryloyloxyethyl dihydrogen phosphate, 9-acryloyloxynonyl dihydrogen phosphate, 10-acryloyloxydecyl dihydrogen phosphate, 11-acryloyloxy.
- Undecyl dihydrogen phosphate 20-acryloyloxyeicosyl dihydrogen phosphate, 1,3-diacryloyloxypropyl-2-dihydrogen phosphate, 2-acryloyloxyethylphenyl phosphate, 2-acryloyloxyethyl 2 ' -Bromoethyl phosphoric acid, acryloyloxyethyl phenyl phosphonate, and acid chlorides thereof.
- Examples of the monomer having a methacryloyl group and a pyrophosphate residue include di (2-methacryloyloxyethyl) pyrophosphate and acid chlorides thereof.
- Examples of the monomer having an acryloyl group and a pyrophosphate residue include di (2-acryloyloxyethyl) pyrophosphate and acid chlorides thereof.
- Examples of the monomer having a methacryloyl group and a thiophosphoric acid residue include 2-methacryloyloxyethyl dihydrogen dithiophosphate, 10-methacryloyloxydecyl dihydrogen thiophosphate, and acid chlorides thereof.
- Examples of the monomer having an acryloyl group and a thiophosphate residue include 2-acryloyloxyethyl dihydrogen dithiophosphate, 10-acryloyloxydecyl dihydrogen thiophosphate, and acid chlorides thereof.
- Examples of the monomer having a methacryloyl group and a carboxylic acid residue include, for example, 4-methacryloyloxyethoxycarbonylphthalic acid, 5-methacryloylaminopentylcarboxylic acid and 11-methacryloyloxy-1,1-undecanedicarboxylic acid, and acids thereof Examples include chloride or acid anhydride.
- Examples of the monomer having an acryloyl group and a carboxylic acid residue include 4-acryloyloxyethoxycarbonylphthalic acid, 5-acryloylaminopentylcarboxylic acid and 11-acryloyloxy-1,1-undecanedicarboxylic acid, and acids thereof. Examples include chloride or acid anhydride.
- Examples of the monomer having a methacryloyl group and a sulfonic acid residue include 2-sulfoethyl methacrylate and 2-methacrylamide-2-methylpropanesulfonic acid.
- Examples of the monomer having an acryloyl group and a sulfonic acid residue include 2-sulfoethyl acrylate and 2-acrylamido-2-methylpropanesulfonic acid.
- a polymerization initiator can be mentioned as another example of components other than the polyfunctional monomer for dental materials of the present invention contained in the dental material of the first aspect of the present invention.
- the polymerization initiator may be a general polymerization initiator used in the dental field, and is usually selected in consideration of the polymerizability of the polymerizable monomer and the polymerization conditions.
- a redox polymerization initiator in which an oxidizing agent and a reducing agent are combined is suitable.
- a redox polymerization initiator it is necessary to take a form in which an oxidizing agent and a reducing agent are separately packaged and to mix both of them immediately before use.
- oxidizing agent examples include, but are not limited to, organic peroxides such as diacyl peroxides, peroxyesters, dialkyl peroxides, peroxyketals, ketone peroxides, and hydroperoxides. Can do.
- organic peroxide examples include diacyl peroxides such as benzoyl peroxide, 2,4-dichlorobenzoyl peroxide and m-toluoyl peroxide; t-butylperoxybenzoate, bis-t-butylperoxy Peroxyesters such as isophthalate, 2,5-dimethyl-2,5-bis (benzoylperoxy) hexane, t-butylperoxy-2-ethylhexanoate and t-butylperoxyisopropylcarbonate; dicumyl Dialkyl peroxides such as peroxide, di-t-butyl peroxide and lauroyl peroxide; peroxyketals such as 1,1-bis (t-butylperoxy) -3,3,5-trimethylcyclohexane; methyl ethyl ketone Paoki Ketone peroxides such as id, etc. hydroperoxide such as t- butyl
- the reducing agent is not particularly limited, but usually a tertiary amine is used.
- Tertiary amines include, for example, N, N-dimethylaniline, N, N-dimethyl-p-toluidine, N, N-dimethyl-m-toluidine, N, N-diethyl-p-toluidine, N, N— Dimethyl-3,5-dimethylaniline, N, N-dimethyl-3,4-dimethylaniline, N, N-dimethyl-4-ethylaniline, N, N-dimethyl-4-i-propylaniline, N, N- Dimethyl-4-t-butylaniline, N, N-dimethyl-3,5-di-t-butylaniline, N, N-bis (2-hydroxyethyl) -p-toluidine, N, N-bis (2- Hydroxyethyl) -3,5-dimethylaniline, N, N-bis (2-hydroxyeth
- redox systems such as cumene hydroperoxide / thiourea system, ascorbic acid / Cu 2+ salt system, organic peroxide / amine / sulfinic acid (or its salt) system, etc.
- a polymerization initiator can be used.
- tributylborane, organic sulfinic acid and the like are also preferably used as the polymerization initiator.
- a peroxide or an azo compound In the case of performing thermal polymerization by heating, it is preferable to use a peroxide or an azo compound.
- the peroxide is not particularly limited, and examples thereof include benzoyl peroxide, t-butyl hydroperoxide, cumene hydroperoxide and the like.
- the azo compound is not particularly limited, and examples thereof include azobisisobutyronitrile.
- redox initiators such as ⁇ -diketone / tertiary amine, ⁇ -diketone / aldehyde, ⁇ -diketone / mercaptan are preferable.
- the photopolymerization initiator is not particularly limited, and examples thereof include ⁇ -diketone / reducing agent, ketal / reducing agent, and thioxanthone / reducing agent.
- examples of the ⁇ -diketone include camphorquinone, benzyl and 2,3-pentanedione.
- the ketal include benzyl dimethyl ketal and benzyl diethyl ketal.
- Examples of thioxanthone include 2-chlorothioxanthone and 2,4-diethylthioxanthone.
- Examples of the reducing agent include Mihira-ketone, 2- (dimethylamino) ethyl methacrylate, N, N-bis [(meth) acryloyloxyethyl] -N-methylamine, ethyl N, N-dimethylaminobenzoate, Butyl 4-dimethylaminobenzoate, butoxyethyl 4-dimethylaminobenzoate, N-methyldiethanolamine, 4-dimethylaminobenzophenone, N, N-bis (2-hydroxyethyl) -p-toluidine, dimethylaminophenanthol, etc.
- An ⁇ -diketone / organic peroxide / reducing agent system obtained by adding an organic peroxide to these redox systems is also preferably used.
- benzoin alkyl ether In the case of performing photopolymerization by ultraviolet irradiation, benzoin alkyl ether, benzyl dimethyl ketal and the like are suitable.
- a photopolymerization initiator of (bis) acylphosphine oxides is also preferably used.
- examples of the acylphosphine oxides include 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 2,6-dimethoxybenzoyldiphenylphosphine oxide, and 2,6-dichlorobenzoyldiphenyl.
- bisacylphosphine oxides include bis- (2,6-dichlorobenzoyl) phenylphosphine oxide, bis- (2,6-dichlorobenzoyl) -2,5-dimethylphenylphosphine oxide, bis- ( 2,6-dichlorobenzoyl) -4-propylphenylphosphine oxide, bis- (2,6-dichlorobenzoyl) -1-naphthylphosphine oxide, bis- (2,6-dimethoxybenzoyl) phenylphosphine oxide, bis -(2,6-dimethoxybenzoyl) -2,4,4-trimethylpentylphosphine oxide, bis- (2,6-dimethoxybenzoyl) -2,5-dimethylphenylphosphine oxide, bis- (2,4,4) 6-Trimethylbenzoyl) phenyl Such as scan fins oxide and (2,5,6-trimethylbenzo
- acylphosphine oxide photopolymerization initiators can be used alone or in combination with reducing agents such as various amines, aldehydes, mercaptans and sulfinates. These can be suitably used in combination with the visible light photopolymerization initiator.
- the polymerization initiator or the photopolymerization initiator can be used alone or in combination of two or more, and the blending amount is usually 0.01 to 20 parts by weight, preferably 100 parts by weight with respect to 100 parts by weight of the dental material. It is used in the range of 0.1 to 5 parts by weight.
- a filler can be mentioned as another example of components other than the polyfunctional monomer for dental materials of this invention contained in the dental material of the 1st aspect of this invention.
- filler a general filler used in the dental field can be used.
- Fillers are generally divided into organic fillers and inorganic fillers.
- the organic filler include polymethyl methacrylate, polyethyl methacrylate, methyl methacrylate-ethyl methacrylate copolymer, crosslinked polymethyl methacrylate, crosslinked polyethyl methacrylate, ethylene-vinyl acetate copolymer, and Examples thereof include fine powders such as styrene-butadiene copolymer.
- the inorganic filler examples include various glasses (mainly composed of silicon dioxide, containing oxides such as heavy metals, boron and aluminum as necessary), various ceramics, diatomaceous earth, kaolin, clay mineral (montmorillonite, etc.). And fine powders such as activated clay, synthetic zeolite, mica, calcium fluoride, ytterbium fluoride, calcium phosphate, barium sulfate, zirconium dioxide, titanium dioxide, and hydroxyapatite.
- these inorganic fillers those used as an X-ray contrast agent are preferable.
- inorganic fillers that can also be used as an X-ray contrast agent include, for example, barium borosilicate glass (such as Kimble Raysorb T3000, Shot 8235, Shot GM27884, and Shot GM39923), strontium boroaluminosilicate glass (Raysorb T4000, Shot G018-093 and shot GM32087), lanthanum glass (shot GM31684, etc.), fluoroaluminosilicate glass (shot G018-091 and shot G018-117, etc.), boroaluminosilicate glass containing zirconium and / or cesium (shot G018-307) , G018-308 and G018-310).
- barium borosilicate glass such as Kimble Raysorb T3000, Shot 8235, Shot GM27884, and Shot GM39923
- strontium boroaluminosilicate glass Raysorb T4000, Shot G018-093 and shot GM32087
- an organic-inorganic composite filler obtained by adding a polymerizable monomer to these inorganic fillers in advance to form a paste, polymerizing and curing, and pulverizing may be used.
- a dental material in which a micro filler having a particle size of 0.1 ⁇ m or less is blended is one of the preferred embodiments for a dental composite resin.
- silica for example, trade name Aerosil
- alumina for example, trade name Aerosil
- zirconia, titania and the like are preferable.
- the blending of such an inorganic filler having a small particle diameter is advantageous in obtaining polishing smoothness of the cured composite resin.
- These fillers may be subjected to surface treatment with a silane coupling agent or the like depending on the purpose.
- a silane coupling agent examples include known silane coupling agents such as ⁇ -methacryloxyalkyltrimethoxysilane (carbon number between methacryloxy group and silicon atom: 3 to 12), ⁇ -methacryloxyalkyltriethoxy.
- Organosilicon compounds such as silane (carbon number between methacryloxy group and silicon atom: 3 to 12), vinyltrimethoxysilane, vinylethoxysilane and vinyltriacetoxysilane are used.
- the concentration of the surface treatment agent is usually 0.1 to 20 parts by weight, preferably 1 to 10 parts by weight, based on 100 parts by weight of the filler.
- the blending amount of the filler may be appropriately determined in consideration of the operability (consistency) of the composite resin paste and the mechanical properties of the cured product, and is 100 parts by weight of all components other than the filler contained in the dental material. On the other hand, it is usually 10 to 2000 parts by weight, preferably 50 to 1000 parts by weight, more preferably 100 to 600 parts by weight.
- the dental material containing a monomer containing a (meth) acryloyl group, a polymerization initiator, and a filler as described above is sometimes called a composite resin.
- the dental material of the first aspect of the present invention is a polyfunctional monomer for dental material of the present invention described above, a polymerizable monomer other than the polyfunctional monomer of the present invention (for example, (meth) acrylate other than the polyfunctional monomer of the present invention).
- Components other than the group-containing monomer, the monomer having an epoxy group), the polymerization initiator, and the filler may be appropriately included depending on the purpose.
- the polymerization inhibitor already described above may be included to improve storage stability.
- pigments such as a well-known pigment and dye, can be included.
- a known reinforcing material such as fiber may be included.
- the blending amount of the polyfunctional monomer according to the first aspect of the present invention in the dental material is not particularly limited, but is, for example, in the range of 0.1 to 99%.
- the preferred blending amount may vary depending on the use for the dental material.
- a polymerizable monomer component a polymerizable monomer other than the above-mentioned polyfunctional monomer for the dental material of the present invention and the polyfunctional monomer of the present invention described above
- (meth) acrylate group-containing monomer other than the polyfunctional monomer of the present invention, monomer having an epoxy group is added in an amount of 1 to 50% by weight, more preferably 3 to 30% by weight.
- the blending amount of the polyfunctional monomer is 1 to 50 in the polymerizable monomer component. % By weight is preferable, and 3 to 30% by weight is more preferable.
- Applications of dental materials are dental adhesives (orthodontic adhesives, bonding materials, adhesive resin cements, filling adhesive composite resins, resin-added glass ionomer cements, etc.), dental primers, and dental fissure sealants.
- the blending amount of the polyfunctional monomer is preferably 1 to 50% by weight, more preferably 3 to 20% by weight in the polymerizable monomer component.
- the polyfunctional monomer dental material of the first aspect of the present invention may be negative in a reverse mutation test.
- the test method of the reverse mutation test (Ames test) is the same as the method of the reverse mutation test described above, wherein the dental material monomer composition according to the first aspect of the present invention is used as the polyfunctional monomer dental material according to the first aspect of the present invention. The same procedure is used instead.
- the dental material of the polyfunctional monomer according to the first aspect of the present invention may have a relative cell viability within a certain range in a cell test by the NRU method using Balb / 3T3 cells.
- the cell test is performed in the same procedure as in the above-described cell test by the NRU method, except that the dental material monomer composition of the first aspect of the present invention is replaced with the polyfunctional monomer dental material of the first aspect of the present invention. .
- the concentration of the test substance contained in the test material (polyfunctional monomer for dental material contained in the dental material) in the test solution and the relative cell growth rate (%) of the dental material are those of the first aspect of the present invention described above. It may be the same as in the case of the monomer composition for dental materials.
- the dental material of the polyfunctional monomer of the first aspect of the present invention may have a relative cell growth rate within a certain range in a cell test by the WST method using Balb / 3T3 cells.
- the cell test is performed in the same procedure as in the above-described cell test by the WST method, except that the dental material monomer composition of the first aspect of the present invention is replaced with the polyfunctional monomer dental material of the first aspect of the present invention. .
- the concentration of the test substance contained in the test material (polyfunctional monomer for dental material contained in the dental material) in the test solution and the relative cell growth rate (%) of the dental material are those of the first aspect of the present invention described above. It may be the same as in the case of the monomer composition for dental materials.
- a polyfunctional monomer for dental materials according to the first aspect of the present invention a polymerizable monomer other than the polyfunctional monomer (for example, a (meth) acrylate group-containing monomer other than the polyfunctional monomer of the present invention), an epoxy group Monomer), a polymerization initiator, a filler, other components and the like, and the method for producing the dental material of the first aspect of the present invention is not particularly limited as long as it is a known method.
- the dental material according to the first aspect of the present invention can be cured under appropriate conditions in accordance with the polymerization method of the polymerization initiator described above.
- the dental material according to the first aspect of the present invention containing a photopolymerization initiator by visible light irradiation the dental material is processed into a predetermined shape, and then a predetermined light irradiation device is used. By irradiating with visible light for a time, a desired cured product can be obtained. Conditions such as irradiation intensity and irradiation intensity can be appropriately changed according to the curability of the dental material.
- the mechanical properties of the cured product can be improved by further heat-treating the cured product that has been cured by light irradiation, such as visible light, under appropriate conditions.
- the dental material according to the first aspect of the present invention containing a polymerization initiator by heating the dental material is processed into a predetermined shape and then heated at an appropriate temperature and time.
- a desired cured product can be obtained.
- the cured material of the dental material according to the first aspect of the present invention obtained as described above may be used for dental treatment.
- the method for using the dental material according to the first aspect of the present invention is not particularly limited as long as it is generally known as a method for using the dental material.
- the dental material according to the first aspect of the present invention is used as a composite resin for filling a carious cavity, the dental material is filled in the cavity and then photocured using a known light irradiation device. Can achieve the purpose.
- the dental material according to the first aspect of the present invention is used as a composite resin for filling a carious cavity, the dental material is filled in the cavity and then photocured using a known light irradiation device. Can achieve the purpose.
- a composite resin for crown restoration after processing into an appropriate shape, it is photocured using a known light irradiation device, and further, if necessary, heat treatment is performed under predetermined conditions. Can be obtained.
- the dental material of the first aspect of the present invention can be suitably used for dental treatment applications, such as a filling composite resin, a hard crown resin, a denture base resin, a denture base lining material, an impression material, Dental adhesives (orthodontic adhesives, bonding materials (which are more commonly described), adhesive resin cements, adhesive composite resins for filling, and resin-added glass ionomer cements), dental primers, tooth fissures Examples thereof include a sealing material, a CAD / CAM resin block, a temporary crown, and an artificial tooth material.
- the kit according to the first aspect of the present invention includes the dental material according to the first aspect.
- the kit of the first aspect of the present invention is a kit in which each component of the dental material is filled as one agent, the polymerization form, storage stability, etc. are taken into consideration, and each component of the dental material is divided into two or more agents. Examples include a kit composed of a plurality of filled agents. Such a kit may contain other dental materials to be used simultaneously than the dental material of the first aspect of the present invention.
- the hydroxyl group-containing monomer for dental materials has the following general formula (8B) in which the following core (X) and the following end group (Y2B) are bonded directly or through the following linking group (Z). It is a compound shown by these.
- n 8aB represents the number of terminal groups (Y2B) directly bonded to the nucleus (X), and n 8bB represents a linking group (Z) to the nucleus (X). through the number of bonds to that terminal group (Y2B), the sum of n 8Ab and n 8Bb is equal to the valence of core portion (X).
- n 8aB and n 8bB are integers of 0 or more, and the combination is not particularly limited as long as the sum is 3 or more.
- n 8aB is 0, n 8bB is an integer of 3 or more. In this case, all end groups (Y2B) are bonded to the core X via a linking group (Z). Yes.
- n 8bB is 0, n 8aB is an integer of 3 or more. In this case, all end groups (Y2B) are directly bonded to the core part X.
- the nucleus (X) is a trivalent or higher polyvalent organic group containing an oxygen atom or a nitrogen atom, and an atom bonded to the terminal group (Y2B) or the linking group (Z) being an oxygen atom or a nitrogen atom. .
- the oxygen atom or nitrogen atom bonded to the terminal group (Y2B) or the linking group (Z) is a group other than the terminal group (Y2B) or the linking group (Z) other than a methylene group or a divalent aromatic carbon group.
- Any hydrogen atom contained in the methylene group or divalent aromatic carbon group may be replaced with a monovalent hydrocarbon group having 1 to 12 carbon atoms.
- the number of carbon atoms in the core part (X) is usually in the range of 1 to 200, preferably 1 to 100, more preferably 1 to 30, and further preferably 2 to 20.
- the valence of the core part (X) is 3 or more as described above, but it is preferably 3 to 12 valence, more preferably 3 to 8 valence.
- the atom bonded to the terminal group (Y2B) or the linking group (Z) is selected from an oxygen atom or a nitrogen atom as described above, and is preferably an oxygen atom.
- Examples of the core (X) include groups represented by the above general formulas (6a) to (6j) exemplified as the core (X) of the polyfunctional monomer for dental materials.
- the terminal group (Y2B) is a (meth) acryloyl group-containing group (Y3) represented by the above general formula (9) described as the (meth) acryloyl group-containing group (Y3) contained in the polyfunctional monomer for dental materials.
- a (meth) acryloyl group or a hydrocarbon group having 1 to 20 carbon atoms, and a plurality of terminal groups (Y2B) may be the same or different, provided that all of the compounds represented by formula (8B) Of the end groups (Y2B), one or more are (meth) acryloyl group-containing groups (Y3) and one or more are hydrogen atoms.
- the (meth) acryloyl group-containing group (Y3) represented by the general formula (9) is exemplified as a specific example of the (meth) acryloyl group-containing group (Y3) contained in the polyfunctional monomer for dental materials. And groups represented by the above general formulas (9a) to (9f).
- the terminal group (Y2B) is a (meth) acryloyl group-containing group (Y3), a (meth) acryloyl group, a hydrocarbon group having 1 to 20 carbon atoms, or a hydrogen atom represented by the general formula (9). However, it is preferably a (meth) acryloyl group-containing group (Y3) or a hydrogen atom.
- linking group (Z) is the same as the divalent group represented by the general formula (2) described as the linking group (Z) contained in the polyfunctional monomer for dental materials, and is represented by the above general formula (8B).
- the linking groups (Z) may be the same or different.
- n 2a , n 2b , n 2c and n 2d in the general formula (2) are the same as in the case of the polyfunctional monomer for dental materials.
- the left end of the group represented by the general formula (2) is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y2B).
- the linking group (Z) is preferably a divalent group represented by the above general formula (4) described as a suitable example of the linking group (Z) contained in the polyfunctional monomer for dental materials.
- the linking groups (Z) may be the same or different.
- n 4a , n 4b and n 4c in the general formula (4) are the same as in the case of the polyfunctional monomer for dental materials.
- the left end of the group represented by the general formula (2) is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y2B).
- the description about each repeating unit in the said General formula (4) is the same as the description of each repeating unit in the said General formula (2).
- the linking group (Z) is more preferably a divalent group represented by the general formula (5) described as a suitable example of the linking group (Z) contained in the polyfunctional monomer for dental materials.
- the linking groups (Z) may be the same or different.
- n 5a and n 5b in the general formula (5) are the same as in the case of the polyfunctional monomer for dental materials.
- the left end of the group represented by the general formula (2) is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y2B).
- the description about each repeating unit in the said General formula (5) is the same as the description of each repeating unit in the said General formula (2).
- linking group (Z) as, in those repeating units are composed only of oxyethylene units (formula (5), n 5b is 0, n 5a is 1-100 , Preferably 1 to 20), or composed only of oxypropylene units (in formula (5), n 5a is 0, n 5b is 1 to 100, preferably 1 to 20) ,
- a polymer block composed of oxypropylene units-a polymer block composed of oxyethylene units-a polymer block composed of oxypropylene units in the general formula (5), the following structure (5 ') And the like having a structure connected with a).
- n 5a1 , n 5a2 and n 5b represent the number of units of each repeating unit, and are each 1 to 100, preferably 1 to 20.
- the sum of n 5a1 , n 5a2 and n 5b is 1 to 100, preferably 1 to 20.
- the left end of the group is bonded to the core (X), the right end of the group is bonded to the end group (Y2B), and the oxypropylene polymer block and the oxyethylene polymer block in parentheses are bonded in this order. is doing.
- the description about each repeating unit in the said General formula (5 ') is the same as the description of each repeating unit in the said General formula (2).
- the polyfunctional monomer for dental materials of the present invention has, for example, the following general formula (1B) in which the following core (X) and the following end group (Y1B) are bonded directly or through the following linking group (Z). It is obtained by reacting at least one of active protons in the indicated compound with an isocyanate group in the (meth) acryloyl group-containing isocyanate compound represented by the following general formula (3) to produce a corresponding carbamate group or urea group. It is done. However, at least one of the active protons remains unreacted.
- an active proton refers to a hydrogen atom that binds to alcoholic oxygen and amine nitrogen and has reactivity at a practical rate with isocyanate.
- the production conditions of the polyfunctional monomer for dental materials of the present invention are, for example, the following general formula (the following general formula (X) and the following end group (Y1B) are bonded directly or through the following linking group (Z) ( 1B) and a raw material containing a (meth) acryloyl group-containing isocyanate compound represented by the following general formula (3) (an isocyanate group contained in a compound represented by the following general formula (3)
- the number of active protons bonded to oxygen and nitrogen atoms contained in the compound represented by the following general formula (1B) (hereinafter referred to as the reaction ratio during production) ⁇ 1 is there.
- the reaction ratio at the time of production was (1 / (number of active protons bonded to oxygen atom and nitrogen atom contained in the compound represented by the following general formula (1B) (compound '(1B) in one molecule) It is preferable that the number of active protons in the compound represented by the following general formula (1B) remains in the reaction product in terms of the stoichiometric ratio. It becomes.
- the number of moles of active protons in the raw material containing the compound represented by the following general formula (1B) is determined by a known analysis method, for example, measurement of hydroxyl value, specifically, JIS K-0070-1992, JIS K K1557-17-1. , ISO 14900-2001, and methods based on these can be calculated.
- the number of moles of isocyanate groups contained in the compound represented by the following general formula (3) is determined by a known analysis method, for example, NCO value measurement, specifically JIS K-7301-1995, JIS K 1603-2007, JIS It can be calculated by K ⁇ ⁇ 1556-2006, ISO 14896-2006, and methods based on these.
- n 1aB represents the number of end groups (Y1B) which is directly bonded to the core portion (X), n 1bb via a linking group (Z) in the core portion (X) bond
- the sum of n 1aB and n 1bB is equal to the valence of the core part (X).
- n 1aB and n 1bB are integers of 0 or more, and the combination is not particularly limited as long as the sum is 3 or more. As an example of the combination, if n 1aB is 0, n 1bB is an integer of 3 or more. In this case, all end groups (Y1B) are bonded to the core X via a linking group (Z). Yes.
- n 1bB is 0, n 1aB is an integer of 3 or more.
- all end groups (Y2B) are directly bonded to the nucleus X.
- the explanation of the core (X) and the linking group (Z) is as described for the general formula (8B).
- the terminal group (Y1B) is a (meth) acryloyl group, a monovalent hydrocarbon group having 1 to 20 carbon atoms, or a hydrogen atom, and a plurality of Y1Bs may be the same or different. However, two or more of the terminal groups (Y1B) contained in the compound represented by the general formula (1B) are hydrogen atoms.
- the terminal group (Y1B) is preferably a (meth) acryloyl group or a hydrogen atom, and more preferably only a hydrogen atom.
- Examples of the compound of the general formula (1B) include, for example, the general formulas (6′a) to (6) described above as specific examples of the compound of the general formula (1A) used for the production of the polyfunctional monomer for dental materials.
- the polyhydric alcohol shown by 6'h) is mentioned.
- n 6'G in the general formula (6'g) is the same as in the compound of the general formula (1A).
- the above general formula (1) exemplified as a specific example of the compound of the general formula (1A) used for the production of the polyfunctional monomer for dental materials is used.
- examples thereof include polyols represented by 6′i) to (6′k).
- n 6′ia , n 6′ja , and n 6′ka in general formulas (6′i), (6′j), and (6′k) general formula (6′i) and definitions and preferred aspects of the n 6'Ib and n 6'Jb in (6'j), defined and preferred aspects of the n 6'Kb and n 6'Kc in the general formula (6'k), the general formula
- X in (6′i), (6′j), and (6′k) are the same as in the case of the compound of the general formula (1A) used for the production of the polyfunctional monomer for dental materials. is there.
- polyols having repeating units such as oxyethylene units and oxypropylene units in the molecule are already widely used in the industry as materials such as polyurethane.
- the production method is not particularly limited, but it can be obtained by adding ethylene oxide, propylene oxide or the like to a polyol as represented by the general formulas (6'a) to (6'h) by a known method.
- R 3a represents a hydrogen atom or a methyl group
- R 3b represents a linear alkylene group having 2 to 6 carbon atoms, or a linear oxyalkylene group having 2 to 6 carbon atoms
- the straight chain alkylene group or the hydrogen atom contained in the straight chain oxyalkylene group may be substituted with an alkyl group having 1 to 6 carbon atoms or a (meth) acryloyloxymethylene group.
- (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) As a specific example of the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3), as a suitable example of the compound represented by the general formula (3) used for the production of a polyfunctional monomer for dental materials. Mention may be made of at least one selected from the group consisting of the compounds represented by the general formulas (3a) to (3f) described above.
- These (meth) acryloyl group-containing isocyanate compounds may be used alone or in combination of two or more.
- the hydroxyl group-containing monomer for dental materials of the present invention is obtained by reacting the compound represented by the general formula (1B) with the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) as described above.
- the reaction can be carried out by a known method or a method according to the known method.
- the hydroxyl group-containing monomer for dental materials of the present invention can be obtained by mixing the compound represented by the general formula (1B) with the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3). it can. At this time, a hydroxyl group or an amino group in the compound represented by the general formula (1B) reacts with an isocyanate group in the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3), whereby a carbamoyl group is obtained. Or a urea group is formed. Such a reaction is sometimes called a urethanization reaction.
- a catalyst may or may not be added, but it is preferable to add a catalyst in order to improve the reaction rate.
- a catalyst a known catalyst that accelerates the urethanization reaction can be used.
- the specific example of the urethanization catalyst is the same as that for producing a polyfunctional monomer for dental materials.
- dibutyltin dilaurate and tin octoate are preferable because the reaction proceeds in a small amount and the selectivity to the diisocyanate compound is high.
- the total weight of the compound represented by the general formula (1B) and the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) is 100 parts by weight. It is preferable to add 001 to 0.5 parts by weight, more preferably 0.002 to 0.3 parts by weight, still more preferably 0.01 to 0.3 parts by weight. It is more preferable to add 01 to 0.2 parts by weight, and it is more preferable to add 0.05 to 0.2 parts by weight.
- the addition amount is less than the above lower limit value, the effect of the catalyst may be reduced, and the reaction time may be remarkably increased. If the addition amount exceeds the above upper limit value, the catalyst effect becomes excessive and a large amount of reaction heat is generated, resulting in a temperature. Control can be difficult.
- the entire amount of the catalyst may be added at the start of the reaction, or may be added to the reaction system sequentially or divided as necessary. Such sequential or divided introduction of the catalyst suppresses the generation of a large amount of reaction heat at the initial stage of the reaction, so that the reaction temperature can be controlled more easily.
- the reaction temperature is not particularly limited, but is preferably 0 to 120 ° C., more preferably 20 to 100 ° C., and further preferably 40 to 80 ° C.
- the reaction rate When the reaction is carried out at a temperature lower than the lower limit, the reaction rate extremely decreases, so that a very long time is required until the reaction is completed, and in some cases, the reaction may not be completed.
- impurities may be generated due to side reactions. Such impurities may cause coloring of the manufactured hydroxyl-containing monomer for dental materials.
- the reaction temperature is preferably controlled from the viewpoint of stable production in the above-mentioned preferable temperature range.
- the urethanization reaction is an exothermic reaction
- cooling may be performed when the exothermic amount is large and the temperature of the reaction product may rise beyond the preferable reaction temperature range.
- heating may be performed when the reaction is almost completed and the temperature of the reaction product may fall beyond the preferable reaction temperature range.
- the hydroxyl group-containing monomer for dental material of the present invention has polymerization activity. Therefore, an unintended polymerization reaction may proceed during the production when exposed to a high temperature.
- a known polymerization inhibitor can be added before starting the reaction or during the reaction.
- the polymerization inhibitor is not particularly limited as long as unintentional polymerization of the (meth) acryloyl group can be suppressed when producing the hydroxyl group-containing monomer for dental materials of the present invention.
- Specific examples and preferred examples thereof are polyfunctional monomers for dental materials. It is the same as the case of manufacturing.
- the amount of the polymerization inhibitor to be added is not particularly limited, but with respect to 100 parts by weight of the total weight of the compound represented by the general formula (1B) and the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3).
- 0.001 to 0.5 parts by weight is preferably added, 0.002 to 0.3 parts by weight is more preferably added, and 0.005 to 0.3 parts by weight is more preferably added. It is more preferable to add 0.005 to 0.1 parts by weight, and it is more preferable to add 0.01 to 0.1 parts by weight.
- the addition amount is lower than the lower limit value, the ability may not be exhibited as a polymerization inhibitor, and if the addition amount exceeds the upper limit value, it is cured when used as a dental material which is a use of a hydroxyl group-containing monomer for dental materials.
- the speed may be extremely slow, and practicality may be limited.
- a solvent may be used.
- the solvent has practically no reactivity with the compound represented by the general formula (1B) and the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3), does not inhibit the reaction, If it can dissolve a thing, it will not specifically limit. Moreover, you may react without using a solvent. Since the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) is usually a low-viscosity liquid, it can be mixed with the compound represented by the general formula (1B) without using a solvent. The reaction can be carried out.
- the method of mixing the compound represented by the general formula (1B) and the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) is not particularly limited.
- a method of adding and mixing the compound represented by the above general formula (1B) in the reaction vessel while controlling the amount of the (meth) acryloyl group-containing isocyanate compound represented by the above general formula (3) is not particularly limited.
- a method of adding and mixing the controlled addition amount of the compound represented by the general formula (1B) to the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) in the reaction vessel A method in which a compound represented by the above general formula (1B) and a (meth) acryloyl group-containing isocyanate compound represented by the above general formula (3) are simultaneously added to the reaction vessel while controlling the input amount and mixed. There is. According to such a mixing method, the amount of heat generated by the urethanization reaction can be controlled within an appropriate range, so that temperature control during the reaction is facilitated.
- the urethanization reaction is carried out by raising the temperature after putting the total amount of the compound represented by the general formula (1B) and the (meth) acryloyl group-containing isocyanate compound represented by the general formula (3) into a reaction vessel.
- the method can also be adopted.
- the reaction temperature may increase suddenly due to the heat of reaction, so temperature control by cooling may be necessary as appropriate.
- Oxygen is effective as a polymerization inhibitor for compounds containing a (meth) acryloyl group. For this reason, oxygen may be introduced into the reactor during the reaction in order to prevent unintended polymerization of (meth) acryloyl groups.
- oxygen introduction transduction, and a suitable aspect, it is the same as that of the case of manufacturing the polyfunctional monomer for dental materials.
- the (meth) acryloyl group-containing isocyanate compound represented by the above general formula (3) may react with water to cause unintended impurities. Therefore, it is preferable that water is not present in the reaction system as much as possible when the urethanization reaction is performed.
- the amount of water contained in the compound represented by the general formula (1B) is as small as possible. Specifically, the amount of water is 0.5% relative to the compound represented by the general formula (1B). It is preferably no greater than wt%, more preferably no greater than 0.3 wt%, and even more preferably no greater than 0.1 wt%.
- the amount of water contained in the compound represented by the general formula (1B) exceeds the above value, it is preferably used as a raw material for the hydroxyl group-containing monomer for dental materials of the present invention after removing water by a known method. .
- the hydroxyl group-containing monomer for dental materials according to the second aspect of the present invention can be used as a monomer composition for dental materials by blending other components, for example, components other than polyfunctional monomers suitable for dental materials.
- This monomer composition for dental material is a polymerizable monomer other than the hydroxyl group-containing monomer for dental material of the second aspect of the present invention that can be blended in the dental material described later (for example, (meth) other than the hydroxyl group-containing monomer of the present invention).
- the content of the hydroxyl group-containing monomer for a dental material according to the second aspect of the present invention is 1.0 mass with respect to the whole monomer composition for a dental material.
- % Or more (10% by mass or more, 50% by mass or more, 80% by mass or more, 90% by mass or more, etc.) and 100% by mass or less (99% by mass or less, 90% by mass or less, 80% by mass or less, 50% by mass).
- the dental material monomer composition according to the second aspect of the present invention is desirably negative in a reverse mutation test.
- the test method of the reverse mutation test (Ames test) is the same as the above-described method for the reverse mutation test of the monomer composition for dental material of the first aspect of the present invention, and the monomer composition for dental material of the first aspect of the present invention. Is replaced with the monomer composition for dental materials of the second aspect of the present invention, and the same procedure is followed.
- the relative cell viability may be within a certain range in a cell test by the NRU method using Balb / 3T3 cells.
- the cell test is carried out in the same procedure as in the cell test by the NRU method described above, except that the monomer composition for dental material of the first aspect of the present invention is replaced with the monomer composition for dental material of the second aspect of the present invention. .
- the dental material of the polyfunctional monomer of the first aspect of the present invention may have a relative cell growth rate within a certain range in a cell test by the WST method using Balb / 3T3 cells.
- the cell test is carried out in the same procedure as in the cell test by the WST method described above, except that the monomer composition for dental material of the first aspect of the present invention is replaced with the monomer composition for dental material of the second aspect of the present invention. .
- the hydroxyl group-containing monomer for dental materials according to the second aspect of the present invention is suitable as a raw material for dental materials.
- Components other than the hydroxyl group-containing monomer for dental material of the present invention for example, polymerizable monomers other than the hydroxyl group-containing monomer for dental material of the present invention (hydroxyl group-containing monomer of the present invention) (Meth) acrylate group-containing monomer other than the above, a monomer containing an epoxy group, and the like) can be used to produce a dental material containing the hydroxyl group-containing monomer for dental materials of the present invention.
- Examples of components other than the hydroxyl group-containing monomer for dental materials of the present invention include (meth) acrylate group-containing monomers other than the hydroxyl group-containing monomer of the present invention.
- the (meth) acrylate group-containing monomer other than the hydroxyl group-containing monomer of the present invention includes one or more (meth) acrylate groups in the molecule.
- the number of polymerizable groups contained may be one, or two or more.
- the (meth) acrylate group-containing monomer other than the hydroxyl group-containing monomer of the present invention may be composed of one kind of compound or a mixture of two or more kinds of compounds.
- Examples of the (meth) acrylate group-containing monomer other than the above-mentioned hydroxyl group-containing monomer having only one polymerizable group include, for example, the general formula (21) exemplified as the monomer that can be used together with the polyfunctional monomer for dental materials. Monomer. (However, among the monomers represented by the general formula (21), the monomer corresponding to the hydroxyl group-containing monomer for dental materials of the present invention is excluded).
- Specific examples of the monovalent organic group that can be R 21b of the general formula (21) are the same as those of the monomer represented by the general formula (21) that can be used together with the polyfunctional monomer for dental materials.
- Specific examples of the compound having a methacryloyl group represented by the general formula (21) are the same as those of the monomer represented by the general formula (21) that can be used together with the polyfunctional monomer for dental materials.
- Specific examples of the compound having an acryloyl group represented by the general formula (21) are the same as those of the monomer represented by the general formula (21) that can be used together with the polyfunctional monomer for dental materials.
- Examples of the (meth) acrylate group-containing monomer other than the above-mentioned hydroxyl group-containing monomer of the present invention having two or more polymerizable groups include, for example, other than the polyfunctional monomer for dental materials that can be used together with the polyfunctional monomer for dental materials (meta )
- Examples of the monomer represented by the above general formula (22) exemplified as the acrylate group-containing monomer (however, among the monomers represented by the general formula (22), a monomer corresponding to the hydroxyl group-containing monomer for dental materials of the present invention) Is excluded.)
- divalent organic group that can be R 22c of the general formula (22) are the same as those of the monomer represented by the general formula (22) used together with the polyfunctional monomer for dental materials.
- an example of a suitable monomer is a monomer in which R 22c is a linear alkylene group having 2 to 20 carbon atoms, preferably 4 to 12 carbon atoms.
- R 22C is a linear oxyalkylene group having 2 to 20 carbon atoms, preferably 4 to 12 carbon atoms. Monomer.
- the carbamoyl group represented by the general formula (23) exemplified as the monomer that can be used together with the polyfunctional monomer for dental materials is used.
- divalent organic group that can be R 23c and R 23d in the general formula (23) are the same as those of the monomer represented by the general formula (23) that can be used together with the polyfunctional monomer for dental materials.
- divalent organic group having 1 to 20 carbon atoms which may contain oxygen which can be R 23e in the general formula (23) are shown in the general formula (23) which can be used together with the polyfunctional monomer for dental materials. The same as in the case of the monomer to be prepared.
- Specific examples of the compound having an acryloyl group represented by the general formula (23) are the same as those of the monomer represented by the general formula (23) that can be used together with the polyfunctional monomer for dental materials.
- the compounds exemplified as another preferred example of the compound having a (meth) acryloyl group represented by the general formula (23) are the general formulas (24a) to (24e) that can be used together with the polyfunctional monomer for dental materials. Or at least one selected from the group consisting of compounds represented by:
- the compound illustrated as another example of the preferable monomer represented by the general formula (22) includes a monomer represented by the general formula (25) that can be used together with the polyfunctional monomer for dental materials.
- divalent organic group having 1 to 20 carbon atoms that may contain oxygen that can be R 25e in the above general formula (25) are the general formula (25) that can be used together with the polyfunctional monomer for dental materials. Similar to the case of the monomers shown.
- Specific examples of the compound having a methacryloyl group represented by the general formula (25) are the same as those of the monomer represented by the general formula (25) that can be used together with the polyfunctional monomer for dental materials.
- Specific examples of the compound having an acryloyl group represented by the general formula (25) are the same as those of the monomer represented by the general formula (25) that can be used together with the polyfunctional monomer for dental materials.
- the dental material containing the hydroxyl-containing monomer for dental materials of this invention for the use of a dental adhesive, as (meth) acrylate group containing monomers other than the said hydroxyl-containing monomer of this invention, adhesive of It is preferable that the monomer which exhibits a function is contained.
- the (meth) acrylate group-containing monomer other than the hydroxyl group-containing monomer of the present invention that exhibits such an adhesion function include, for example, a monomer having at least one polymerizable group selected from a methacryloyl group and an acryloyl group and an acidic group. It is done.
- the acidic group include a phosphoric acid residue, a pyrophosphoric acid residue, a thiophosphoric acid residue, a carboxylic acid residue, and a sulfonic acid residue.
- Specific examples of the monomer having a methacryloyl group and a phosphoric acid residue are the same as the specific examples of the monomer having a methacryloyl group and a phosphoric acid residue that can be used together with the polyfunctional monomer for dental materials.
- Specific examples of the monomer having an acryloyl group and a phosphoric acid residue are the same as the specific examples of the monomer having an acryloyl group and a phosphoric acid residue that can be used together with the polyfunctional monomer for dental materials.
- Examples of the monomer having a methacryloyl group and a pyrophosphate residue include di (2-methacryloyloxyethyl) pyrophosphate and acid chlorides thereof.
- Examples of the monomer having an acryloyl group and a pyrophosphate residue include di (2-acryloyloxyethyl) pyrophosphate and acid chlorides thereof.
- Examples of the monomer having a methacryloyl group and a thiophosphoric acid residue include 2-methacryloyloxyethyl dihydrogen dithiophosphate, 10-methacryloyloxydecyl dihydrogen thiophosphate, and acid chlorides thereof.
- Examples of the monomer having an acryloyl group and a thiophosphate residue include 2-acryloyloxyethyl dihydrogen dithiophosphate, 10-acryloyloxydecyl dihydrogen thiophosphate, and acid chlorides thereof.
- Examples of the monomer having a methacryloyl group and a carboxylic acid residue include, for example, 4-methacryloyloxyethoxycarbonylphthalic acid, 5-methacryloylaminopentylcarboxylic acid and 11-methacryloyloxy-1,1-undecanedicarboxylic acid, and acids thereof Examples include chloride or acid anhydride.
- Examples of the monomer having an acryloyl group and a carboxylic acid residue include 4-acryloyloxyethoxycarbonylphthalic acid, 5-acryloylaminopentylcarboxylic acid and 11-acryloyloxy-1,1-undecanedicarboxylic acid, and acids thereof. Examples include chloride or acid anhydride.
- Examples of the monomer having a methacryloyl group and a sulfonic acid residue include 2-sulfoethyl methacrylate and 2-methacrylamide-2-methylpropanesulfonic acid.
- Examples of the monomer having an acryloyl group and a sulfonic acid residue include 2-sulfoethyl acrylate and 2-acrylamido-2-methylpropanesulfonic acid.
- a polymerization initiator can be mentioned as another example of components other than the hydroxyl-containing monomer for dental materials of this invention contained in the dental material of the 2nd aspect of this invention. Specific examples and preferred examples of the polymerization initiator are the same as the polymerization initiator that can be included in the dental material of the first aspect of the present invention.
- the polymerization initiator or the photopolymerization initiator may be used alone or in combination of two or more, and the blending amount is usually 0.01 to 20 parts by weight, preferably 0. It is used in the range of 1 to 5 parts by weight.
- a filler can be mentioned as another example of components other than the hydroxyl-containing monomer for dental materials of this invention contained in the dental material of the 2nd aspect of this invention. Specific examples and preferred examples of the filler are the same as the filler that can be included in the dental material of the first aspect of the present invention.
- fillers can be appropriately added depending on the use of the dental material. When these fillers are used, these fillers are appropriately used alone or in combination of two or more.
- the preferable range of the filler content varies depending on the application.
- a dental bonding material which is one of dental adhesive materials
- about 0.1 to 5 parts by weight may be contained in 100 parts by weight of the dental material.
- a dental adhesive cement which is one of dental adhesives
- 30 to 70 parts by weight in 100 parts by weight of dental material is used for improving mechanical strength and adjusting consistency. May be contained to some extent.
- a dental adhesive composite resin which is one of dental adhesives
- 50 to 90 parts in 100 parts by weight of dental material is used for improving mechanical strength and adjusting the consistency. It may be contained in about parts by weight.
- the dental material of the second aspect of the present invention includes the above-mentioned hydroxyl group-containing monomer for dental material of the present invention and a polymerizable monomer other than the hydroxyl group-containing monomer of the present invention (for example, (meth) acrylates other than the hydroxyl group-containing monomer of the present invention).
- a polymerizable monomer other than the hydroxyl group-containing monomer of the present invention for example, (meth) acrylates other than the hydroxyl group-containing monomer of the present invention.
- Components other than the group-containing monomer, the monomer having an epoxy group), the polymerization initiator, and the filler may be appropriately included depending on the purpose.
- the polymerization inhibitor already described above may be included to improve storage stability.
- pigments such as a well-known pigment and dye, can be included.
- a known reinforcing material such as fiber may be included.
- a solvent such as acetone, ethanol, or water may be included as necessary.
- the blending amount of the hydroxyl group-containing monomer for dental materials according to the second aspect of the present invention in the dental material is not particularly limited, but is, for example, in the range of 0.1 to 99%.
- the preferred blending amount may vary depending on the use for the dental material.
- a polymerizable monomer component a polymerizable monomer other than the above-mentioned dental material hydroxyl group-containing monomer and the above dental material hydroxyl group-containing monomer (for example, 1 to 50% by weight, more preferably 1 to 40% by weight, and still more preferably 3 to 30% by weight in the (meth) acrylate group-containing monomer other than the hydroxyl group-containing monomer of the present invention and the monomer having an epoxy group.
- the amount of the hydroxyl group-containing monomer is preferably 1 to 50% by weight in the polymerizable monomer component.
- the dental material is used for a dental adhesive (adhesive resin cement, filling adhesive composite).
- Resin a dental adhesive
- the amount of the hydroxyl group-containing monomer is preferably 1 to 50% by weight in the polymerizable monomer component, and more preferably 1 to 20 wt%.
- the dental material of the hydroxyl group-containing monomer for dental materials according to the second aspect of the present invention is desirably one that shows a negative in the reverse mutation test.
- the test method of the reverse mutation test (Ames test) is the same as the above-described reverse mutation test method, wherein the monomer composition for dental material according to the first aspect of the present invention is used as the hydroxyl group-containing monomer for dental material according to the second aspect of the present invention. Replace the dental material with the same procedure.
- the hydroxyl group-containing monomer dental material of the second aspect of the present invention may have a relative cell viability within a certain range in a cell test by the NRU method using Balb / 3T3 cells.
- the cell test is the same as that of the NRU cell test described above except that the dental material monomer composition of the first aspect of the present invention is replaced with the dental material of the hydroxyl group-containing monomer for dental material of the second aspect of the present invention.
- the concentration of the test substance contained in the test material (the hydroxyl group-containing monomer for dental material contained in the dental material) in the test solution and the relative cell growth rate (%) of the dental material are those of the first aspect of the present invention described above. It may be the same as in the case of the monomer composition for dental materials.
- the hydroxyl group-containing monomer dental material of the second aspect of the present invention may have a relative cell growth rate within a certain range in a cell test by the WST method using Balb / 3T3 cells.
- the cell test is the same as the cell test by the WST method described above except that the dental material monomer composition of the first aspect of the present invention is replaced with the dental material of the hydroxyl group-containing monomer for dental material of the second aspect of the present invention.
- the concentration of the test substance contained in the test material (the hydroxyl group-containing monomer for dental material contained in the dental material) in the test solution and the relative cell growth rate (%) of the dental material are those of the first aspect of the present invention described above. It may be the same as in the case of the monomer composition for dental materials.
- the hydroxyl group-containing monomer for dental materials according to the second aspect of the present invention a polymerizable monomer other than the hydroxyl group-containing monomer (for example, a (meth) acrylate group-containing monomer other than the hydroxyl group-containing monomer of the present invention, an epoxy group) Monomer), a polymerization initiator, a filler, other components, and the like, and the method for producing the dental material of the second aspect of the present invention is not particularly limited as long as it is a known method.
- the dental material of the second aspect of the present invention can be cured under appropriate conditions in accordance with the polymerization method of the polymerization initiator described above.
- the dental material according to the second aspect of the present invention containing a photopolymerization initiator by visible light irradiation the dental material is processed into a predetermined shape, and then a predetermined light irradiation device is used. By irradiating with visible light for a time, a desired cured product can be obtained. Conditions such as irradiation intensity and irradiation intensity can be appropriately changed according to the curability of the dental material.
- the mechanical properties of the cured product can be improved by further heat-treating the cured product that has been cured by light irradiation, such as visible light, under appropriate conditions.
- the dental material of the second aspect of the present invention containing a polymerization initiator by heating, the dental material is processed into a predetermined shape and then heated at an appropriate temperature and time.
- a desired cured product can be obtained.
- the cured product of the dental material according to the second aspect of the present invention obtained as described above may be used for dental treatment.
- the dental material of the second aspect of the present invention can be suitably used for dental treatment applications, such as a filling composite resin, a hard crown resin, a denture base resin, a denture base lining material, an impression material, Dental adhesive (orthodontic adhesive, bonding material, adhesive resin cement, filling adhesive composite resin, and resin-added glass ionomer cement), dental primer, dental fissure sealant, CAD / CAM resin block , Temporary crowns, and artificial tooth materials.
- the hydroxyl group-containing monomer for a dental material in the present invention has a function of improving the adhesive strength with a tooth during a dental treatment, and thus is particularly suitable for use as a dental adhesive and a dental primer.
- the hydroxyl group-containing monomer for dental material of the second aspect of the present invention is:
- the molecule contains both a hydroxyl group and a (meth) acryloyl group, which interacts with the surface of the tooth through the hydroxyl group and bonds to the resin matrix via the (meth) acryloyl group. It is assumed that both functions are combined.
- the hydroxyl group-containing monomer for dental materials according to the second aspect of the present invention has a carbamate structure in the molecule.
- the carbamate structure is known to show the effect of imparting high mechanical properties to the urethane polymer due to its aggregating action in the so-called urethane polymer, but in the molecule of the hydroxyl group-containing monomer for dental materials according to the second aspect of the present invention.
- the contained carbamate structure may also have a favorable influence on the strength after curing of the dental material of the second aspect of the present invention.
- an improvement in the strength of the adhesive layer has a favorable effect on its adhesive properties.
- the method for using the dental material according to the second aspect of the present invention is not particularly limited as long as it is generally known as a method for using the dental material.
- the dental material according to the second aspect of the present invention is used as a bonding material, the dental material is applied to the cavity in the oral cavity, and then dried as necessary. After photocuring using an apparatus, the filling composite resin is filled.
- the dental material according to the second aspect of the present invention when used as an adhesive resin cement, the tooth surface and the surface to which the prosthesis is bonded are subjected to primer treatment on the prosthesis as necessary, and then the The dental material of the second aspect is applied, and the prosthesis is crimped to a predetermined place in the oral cavity.
- the dental material of the second aspect of the present invention when used as a primer for dentin, the dental material is applied to the cavity in the oral cavity, and then dried as necessary. Then, after light curing using a known light irradiation device, the prosthesis to which the adhesive cement has been applied is pressure-bonded to the cavity.
- the dental material according to the second aspect of the present invention when used as a filling adhesive composite resin, the dental material is directly filled in the cavity in the oral cavity and then photocured using a known light irradiation device. The purpose can be achieved.
- the kit of the second aspect of the present invention includes the dental material.
- the kit of the second aspect of the present invention is a kit in which each component of the dental material is filled as one agent, the polymerization form, storage stability, etc. are taken into consideration, and each component of the dental material is divided into two or more agents. Examples include a kit composed of a plurality of filled agents.
- the kit of the present invention may contain other dental materials to be used at the same time other than the dental material of the second aspect of the present invention. Such a kit is used for applications such as a bonding material, an adhesive cement, a primer, and an adhesive composite resin.
- Production Example 6A A synthetic operation similar to that in Production Example 1A was performed using 2-acryloyloxyethyl isocyanate (produced by Showa Denko KK, Karenz AOI (registered trademark)) instead of 2-methacryloyloxyethyl isocyanate described in Production Example 1A.
- the product containing the polyfunctional monomer 6 having the structural formula shown in Table 1A was obtained.
- Example 1A-1 0.37 g of polyfunctional monomer 1A obtained in Production Example 1A, 1.94 g of urethane acrylate compound 7A having the following structural formula, triethylene glycol dimethacrylate (NK ester 3G manufactured by Shin-Nakamura Chemical Co., Ltd., hereinafter abbreviated as TEGDMA) 12 g (0.42 mmol) was put in a container and stirred at 50 ° C. until uniform to obtain a polymerizable monomer composition.
- TEGDMA triethylene glycol dimethacrylate
- this polymerizable monomer composition 60 parts by weight of barium aluminum borosilicate glass filler (GM27884, particle size 1.5 ⁇ m, 1.6% silane-treated product, manufactured by NEC SCHOTT Components Co., Ltd.), 2 , 4,6-Trimethylbenzoyl-diphenyl-phosphine oxide (IRGACURE TPO BASF, hereinafter abbreviated as TPO) 0.2 part by weight was added and mixed to obtain a composition for use as a uniform paste dental material.
- barium aluminum borosilicate glass filler GM27884, particle size 1.5 ⁇ m, 1.6% silane-treated product, manufactured by NEC SCHOTT Components Co., Ltd.
- TPO 4,6-Trimethylbenzoyl-diphenyl-phosphine oxide
- Example 1A-2 A composition used as a dental material was obtained in accordance with the procedure of Example 1A-1, except that the polyfunctional monomer 5A obtained in Production Example 5A was used instead of the polyfunctional monomer 1A. Further, the same operation as in Example 1A-1 was performed, and the result of the bending test was obtained. The results are shown in Table 2A.
- Example 2A-1 A composition used as a dental material was obtained according to the procedure of Example 1A-1, except that the urethane acrylate compound 8A was used instead of the urethane acrylate compound 7A. Further, the same operation as in Example 1A-1 was performed, and the result of the bending test was obtained. The results are shown in Table 2A.
- the cured product of the composition used as the dental material containing the polyfunctional monomer for dental materials according to the first aspect of the present invention has a breaking strength and a fracture as compared with the cured product of the conventional composition. It can be seen that the energy is greatly improved. That is, it was suggested that the use of the polyfunctional monomer for dental material of the present invention having both toughness and rigidity improves the strength and toughness of the cured material of the dental material.
- Example 3A-1 To 100 parts by weight of the polyfunctional monomer 1A obtained in Production Example 1A, 0.5 part by weight of TPO was added and stirred at room temperature until uniform to obtain a monomer solution. Then, 20 seconds of light irradiation was performed using a dental light irradiator (Translux 2 Wave, manufactured by Heraeus Kultzer), and the polymerization rate was measured using infrared spectroscopy (IR) (Spectrum Two, manufactured by PerkinElmer). Went. The results are shown in Table 3. The polymerization rate (%) was calculated using the following formula.
- IR infrared spectroscopy
- Examples 3A-2 to 3A-5 The polymerization rates of the polyfunctional monomers 2A, 3A, 4A and 6A obtained in the production examples were measured in the same manner as in Example 3A-1. The results are shown in Table 3A.
- Example 3A-1 The polymerization rate of the general-purpose dental material methacrylic compound TEGDMA was measured in the same manner as in Example 3A-1. The results are shown in Table 3A.
- Production Example 7B Production Example 1 except that polyol 6B shown in Table 1B was used instead of the polyol described in Production Example 1B and 3/4 equivalent of Karenz MOI-EG (registered trademark) was reacted with respect to the number of OH moles of polyol 6B.
- a product containing the hydroxyl group-containing monomer 7B was obtained by performing the same synthetic operation as 1B.
- Production Example 8B Production Example 1 except that polyol 3B shown in Table 1B was used instead of the polyol described in Production Example 1B and 2/3 equivalents of Karenz MOI-EG (registered trademark) was reacted with respect to the number of OH moles of polyol 3B. By performing the same synthetic operation as 1B, a product containing the hydroxyl group-containing monomer 8B was obtained.
- Example 1B 10.33 g (5.5 parts by weight) of the compound 1B obtained in Production Example 1B, 0.50 g (8.3 parts by weight) of Bis-GMA (bisphenol A diglycidyl methacrylate: Shin-Nakamura Chemical Co., Ltd.), E4BADMA (Bisphenol A dimethacrylate ester 4 mol ethylene oxide modified compound SR540, manufactured by SARTOMER) 0.26 g (4.2 parts by weight), UDMA (2,2,4-trimethylhexamethylenebis (2-carbamoyloxyethyl) dimethacrylate) 0.31 g (5.2 parts by weight), ETMPTA-3EO (trimethylolpropane triacrylate 3 mol ethylene oxide modified compound, manufactured by Kyoeisha Chemical Co., Ltd.) 0.37 g (6.2 parts by weight), MDP (10-methacryloyloxydecyl) Dihydrogen phosphate) 0.37 g (6.
- Bis-GMA bisphenol A diglycidyl methacryl
- Example 1B is a composition suitable for evaluating the performance as a resin, for example.
- a visible light irradiation device Translux 2 Wave, manufactured by Heraeus Kultzer
- a visible light irradiation device Translux 2 Wave, manufactured by Heraeus Kultzer
- the mold was removed to prepare an adhesion sample.
- a general-purpose testing machine precision universal material testing machine 210X, manufactured by INTESCO Corporation
- a shear load was applied at a crosshead speed of 0.0 mm / min, and the shear adhesive strength was determined from the shear load when the composition formed in a columnar shape on the bovine tooth surface separated from the surface.
- Table 2B The result of the shear test of the composition used as the obtained dental material is shown in Table 2B.
- Example 1B A composition used as a dental material was obtained in accordance with the operation of Example 1B, except that HEMA (manufactured by Mitsubishi Rayon Co., Ltd., Acryester HO (registered trademark)) was used instead of Compound 1B. Furthermore, the same operation as in Example 1B was performed, and the result of the shear test was obtained. The results are shown in Table 2B.
- HEMA manufactured by Mitsubishi Rayon Co., Ltd., Acryester HO (registered trademark)
- Example 2B Except not adding compound 1B, the composition used as a dental material was obtained in accordance with the operation of Example 1B. Furthermore, the same operation as in Example 1B was performed, and the result of the shear test was obtained. The results are shown in Table 2B.
- the hydroxyl group-containing polymerizable monomer for dental materials of the second aspect of the present invention has improved adhesion strength to bovine teeth, particularly enamel, compared to conventional hydroxyl group-containing dental material compounds. It can be seen that it exhibits a high primer effect. That is, the use of the hydroxyl group-containing polymerizable monomer for a dental material according to the second aspect of the present invention has shown the possibility of providing a dental material having a high priming ability to the tooth.
- Example 2B 0.40 g (20 parts by weight) of Compound 1B obtained in Production Example 1B, 0.20 g (10 parts by weight) of UDMA (2,2,4-trimethylhexamethylenebis (2-carbamoyloxyethyl) dimethacrylate), TEGDMA (Triethylene glycol dimethacrylate: NK ester 3G manufactured by Shin-Nakamura Chemical Co., Ltd.) 0.20 g (10 parts by weight), MDP (10-methacryloyloxydecyl dihydrogen phosphate) 0.26 g (13 parts by weight), CQ ( Camphorquinone: Wako Pure Chemical Industries, Ltd.) 0.020 g (1.0 part by weight), 4- (dimethylamino) benzoic acid 2-butoxyethyl (Tokyo Chemical Industry Co., Ltd.) 0.020 g (1.0 weight) Part), ethanol (super dehydration: Wako Pure Chemical Industries, Ltd.) 0.60 g (30 parts by weight), and distilled water 0.
- This surface was irradiated with light for 20 seconds using a visible light irradiation device (Translux 2 Wave, manufactured by Heraeus Kultzer). Further, a plastic mold (ULTRADENT) with a diameter of 2.38 mm is set on this, filled with a dental composite resin (Venus Diamond, made by Heraeus Kultzer), and irradiated with light for 20 seconds using a visible light irradiation device. And cured. Thereafter, the mold was removed to prepare an adhesion sample. After storing the sample in warm water at 37 ° C.
- a visible light irradiation device Translux 2 Wave, manufactured by Heraeus Kultzer
- Examples 3B to 5B A composition used as a dental material was prepared in the same manner as in Example 2B except that the hydroxyl group-containing monomer 3B, 4B, or 6B obtained in the above Production Example was used instead of Compound 1B. . Subsequently, the same test as in Example 2B was performed, and the result of the shear test was obtained. The results are shown in Table 3B.
- Example 3 A composition used as a dental material was prepared in the same manner as in Example 2B, except that HEMA (manufactured by Mitsubishi Rayon Co., Ltd., Acryester HO (registered trademark)) was used instead of Compound 1B. . Subsequently, the same test as in Example 2B was performed, and the result of the shear test was obtained. The results are shown in Table 3B.
- Example 6B to 13B A composition used as a dental material was prepared in the same manner as in Example 2B, except that bovine dentin was used instead of bovine enamel and the compounds listed in Table 4B were used. Next, the same test as in Example 2B was performed, and the result of the shear test was obtained. The results are shown in Table 4B.
- Example 4B A composition used as a dental material was prepared in the same manner as in Example 6B except that HEMA (manufactured by Mitsubishi Rayon Co., Ltd., Acryester HO (registered trademark)) was used instead of Compound 1B. . Next, the same test as in Example 2 was performed to obtain a shear test result. The results are shown in Table 4B.
- the hydroxyl group-containing polymerizable monomer for dental materials of the present invention has higher adhesive strength and higher adhesion to bovine enamel and dentin than the conventional hydroxyl group-containing dental material compounds. It can be seen that the primer action is exhibited. That is, the use of the polymerizable monomer for dental material of the present invention has shown the possibility of providing a dental material having a high priming ability to the tooth.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Dental Preparations (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
また、歯質への接着性に関しては、さらなる向上が望まれているのが実情である。上記問題点に鑑み、本発明の第2態様は、歯科治療の際に歯質との接着強度を向上させる機能を有する歯科材料用水酸基含有モノマーを提供することを目的とする。
[1A] 下記核部(X)と下記末端基(Y2A)とが直接または下記連結基(Z)を介して結合した下記一般式(8A)で示される化合物を含む歯科材料用多官能モノマー。
核部(X)は酸素原子または窒素原子を含有し、末端基(Y2A)または連結基(Z)と結合する原子が酸素原子または窒素原子である炭素数1~200の3価以上の多価有機基であり、
末端基(Y2A)は、下記一般式(9)で示される(メタ)アクリロイル基含有基(Y3)、(メタ)アクリロイル基、または炭素数1~20の炭化水素基であり、複数ある末端基(Y2A)は同一でも異なっていてもよく、ただし、一般式(8A)で示される化合物中のすべての末端基(Y2A)のうち、3以上は(メタ)アクリロイル基含有基(Y3)または(メタ)アクリロイル基でありかつ1以上は(メタ)アクリロイル基含有基(Y3)であり、
連結基(Z)は下記一般式(2)で示される2価の基であり、上記一般式(8A)で示される化合物中に連結基(Z)が複数含まれる場合には、連結基(Z)は同一でも異なっていてもよい。)
[3A] 上記末端基(Y2A)が、(メタ)アクリロイル基含有基(Y3)である[1A]または[2A]に記載の歯科材料用多官能モノマー。
[4A] 上記連結基(Z)におけるn2a、n2b、n2c、およびn2dがそれぞれ0~20であり、n2a、n2b、n2c、およびn2dの合計が1~20である[1A]~[3A]のいずれかに記載の歯科材料用多官能モノマー。
[5A] 上記連結基(Z)が下記一般式(4)で示される2価の基である[1A]~[4A]のいずれかに記載の歯科材料用多官能モノマー。
[8A] 上記核部(X)が、下記一般式(6a)~(6j)で示される基からなる群より選択される少なくとも1つである[1A]~[7A]のいずれかに記載の歯科材料用多官能モノマー。
核部(X)は酸素原子または窒素原子を含有し、末端基(Y1A)または連結基(Z)と結合する原子が酸素原子または窒素原子である炭素数1~200の3価以上の多価有機基であり、
末端基(Y1A)は、(メタ)アクリロイル基、炭素数1~20の1価の炭化水素基、または水素原子であり、複数あるY1Aは同一でも異なっていてもよく、ただし、上記一般式(1A)で示される化合物中に含まれる末端基(Y1A)のうち3以上は水素原子または(メタ)アクリロイル基であり、かつ1以上は水素原子であり、
連結基(Z)は下記一般式(2)で示される2価の基であり、上記一般式(1A)で示される化合物中に連結基(Z)が複数含まれる場合には、連結基(Z)は同一でも異なっていてもよい。)
[12A] 上記連結基(Z)におけるn2a、n2b、n2c、およびn2dがそれぞれ0~20であり、n2a、n2b、n2c、およびn2dの合計が1~20である[10A]または[11A]に記載の歯科材料用多官能モノマー。
[13A] 上記連結基(Z)が下記一般式(4)で示される2価の基である[10A]~[12A]のいずれかに記載の歯科材料用多官能モノマー。
[16A] 上記化合物(1A)が、下記一般式(6’a)~(6’k)で示される化合物からなる群より選択される少なくとも1つである[10A]~[15A]のいずれかに記載の歯科材料用多官能モノマー。
上記一般式(6’i)および(6’j)中のn6'i-bおよびn6'j-bは、それぞれオキシエチレン、オキシプロピレンユニットの個数を示し、それぞれ1~100の範囲であり、それぞれのアームごとのユニットの個数は同じでも異なっていてもよく、上記一般式(6’k)中のn6'k-bおよびn6'k-cは、それぞれオキシエチレン、オキシプロピレンユニットの個数を示し、その和は1~100の範囲であり、それぞれのアームごとのユニットの個数の和は同じでも異なっていてもよい。)
[19A] 復帰突然変異試験において陰性を示す、[18A]に記載の歯科材料用モノマー組成物。
[20A] [1A]~[17A]のいずれかに記載の歯科材料用多官能モノマーを含有する歯科材料。
[21A] 復帰突然変異試において陰性を示す、[20A]に記載の歯科材料。
[22A] [20A]または[21A]に記載の歯科材料を硬化させてなる硬化物。
[23A] [20A]または[21A]に記載の歯科材料を含むキット。
[1B]下記核部(X)と下記末端基(Y2B)とが直接または下記連結基(Z)を介して結合した下記一般式(8B)で示される化合物を含む歯科材料用水酸基含有モノマー。
核部(X)は酸素原子または窒素原子を含有し、末端基(Y2B)または連結基(Z)と結合する原子が酸素原子または窒素原子である炭素数1~200の3価以上の多価有機基であり、
末端基(Y2B)は、下記一般式(9)で示される(メタ)アクリロイル基含有基(Y3)、(メタ)アクリロイル基、炭素数1~20の炭化水素基、または水素原子であり、複数ある末端基(Y2B)は同一でも異なっていてもよく、ただし、一般式(8B)で示される化合物中のすべての末端基(Y2B)のうち、1以上は(メタ)アクリロイル基含有基(Y3)でありかつ1以上は水素原子であり、
連結基(Z)は下記一般式(2)で示される2価の基であり、上記一般式(8B)で示される化合物中に連結基(Z)が複数含まれる場合には、連結基(Z)は同一でも異なっていてもよい。)
[3B]上記連結基(Z)におけるn2a、n2b、n2c、およびn2dがそれぞれ0~20であり、n2a、n2b、n2c、およびn2dの合計が1~20である[1B]または[2B]に記載の歯科材料用水酸基含有モノマー。
[4B]上記連結基(Z)が下記一般式(4)で示される2価の基である[1B]~[3B]のいずれかに記載の歯科材料用水酸基含有モノマー。
[7B]上記核部(X)が、下記一般式(6a)~(6j)で示される基からなる群より選択される少なくとも1つである[1B]~[6B]のいずれかに記載の歯科材料用水酸基含有モノマー。
核部(X)は酸素原子または窒素原子を含有し、末端基(YI)または連結基(Z)と結合する原子が酸素原子または窒素原子である炭素数1~200の3価以上の多価有機基であり、
末端基(Y1B)は、(メタ)アクリロイル基、炭素数1~20の1価の炭化水素基、または水素原子であり、複数あるY1Bは同一でも異なっていてもよく、ただし、上記一般式(1B)で示される化合物中に含まれる末端基(Y1B)のうち2以上は水素原子であり、
連結基(Z)は下記一般式(2)で示される2価の基であり、上記一般式(1B)で示される化合物中に連結基(Z)が複数含まれる場合には、連結基(Z)は同一でも異なっていてもよい。)
[11B]上記連結基(Z)におけるn2a、n2b、n2c、およびn2dがそれぞれ0~20であり、n2a、n2b、n2c、およびn2dの合計が1~20である[9B]または[10B]に記載の歯科材料用水酸基含有モノマー。
[12B]上記連結基(Z)が下記一般式(4)で示される2価の基である[9B]~[11B]のいずれかに記載の歯科材料用水酸基含有モノマー。
[14B]上記核部(X)が、3~12価の有機基である[9B]~[13B]のいずれかに記載の歯科材料用水酸基含有モノマー。
[15B]上記化合物(1B)が、下記一般式(6’a)~(6’k)で示される化合物からなる群より選択される少なくとも1つである[9B]~[14B]のいずれかに記載の歯科材料用水酸基含有モノマー。
上記一般式(6’i)および(6’j)中のn6'i-bおよびn6'j-bは、それぞれオキシエチレン、オキシプロピレンユニットの個数を示し、それぞれ1~100の範囲であり、それぞれのアームごとのユニットの個数は同じでも異なっていてもよく、上記一般式(6’k)中のn6'k-bおよびn6'k-cは、それぞれオキシエチレン、オキシプロピレンユニットの個数を示し、その和は1~100の範囲であり、それぞれのアームごとのユニットの個数の和は同じでも異なっていてもよい。)
本発明の第1態様である歯科材料用多官能モノマーを含有する組成物を硬化させることにより、高い強度を有する硬化物が得られる。また上記歯科材料用多官能モノマーを含む歯科材料は、硬化後に未反応の重合性末端の残存率が低い。
本発明の第2態様である歯科材料用水酸基含有モノマーは、歯科治療の際に歯質との接着強度を向上させる機能を有する。
本発明の第1態様である歯科材料用多官能モノマーは、下記核部(X)と下記末端基(Y2A)とが直接または下記連結基(Z)を介して結合した下記一般式(8A)で示される化合物である。
上記核部(X)は、酸素原子または窒素原子を含有し、末端基(Y2A)または連結基(Z)と結合する原子が酸素原子または窒素原子である3価以上の多価有機基である。上記末端基(Y2A)または連結基(Z)と結合する酸素原子または窒素原子は、上記末端基(Y2A)または連結基(Z)以外とは、メチレン基または2価の芳香族性炭素基と結合している。なおこのメチレン基または2価の芳香族炭素基に含まれる任意の水素原子は、炭素数1~12の一価の炭化水素基と置き換えられていてもよい。核部(X)の炭素数は通常1~200の範囲であるが、好ましくは1~100であり、より好ましくは1~30、さらに好ましくは2~20である。
末端基(Y2A)は、下記一般式(9)で示される(メタ)アクリロイル基含有基(Y3)、(メタ)アクリロイル基、または炭素数1~20の炭化水素基であり、複数ある末端基(Y2A)は同一でも異なっていてもよく、ただし、一般式(8A)で示される化合物中のすべての末端基(Y2A)のうち、3以上は(メタ)アクリロイル基含有基(Y3)または(メタ)アクリロイル基でありかつ1以上は(メタ)アクリロイル基含有基(Y3)である。
連結基(Z)は下記一般式(2)で示される2価の基であり、上記一般式(8A)で示される化合物中に連結基(Z)が複数含まれる場合には、連結基(Z)は同一でも異なっていてもよい。
上記の繰り返し単位は、1種類で構成されていてもよいし、2種類以上で構成されていてもよい。2種以上の繰り返し単位を含む場合、これら繰り返し単位が含まれる形態については特に制限はなく、例えばランダムに各繰り返し単位が含まれていてもよいし、ある繰り返し単位がある一定の個数固まった形態、すなわちブロック的に各繰り返し単位が含まれていてもよい。また、これらの繰り返し単位の順番については、何ら限定されない。
本発明の歯科材料用多官能モノマーは、例えば、下記核部(X)と下記末端基(Y1A)とが直接または下記連結基(Z)を介して結合している下記一般式(1A)で示される化合物中の全ての活性プロトンが、下記一般式(3)で示される(メタ)アクリロイル基含有イソシアネート化合物中のイソシアネート基と反応し、対応するカーバメート基もしくはウレア基が生成することにより得られる。ここで言う活性プロトンとは、アルコール性酸素およびアミン性窒素に結合する、イソシアネートとの実用的速度での反応性を有する水素原子を指す。
末端基(Y1A)は、(メタ)アクリロイル基、炭素数1~20の1価の炭化水素基、または水素原子であり、複数あるY1Aは同一でも異なっていてもよい。ただし、上記一般式(1A)で示される化合物中に含まれる末端基(Y1A)のうち3以上は水素原子または(メタ)アクリロイル基であり、かつ1以上は水素原子である。末端基(Y1A)は、(メタ)アクリロイル基、または水素原子であることが好ましく、水素原子のみで構成されることがより好ましい。
一般式(1A)の化合物としては、例えば、下記一般式(6'a)~(6'h)で示されるポリオールが挙げられる。
本発明の歯科材料用多官能モノマーは、上述のように上記一般式(1A)で示される化合物と、上記一般式(3)で示される(メタ)アクリロイル基含有イソシアネート化合物を反応することにより得られるが、その反応は、公知または公知に準ずる方法により行うことができる。
これらの中でも、少量で反応が進行し、ジイソシアネート化合物に対して選択性が高い、ジブチルスズジラウレートおよびオクタン酸スズが好ましい。
本発明の第1態様である歯科材料用多官能モノマーは、他の成分、例えば歯科材料用に好適な多官能モノマー以外の成分を配合することによって、歯科材料用モノマー組成物として用いることができる。この歯科材料用モノマー組成物は、例えば、後述する歯科材料に配合されうる本発明の第1態様である歯科材料用多官能モノマー以外の重合可能なモノマー(例えば、本発明の多官能モノマー以外の(メタ)アクリレート基含有モノマー)を含有してもよい。
本発明の第1態様の歯科材料用モノマー組成物は、復帰突然変異試験において陰性を示すものであることが望ましい。復帰突然変異試験(Ames試験)とは、組成物の変異原性を、微生物を使って調べる試験を意味する。本発明における復帰突然変異試験は、以下の方法で行われる。
まず、滅菌した試験管に、ジメチルスルホキシド(DMSO)を媒体とする被験組成物液0.1mLと、代謝活性化しない場合は0.1Mリン酸緩衝液(pH7.4)を、代謝活性化する場合は後述するS9mixをそれぞれ0.5mL加えた後、後述する菌懸濁液0.1mLを加え混合する。37℃、約100rpmで20分間プレインキュベーションした後、後述するトップアガー2mLを加えて混和し、後述する最少グルコース寒天平板培地上(5用量以上)に重層する。重層固化を確認した後、最少グルコース寒天平板培地の上下を反転し、37°Cで48時間培養する。培養後のプレートについて、陰性・陽性の判定を行う。なお、陰性対照物質について試験を行う場合は、陰性対照物質としてDMSOを用い、上記の工程における被験組成物液に代えて媒体0.1mLを加える。
陰性・陽性の判断基準に関して、被験組成物が、全ての菌株・全ての用量において、また、代謝活性化しない場合および代謝活性化する場合の両方において、陰性対象物質のみの場合と比較して、平均コロニー数が2倍以内である場合に、その組成物は陰性と判断する。
用量当たりの最少グルコース寒天平板培地は、陰性対照物質については2枚以上、被験組成物についても2枚以上とする。
各菌懸濁液の調製に関して、各菌体について、菌体濃度(1×109菌数/mL以上)と調製したものを用いる。各菌体の培養には、ニュートリエントブロス培養液を用いる。ニュートリエントブロス培養液は、ニュートリエントブロスNo.2(Oxoid、Nutrient Broth No.2)を2.5wt%となるよう精製水で溶解し、121℃で20分間高圧蒸気滅菌を行ない、調製する。
本発明の第1態様の歯科材料用モノマー組成物は、後述するBalb/3T3細胞を用いるNRU法による細胞毒性試験において、相対細胞生存率が一定の範囲内であってもよい。該細胞毒性試験は、以下の方法で行う。
陰性対照液は、D05培養液にDMSOを0.5v/v%になるよう添加して調製する。
D10培養液とは、仔牛血清10vol%、ペニシリン-ストレプトマイシン-アムホテリシンB懸濁液1vol%、100mmol/Lピルビン酸ナトリウム溶液1vol%を含むD-MEMのことを指す。
上述のBalb/3T3細胞の前培養は、まず対数増殖期にある細胞をトリプシン-EDTAを用いて単離した後、D05培養液を用いて細胞濃度1x105cells/mLの細胞懸濁液を調製してから、細胞懸濁液0.1mLを96ウェルプレートに分注播種し(1x104cells/well)、CO2インキュベーター内で25時間静置して行う。
NR(ニュートラルレッド)ストック液とは、ニュートラルレッド(NR)(和光純薬工業株式会社製)の0.4%(w/v)水溶液を指す。
NR再溶解液とは、酢酸、エタノール、水を1:50:49で混合したものを指す。使用前1時間以内に調製する。
本発明の第1態様の歯科材料用モノマー組成物は、Balb/3T3細胞を用いるWST法による細胞試験において、相対細胞増殖率が一定の範囲内であってもよい。該細胞試験は、以下の方法で行う。
陰性対照液は、DMSOをDMEM培養液により0.5vol%になるよう添加して調製する。
DMEM培養液とは、仔牛血清10vol%、ペニシリン-ストレプトマイシン-アムホテリシンB懸濁液(x100)1vol%を含むDulbecco’s Modified Eagle’s Medium(D-MEM)を指す。
上述のBalb/3T3細胞の前培養は、まず対数増殖期にあるBalb/3T3 clone A31細胞を0.25%トリプシン-1mM EDTAを用いて単離した後、DMEM培養液を用いて細胞濃度20000cells/mLの細胞懸濁液を調製してから、細胞懸濁液0.1mLを96ウェルプレートに分注播種し(2000cells/ウェル)、CO2インキュベーター内で24時間静置して行う。
本発明の第1態様である歯科材料用多官能モノマーは、歯科材料の原料として好適である。本発明の歯科材料用多官能モノマーに対して、本発明の歯科材料用多官能モノマー以外の成分(例えば、歯科材料用多官能モノマー以外の重合可能なモノマー(本発明の多官能モノマー以外の(メタ)アクリレート基含有モノマー、エポキシ基を含有するモノマー等)を配合することによって、本発明の歯科材料用多官能モノマーを含有する歯科材料を製造することができる。
本発明の第1態様である歯科材料用多官能モノマー以外の成分の一例としては、本発明の多官能モノマー以外の(メタ)アクリレート基含有モノマーを挙げることができる。
重合性基を1つだけ有する上記の多官能モノマー以外の(メタ)アクリレート基含有モノマーとしては、例えば、下記一般式(21)で示されるモノマーが挙げられる。
上記二価の有機基としては、例えば、アルキレン基等の炭素数1~20の非環状炭化水素基、シクロアルキレン基、アリーレン基等の炭素数1~20の環状炭化水素基などの炭化水素基;オキシアルキレン基等の上記炭化水素基の少なくとも一部の炭素-炭素結合の間に、酸素が挿入された基(ただし酸素が連続して挿入されることはない。)などの炭素数1~20の酸素含有炭化水素基等が挙げられる。上記炭素数1~20の環状炭化水素基は、非環状炭化水素部分を有していてもよい。また、これら基中に含まれる非環状炭化水素部分は直鎖状または分岐状のいずれでもよい。
アクリロイル基とピロリン酸残基とを有するモノマーとしては、例えば、ピロリン酸ジ(2-アクリロイルオキシエチル)およびこれらの酸塩化物などが挙げられる。
本発明の第1態様の歯科材料に含まれる本発明の歯科材料用多官能モノマー以外の成分の別の一例としては、重合開始剤を挙げることができる。
常温重合を行う場合には、たとえば、酸化剤および還元剤を組み合わせたレドックス系の重合開始剤が好適である。レドックス系の重合開始剤を使用する場合、酸化剤と還元剤が別々に包装された形態をとり、使用する直前に両者を混合する必要がある。
過酸化物としては特に限定されないが、例えば、過酸化ベンゾイル、t-ブチルヒドロペルオキシド、クメンヒドロペルオキシドなどが挙げられる。アゾ系化合物としては特に限定されないが、例えば、アゾビスイソブチロニトリルなどが挙げられる。
光重合開始剤としては、特に限定されないが、例えば、α-ジケトン/還元剤、ケタール/還元剤、チオキサントン/還元剤などが挙げられる。α-ジケトンとしては、例えば、カンファーキノン、ベンジルおよび2,3-ペンタンジオンなどが挙げられる。ケタールとしては、例えば、ベンジルジメチルケタールおよびベンジルジエチルケタールなどが挙げられる。チオキサントンとしては、例えば、2-クロロチオキサントンおよび2,4-ジエチルチオキサントンなどが挙げられる。還元剤としては、例えば、ミヒラ-ケトン等、2-(ジメチルアミノ)エチルメタクリレート、N,N-ビス〔(メタ)アクリロイルオキシエチル〕-N-メチルアミン、N,N-ジメチルアミノ安息香酸エチル、4-ジメチルアミノ安息香酸ブチル、4-ジメチルアミノ安息香酸ブトキシエチル、N-メチルジエタノールアミン、4-ジメチルアミノベンゾフェノン、N,N-ビス(2-ヒドロキシエチル)-p-トルイジンおよびジメチルアミノフェナントール等の第三級アミン;シトロネラール、ラウリルアルデヒド、フタルジアルデヒド、ジメチルアミノベンズアルデヒドおよびテレフタルアルデヒド等のアルデヒド類;2-メルカプトベンゾオキサゾール、デカンチオール、3-メルカプトプロピルトリメトキシシラン、4-メルカプトアセトフェノン、チオサリチル酸およびチオ安息香酸等のチオール基を有する化合物;等を挙げることができる。これらのレドックス系に有機過酸化物を添加したα-ジケトン/有機過酸化物/還元剤の系も好適に用いられる。
本発明の第1態様の歯科材料に含まれる本発明の歯科材料用多官能モノマー以外の成分の別の一例としては、フィラーを挙げることができる。
有機フィラーとしては、例えば、ポリメタクリル酸メチル、ポリメタクリル酸エチル、メタクリル酸メチル-メタクリル酸エチル共重合体、架橋型ポリメタクリル酸メチル、架橋型ポリメタクリル酸エチル、エチレン-酢酸ビニル共重合体およびスチレン-ブタジエン共重合体などの微粉末が挙げられる。
また、粒径が0.1μm以下のミクロフィラーが配合された歯科材料は、歯科用コンポジットレジンに好適な態様の一つである。かかる粒径の小さなフィラーの材質としては、シリカ(例えば、商品名アエロジル)、アルミナ、ジルコニア、チタニアなどが好ましい。このような粒径の小さい無機フィラーの配合は、コンポジットレジンの硬化物の研磨滑沢性を得る上で有利である。
以上のような、(メタ)アクリロイル基を含むモノマー、重合開始剤、およびフィラーを含有する歯科材料は、コンポジットレジンと呼ばれることもある。
本発明の第1態様の歯科材料は、上述の本発明の歯科材料用多官能モノマー、本発明の多官能モノマー以外の重合可能なモノマー(例えば、本発明の多官能モノマー以外の(メタ)アクリレート基含有モノマー、エポキシ基を有するモノマー)、重合開始剤、およびフィラー以外の成分を、目的に応じて適宜含んでもよい。例えば、保存安定性を向上させるために既に上述した重合禁止剤を含んでもよい。また、色調を調整するために、公知の顔料、染料等の色素を含みうる。さらに、硬化物の強度を向上させるために、公知のファイバー等の補強材を含んでもよい。また、水、エタノール、アセトン等の溶媒を含んでもよい。
本発明の第1態様である多官能モノマーの歯科材料への配合量は特に制限されないが、例えば0.1~99%の範囲である。好ましい配合量は、その歯科材料用の用途によって異なる場合もあるが、例えば重合性モノマー成分(上記の本発明の歯科材料用多官能モノマーと上記の本発明の多官能モノマー以外の重合可能なモノマー(例えば、本発明の多官能モノマー以外の(メタ)アクリレート基含有モノマー)、エポキシ基を有するモノマー)中に1~50重量%、より好ましくは3~30重量%配合される。特に、歯科材料の用途が、充填用コンポジットレジン、歯冠用硬質レジン、義歯床用レジン、CAD/CAM用レジンブロックである場合、多官能モノマーの配合量は、重合性モノマー成分中1~50重量%であることが好ましく、3~30重量%であることがより好ましい。歯科材料の用途が歯科用接着材(歯列矯正用接着材、ボンディング材、接着レジンセメント、充填用接着コンポジットレジン、レジン添加型グラスアイオノマーセメント等)、歯科用プライマー、歯牙裂溝封鎖材である場合は、多官能モノマーの配合量は、重合性モノマー成分中1~50重量%であることが好ましく、3~20重量%であることがより好ましい。
本発明の第1態様の多官能モノマーの歯科材料は、復帰突然変異試験において陰性を示すものであってもよい。復帰突然変異試験(Ames試験)の試験方法は、上述の復帰突然変異試験の方法において、本発明の第1態様の歯科材料用モノマー組成物を本発明の第1態様の多官能モノマーの歯科材料に置き換えて、同様の手順で行う。
本発明の第1態様の多官能モノマーの歯科材料は、Balb/3T3細胞を用いるNRU法による細胞試験において、相対細胞生存率が一定の範囲内であってもよい。該細胞試験は、上述のNRU法による細胞試験において、本発明の第1態様の歯科材料用モノマー組成物を本発明の第1態様の多官能モノマーの歯科材料に置き換えて、同様の手順で行う。また、被験材料に含まれる被験物質(歯科材料に含まれる歯科材料用多官能モノマー)の試験液中の濃度、歯科材料の相対細胞増殖率(%)は、上述の本発明の第1態様の歯科材料用モノマー組成物の場合におけるものと同様であってよい。
本発明の第1態様の多官能モノマーの歯科材料は、Balb/3T3細胞を用いるWST法による細胞試験において、相対細胞増殖率が一定の範囲内であってもよい。該細胞試験は、上述のWST法による細胞試験において、本発明の第1態様の歯科材料用モノマー組成物を本発明の第1態様の多官能モノマーの歯科材料に置き換えて、同様の手順で行う。また、被験材料に含まれる被験物質(歯科材料に含まれる歯科材料用多官能モノマー)の試験液中の濃度、歯科材料の相対細胞増殖率(%)は、上述の本発明の第1態様の歯科材料用モノマー組成物の場合におけるものと同様であってよい。
上述の本発明の第1態様である歯科材料用多官能モノマー、該多官能モノマー以外の重合可能なモノマー(例えば、本発明の多官能モノマー以外の(メタ)アクリレート基含有モノマー)、エポキシ基を有するモノマー)、重合開始剤、フィラー、その他の成分等を混和し、本発明の第1態様の歯科材料を製造する方法については、公知の方法であれば特に制限を受けない。
本発明の第1態様の歯科材料は、前述の重合開始剤の重合方式にあわせ適切な条件で硬化することができる。例えば、可視光照射による光重合開始剤を含有している本発明の第1態様の歯科材料の場合は、該歯科材料を所定の形状に加工したのち、公知の光照射装置を用いて所定の時間可視光を照射することにより、所望の硬化物を得ることができる。照射強度、照射強度等の条件は、歯科材料の硬化性に合わせて適切に変更することができる。また、可視光をはじめとした、光照射により硬化した硬化物を、さらに適切な条件で熱処理をすることにより、硬化物の機械的物性を向上させることもできる。また、別の例として、加熱による重合開始剤を含有している本発明の第1態様の歯科材料の場合は、該歯科材料を所定の形状に加工したのち、適切な温度及び時間加熱することにより、所望の硬化物を得ることができる。
以上のようにして得られる上述の本発明の第1態様の歯科材料の硬化物が、歯科治療用途に用いられることもある。
本発明の第1態様の歯科材料の使用方法は、歯科材料の使用法として一般に知られているものであれば、特に制限されない。例えば、本発明の第1態様の歯科材料を齲蝕窩洞充填用コンポジットレジンとして使用する場合は、口腔内の窩洞に該歯科材料を充填した後、公知の光照射装置を用いて光硬化させることにより、目的を達成できる。また、歯冠修復用コンポジットレジンとして使用する場合は、適切な形状に加工した後、公知の光照射装置を用いて光硬化させ、さらに必要であれば所定の条件で熱処理を行うことで、所望の歯冠修復材料を得ることができる。
本発明における第1態様の歯科材料は、歯科治療用途に好適に用いることができ、例えば、充填用コンポジットレジン、歯冠用硬質レジン、義歯床用レジン、義歯床用裏装材、印象材、歯科用接着材(歯列矯正用接着材、ボンディング材(こちらのほうが一般的記載か)、接着レジンセメント、充填用接着コンポジットレジン、およびレジン添加型グラスアイオノマーセメント)、歯科用プライマー、歯牙裂溝封鎖材、CAD/CAM用レジンブロック、テンポラリークラウン、および人工歯材料等を挙げることができる。
本発明の第1態様のキットは上記第1態様の歯科材料を含む。本発明の第1態様のキットは、上記歯科材料の各成分を1剤として充填したキット、重合形式、および保存安定性等を勘案して、上記歯科材料の各成分を2剤以上に分けて充填した複数の剤からなるキットなどが挙げられる。なお、かかるキットには、本発明の第1態様の歯科材料以外の、同時に使用する他の歯科材料が含まれていてもよい。
本発明の第2態様である歯科材料用水酸基含有モノマーは、下記核部(X)と下記末端基(Y2B)とが直接または下記連結基(Z)を介して結合した下記一般式(8B)で示される化合物である。
上記核部(X)は、酸素原子または窒素原子を含有し、末端基(Y2B)または連結基(Z)と結合する原子が酸素原子または窒素原子である3価以上の多価有機基である。上記末端基(Y2B)または連結基(Z)と結合する酸素原子または窒素原子は、上記末端基(Y2B)または連結基(Z)以外とは、メチレン基または2価の芳香族性炭素基と結合している。なおこのメチレン基または2価の芳香族炭素基に含まれる任意の水素原子は、炭素数1~12の一価の炭化水素基と置き換えられていてもよい。核部(X)の炭素数は通常1~200の範囲であるが、好ましくは1~100であり、より好ましくは1~30、さらに好ましくは2~20である。
末端基(Y2B)は、歯科材料用多官能モノマーに含まれる(メタ)アクリロイル基含有基(Y3)として記載された上記一般式(9)で示される(メタ)アクリロイル基含有基(Y3)、(メタ)アクリロイル基、または炭素数1~20の炭化水素基であり、複数ある末端基(Y2B)は同一でも異なっていてもよく、ただし、一般式(8B)で示される化合物中のすべての末端基(Y2B)のうち、1以上は(メタ)アクリロイル基含有基(Y3)でありかつ1以上は水素原子である。
連結基(Z)は歯科材料用多官能モノマーに含まれる連結基(Z)として記載された一般式(2)で示される2価の基と同一であり、上記一般式(8B)で示される化合物中に連結基(Z)が複数含まれる場合には、連結基(Z)は同一でも異なっていてもよい。
本発明の歯科材料用多官能モノマーは、例えば、下記核部(X)と下記末端基(Y1B)とが直接または下記連結基(Z)を介して結合している下記一般式(1B)で示される化合物中の活性プロトンの少なくとも1つが、下記一般式(3)で示される(メタ)アクリロイル基含有イソシアネート化合物中のイソシアネート基と反応し、対応するカーバメート基もしくはウレア基が生成することにより得られる。ただし、上記の活性プロトン中、少なくとも1つの活性プロトンは未反応で残存する。ここで言う活性プロトンとは、アルコール性酸素およびアミン性窒素に結合する、イソシアネートとの実用的速度での反応性を有する水素原子を指す。
末端基(Y1B)は、(メタ)アクリロイル基、炭素数1~20の1価の炭化水素基、または水素原子であり、複数あるY1Bは同一でも異なっていてもよい。ただし、上記一般式(1B)で示される化合物中に含まれる末端基(Y1B)のうち2以上は水素原子である。末端基(Y1B)は、(メタ)アクリロイル基、または水素原子であることが好ましく、水素原子のみで構成されることがより好ましい。
一般式(1B)の化合物としては、例えば、歯科材料用多官能モノマーの製造に用いられる一般式(1A)の化合物の具体的な例として例示された、上記一般式(6’a)~(6’h)で示される多価アルコールが挙げられる。
本発明の歯科材料用水酸基含有モノマーは、上述のように上記一般式(1B)で示される化合物と、上記一般式(3)で示される(メタ)アクリロイル基含有イソシアネート化合物を反応することにより得られるが、その反応は、公知または公知に準ずる方法により行うことができる。
本発明の第2態様である歯科材料用水酸基含有モノマーは、他の成分、例えば歯科材料用に好適な多官能モノマー以外の成分を配合することによって、歯科材料用モノマー組成物として用いることができる。この歯科材料用モノマー組成物は、後述する歯科材料に配合されうる本発明の第2態様の歯科材料用水酸基含有モノマー以外の重合可能なモノマー(例えば、本発明の水酸基含有モノマー以外の(メタ)アクリレート基含有モノマー)を含有してもよい。
本発明の第2態様の歯科材料用モノマー組成物は、Balb/3T3細胞を用いるNRU法による細胞試験において、相対細胞生存率が一定の範囲内であってもよい。該細胞試験は、上述のNRU法による細胞試験において、本発明の第1態様の歯科材料用モノマー組成物を本発明の第2態様の歯科材料用モノマー組成物に置き換えて、同様の手順で行う。また、被験組成物に含まれる被験物質(歯科材料用モノマー組成物に含まれる歯科材料用水酸基含有モノマー)の試験液中の濃度、歯科材料用モノマー組成物の相対細胞増殖率(%)は、上述の本発明の第1態様の歯科材料用モノマー組成物の場合におけるものと同様であってよい。
本発明の第1態様の多官能モノマーの歯科材料は、Balb/3T3細胞を用いるWST法による細胞試験において、相対細胞増殖率が一定の範囲内であってもよい。該細胞試験は、上述のWST法による細胞試験において、本発明の第1態様の歯科材料用モノマー組成物を本発明の第2態様の歯科材料用モノマー組成物に置き換えて、同様の手順で行う。また、被験組成物に含まれる被験物質(歯科材料用モノマー組成物に含まれる歯科材料用水酸基含有モノマー)の試験液中の濃度、歯科材料用モノマー組成物の相対細胞増殖率(%)は、上述の本発明の第1態様の歯科材料用モノマー組成物の場合におけるものと同様であってよい。
本発明の第2態様である歯科材料用水酸基含有モノマーは、歯科材料の原料として好適である。本発明の歯科材料用水酸基含有モノマーに対して、本発明の歯科材料用水酸基含有モノマー以外の成分(例えば、本発明の歯科材料用水酸基含有モノマー以外の重合可能なモノマー(本発明の水酸基含有モノマー以外の(メタ)アクリレート基含有モノマー、エポキシ基を含有するモノマー等)を配合することによって、本発明の歯科材料用水酸基含有モノマーを含有する歯科材料を製造することができる。
本発明の歯科材料用水酸基含有モノマー以外の成分の一例としては、本発明の水酸基含有モノマー以外の(メタ)アクリレート基含有モノマーを挙げることができる。
重合性基を1つだけ有する上記の水酸基含有モノマー以外の(メタ)アクリレート基含有モノマーとしては、例えば、歯科材料用多官能モノマーとともに用いられ得るモノマーとして例示された上記一般式(21)で示されるモノマーが挙げられる。(ただし、一般式(21)で示されるモノマーのうち、本発明の歯科材料用水酸基含有モノマーに該当するモノマーは除く。)。
アクリロイル基とピロリン酸残基とを有するモノマーとしては、例えば、ピロリン酸ジ(2-アクリロイルオキシエチル)およびこれらの酸塩化物などが挙げられる。
本発明の第2態様の歯科材料に含まれる本発明の歯科材料用水酸基含有モノマー以外の成分の別の一例としては、重合開始剤を挙げることができる。重合開始剤の具体例、好適例などについては、本発明の第1態様の歯科材料に含まれ得る重合開始剤と同様である。
本発明の第2態様の歯科材料に含まれる本発明の歯科材料用水酸基含有モノマー以外の成分の別の一例としては、フィラーを挙げることができる。フィラーの具体例、好適例などについては、本発明の第1態様の歯科材料に含まれ得るフィラーと同様である。
本発明の第2態様の歯科材料は、上述の本発明の歯科材料用水酸基含有モノマー、本発明の水酸基含有モノマー以外の重合可能なモノマー(例えば、本発明の水酸基含有モノマー以外の(メタ)アクリレート基含有モノマー、エポキシ基を有するモノマー)、重合開始剤、およびフィラー以外の成分を、目的に応じて適宜含んでもよい。例えば、保存安定性を向上させるために既に上述した重合禁止剤を含んでもよい。また、色調を調整するために、公知の顔料、染料等の色素を含みうる。さらに、硬化物の強度を向上させるために、公知のファイバー等の補強材を含んでもよい。その他、必要に応じて、アセトン、エタノール、水等の溶媒も含んでもよい。
本発明の第2態様である歯科材料用水酸基含有モノマーの歯科材料への配合量は特に制限されないが、例えば0.1~99%の範囲である。好ましい配合量は、その歯科材料用の用途によって異なる場合もあるが、例えば重合性モノマー成分(上記の歯科材料用水酸基含有モノマーと上記の歯科材料用水酸基含有モノマー以外の重合可能なモノマー(例えば、本発明の水酸基含有モノマー以外の(メタ)アクリレート基含有モノマー、エポキシ基を有するモノマー)中に1~50重量%、より好ましくは1~40重量%、さらに好ましくは3~30重量%配合される。特に、歯科材料の用途が、歯科用接着材(ボンディング材)、歯科用プライマーである場合、水酸基含有モノマーの配合量は、重合性モノマー成分中1~50重量%であることが好ましく、1~40重量%であることがより好ましい。歯科材料の用途が、歯科用接着材(接着レジンセメント、充填用接着コンポジットレジン)、歯牙裂溝封鎖材である場合、水酸基含有モノマーの配合量は、重合性モノマー成分中1~50重量%であることが好ましく、1~20重量%であることがより好ましい。
本発明の第2態様の歯科材料用水酸基含有モノマーの歯科材料は、復帰突然変異試験において陰性を示すものであることが望ましい。復帰突然変異試験(Ames試験)の試験方法は、上述の復帰突然変異試験の方法において、本発明の第1態様の歯科材料用モノマー組成物を本発明の第2態様の歯科材料用水酸基含有モノマーの歯科材料に置き換えて、同様の手順で行う。
本発明の第2態様の歯科材料用水酸基含有モノマーの歯科材料は、Balb/3T3細胞を用いるNRU法による細胞試験において、相対細胞生存率が一定の範囲内であってもよい。該細胞試験は、上述のNRU法による細胞試験において、本発明の第1態様の歯科材料用モノマー組成物を本発明の第2態様の歯科材料用水酸基含有モノマーの歯科材料に置き換えて、同様の手順で行う。また、被験材料に含まれる被験物質(歯科材料に含まれる歯科材料用水酸基含有モノマー)の試験液中の濃度、歯科材料の相対細胞増殖率(%)は、上述の本発明の第1態様の歯科材料用モノマー組成物の場合におけるものと同様であってよい。
本発明の第2態様の歯科材料用水酸基含有モノマーの歯科材料は、Balb/3T3細胞を用いるWST法による細胞試験において、相対細胞増殖率が一定の範囲内であってもよい。該細胞試験は、上述のWST法による細胞試験において、本発明の第1態様の歯科材料用モノマー組成物を本発明の第2態様の歯科材料用水酸基含有モノマーの歯科材料に置き換えて、同様の手順で行う。また、被験材料に含まれる被験物質(歯科材料に含まれる歯科材料用水酸基含有モノマー)の試験液中の濃度、歯科材料の相対細胞増殖率(%)は、上述の本発明の第1態様の歯科材料用モノマー組成物の場合におけるものと同様であってよい。
上述の本発明の第2態様である歯科材料用水酸基含有モノマー、該水酸基含有モノマー以外の重合可能なモノマー(例えば、本発明の水酸基含有モノマー以外の(メタ)アクリレート基含有モノマー、エポキシ基を有するモノマー)、重合開始剤、フィラー、その他の成分等を混和し、本発明の第2態様の歯科材料を製造する方法については、公知の方法であれば特に制限を受けない。
本発明の第2態様の歯科材料は、前述の重合開始剤の重合方式にあわせ適切な条件で硬化することができる。例えば、可視光照射による光重合開始剤を含有している本発明の第2態様の歯科材料の場合は、該歯科材料を所定の形状に加工したのち、公知の光照射装置を用いて所定の時間可視光を照射することにより、所望の硬化物を得ることができる。照射強度、照射強度等の条件は、歯科材料の硬化性に合わせて適切に変更することができる。また、可視光をはじめとした、光照射により硬化した硬化物を、さらに適切な条件で熱処理をすることにより、硬化物の機械的物性を向上させることもできる。また、別の例として、加熱による重合開始剤を含有している本発明の第2態様の歯科材料の場合は、該歯科材料を所定の形状に加工したのち、適切な温度及び時間加熱することにより、所望の硬化物を得ることができる。
以上のようにして得られる上述の本発明の第2態様の歯科材料の硬化物が、歯科治療用途に用いられることもある。
本発明における第2態様の歯科材料は、歯科治療用途に好適に用いることができ、例えば、充填用コンポジットレジン、歯冠用硬質レジン、義歯床用レジン、義歯床用裏装材、印象材、歯科用接着材(歯列矯正用接着材、ボンディング材、接着レジンセメント、充填用接着コンポジットレジン、およびレジン添加型グラスアイオノマーセメント)、歯科用プライマー、歯牙裂溝封鎖材、CAD/CAM用レジンブロック、テンポラリークラウン、および人工歯材料等を挙げることができる。本発明における歯科材料用水酸基含有モノマーは、歯科治療の際に歯質との接着強度を向上させる機能を有しているため、特に歯科用接着材、および歯科用プライマー用途に好適である。
本発明の第2態様の歯科材料の使用方法は、歯科材料の使用法として一般に知られているものであれば、特に制限されない。例えば、本発明の第2態様の歯科材料をボンディング材として使用する場合は、口腔内の窩洞に該歯科材料を塗付したのち、必要に応じて乾燥し、また必要に応じて公知の光照射装置を用いて光硬化させたのち、充填用コンポジットレジンを充填する。
本発明の第2態様のキットは上記歯科材料を含む。本発明の第2態様のキットは、上記歯科材料の各成分を1剤として充填したキット、重合形式、および保存安定性等を勘案して、上記歯科材料の各成分を2剤以上に分けて充填した複数の剤からなるキットなどが挙げられる。なお、本発明のキットには、本発明の第2態様の歯科材料以外の、同時に使用する他の歯科材料が含まれていてもよい。かかるキットは、ボンディング材、接着セメント、プライマー、接着コンポジットレジンなどの用途に用いられる。
撹拌羽根、温度計および還流管を備えた100ミリリットル四つ口フラスコ内に、下記表1Aに記載の構造式を持つポリオール(三井化学株式会社製アクトコール(登録商標)、平均分子量1000、水酸基価168mgKOH/g)50.0g(OH基;0.150mol)とジブチル錫ジラウレート(和光純薬工業株式会社製)0.073g(反応全基質重量に対して1000ppm)および2,6-t-ブチル-4-メチルフェノール(和光純薬工業株式会社製)を0.073g(反応全基質重量に対して1000ppm)を添加し、60℃に昇温した。続いて、2-メタクリロイルオキシエチルイソシアネート(昭和電工株式会社製、カレンズMOI(登録商標))23.3g(0.150mol)を10分かけて滴下した。75-85℃となるように反応温度を保ち、5時間反応を行った。反応生成物の赤外吸収スペクトルIR(パーキンエルマー社製,Spectrum Two)を測定したところ、2267cm-1のイソシアネート由来の振動が消失していることを確認した。反応器から排出することにより、下記表1Aの構造式を有するウレタンメタクリル系多官能モノマー1Aを含む生成物71.2gが得られた。生成物の一部を採取し、JIS K 0070-1992に従って水酸基価を測定したところ、1mgKOH/g以下であることを確認した。
製造例1Aに記載のポリオール代わり、表1Aに示すポリオールを用いて製造例1Aと同様の合成操作を行うことで、下記表1Aの構造式を有する多官能モノマー2A~5Aを含む生成物を得た。
製造例1Aに記載の2-メタクリロイルオキシエチルイソシアネートに代わり、2-アクリロイルオキシエチルイソシアネート(昭和電工株式会社製、カレンズAOI(登録商標))を用いて製造例1Aと同様の合成操作を行うことで、下記表1Aの構造式を有する多官能モノマー6を含む生成物を得た。
製造例1Aで得られた多官能モノマー1A0.37gと下記構造式を有するウレタンアクリレート化合物7A1.94g、トリエチレングリコールジメタクリレート(NKエステル3G 新中村化学工業株式会社製、以下TEGDMAと略記)0.12g(0.42mmol)を容器に入れ、均一になるまで50℃で撹拌し、重合性モノマー組成物を得た。次いで、この重合性モノマー組成物40重量部に対して、バリウムアルミニウムボロシリケートガラスフィラー(GM27884、粒径1.5μm、1.6%シラン処理品、NEC SCHOTTコンポーネンツ株式会社製)60重量部、2,4,6-トリメチルベンゾイル-ジフェニル-フォスフィンオキサイド(IRGACURE TPO BASF社製、以下TPOと略記)0.2重量部を添加、混合し、均一なペーストの歯科材料として用いる組成物を得た。
上記で調製した組成物を2×2×25mmのSUS製金型に充填し、カバーフィルムで上から挟んだ後、歯科用可視光線照射装置(αライトV、株式会社モリタ東京製作所製)で片面につき3分間、両面から合計6分間照射して、組成物を硬化させた。硬化物を37℃の脱イオン水中で24時間保存した後、汎用試験機(精密万能材料試験機210X、株式会社INTESCO製)を用いて支点間距離20mm、クロスヘッド速度1mm/分で3点曲げ試験を実施した。該歯科材料として用いる組成物の硬化物の曲げ試験の結果を表2Aに示す。
多官能モノマー1Aの代わりに、製造例5Aで得られた多官能モノマー5Aに変更した以外は、実施例1A-1の操作に従い、歯科材料として用いる組成物を得た。さらに、実施例1A-1と同様の操作を行い、曲げ試験の結果を得た。結果を表2Aに示す。
製造例1Aで得られた多官能モノマー1Aを使用せずに、その使用量分をTEGDMAに置き換え、TEGDMAの量を増加させた以外は、実施例1A-1の操作に従い、歯科材料として用いる組成物を得た。さらに、実施例1A-1と同様の操作を行い、曲げ試験の結果を得た。結果を表2Aに示す。
ウレタンアクリレート化合物7Aの代わりにウレタンアクリレート化合物8Aを使用した以外は、実施例1A-1の操作に従い、歯科材料として用いる組成物を得た。さらに、実施例1A-1と同様の操作を行い、曲げ試験の結果を得た。結果を表2Aに示す。
製造例1Aで得られた多官能モノマー1Aを使用せずに、その使用量分をTEGDMAに置き換え、TEGDMAの量を増加させた以外は、実施例1A-3の操作に従い、歯科材料として用いる組成物を得た。さらに、実施例1A-3と同様の操作を行い、曲げ試験の結果を得た。結果を表2Aに示す。
製造例1Aで得られた多官能モノマー1A 100重量部に対して、TPO 0.5重量部を添加し、均一になるまで室温で撹拌しモノマー溶液を得た。その後、歯科用光照射器(Translux 2Wave、ヘレウスクルツァー社製)を用いて20秒光照射を行い、赤外分光法(IR)(Spectrum Two、パーキンエルマー社製)を用いて重合率の測定を行った。その結果を表3に示す。
重合率(%)は以下の式を用いて算出した。
重合率(%)={1-(IX,C-H/IX,C=O)/(I0,C-H/I0,C=O)}×100
IX,C-H:光照射後の810cm-1(アクリロイル基由来)あるいは815cm-1(メタクリロイル基由来)における吸光度
I0,C-H:光照射前の上記数値
IX,C=O:光照射後の1637cm-1(カルボニル基由来)における吸光度
I0,C=O:光照射前の上記数値
製造例で得られた多官能モノマー2A、3A、4Aおよび6Aの重合率を、実施例3A-1と同様の手法で測定した。その結果を表3Aに示す。
汎用歯科材料メタクリル化合物TEGDMAの重合率を、実施例3A-1と同様の手法で測定した。その結果を表3Aに示す。
撹拌羽根、温度計および還流管を備えた300ミリリットル四つ口フラスコ内に、下記構造式を有するポリオール1B(三井化学株式会社製アクトコール(登録商標)、平均分子量182、水酸基価926mgKOH/g)99.0g(OH基:1.63mol)とジブチル錫ジラウレート(東京化成工業株式会社製)0.27g(反応全基質重量に対して1000ppm)および2,6-t-ブチルー4-メチルフェノール(東京化成工業株式会社製)0.14g(反応全基質重量に対して500ppm)を添加し、55℃に昇温した。続いて、2-メタクリロイルオキシエチルイソシアネート(昭和電工株式会社製、カレンズMOI(登録商標))171g(1.10mol、用いたポリオール1のOHモル数に対して2/3当量)を20分かけて滴下した。80-85℃となるように反応温度を保ち、8時間反応を行った。赤外吸収スペクトルIR(パーキンエルマー社製,Spectrum Two)を測定したところ、2267cm-1のイソシアネート由来の振動が消失していることを確認した。生成物の一部を採取しJIS K 0070に従い水酸基価を測定したところ、119mgKOH/gであった。反応生成物の液体クロマトグラフィー質量分析(LC-MS分析)(日本Waters株式会社製、ACQUITY UPLC BEH C181.7μm(2.1mmx10mm)/ACQUITY UPLC H-Class-SQ Detector 2)を行ったところ、主生成物としてオキシエチレンユニットが一つ導入されたa+b+c=1の化合物1Bの分子量488と合致する質量[M-H]+:489および[M-Na]+:511が検出された。反応器から排出することにより、下記化合物1Bの構造式を有する水酸基含有モノマーを含む生成物 260gが得られた。
製造例1Bに記載のポリオールに代わり、表1Bに示すポリオールを用いて製造例1Bと同様の合成操作を行うことで、水酸基含有モノマー2B~5Bを含む生成物を得た。
製造例1Bに記載のポリオールに代わり、表1Bに示すポリオール6Bを用い、ポリオール6BのOHモル数に対して3/4当量のカレンズMOI(登録商標)を反応させた以外は、製造例1と同様の合成操作を行うことで、水酸基含有モノマー6Bを含む生成物を得た。
製造例1Bに記載のポリオールに代わり、表1Bに示すポリオール6Bを用い、ポリオール6BのOHモル数に対して3/4当量のカレンズMOI-EG(登録商標)を反応させた以外は、製造例1Bと同様の合成操作を行うことで、水酸基含有モノマー7Bを含む生成物を得た。
製造例1Bに記載のポリオールに代わり、表1Bに示すポリオール3Bを用い、ポリオール3BのOHモル数に対して2/3当量のカレンズMOI-EG(登録商標)を反応させた以外は、製造例1Bと同様の合成操作を行うことで、水酸基含有モノマー8Bを含む生成物を得た。
製造例1Bに記載のポリオールに代わり、表1Bに示すポリオール6Bを用い、ポリオール6BのOHモル数に対して1/2当量のカレンズMOI(登録商標)を反応させた以外は、製造例1Bと同様の合成操作を行うことで、水酸基含有モノマー9Bを含む生成物を得た。
製造例1Bで得られた化合物1B 10.33g (5.5重量部)とBis-GMA(ビスフェノールAジグリシジルメタクリレート:新中村化学工業株式会社製)0.50g (8.3重量部)、E4BADMA(ビスフェノールAジメタクリレートエステル4モルエチレンオキシド変性化合物 SR540、SARTOMER社製)0.26g (4.2重量部)、UDMA(2,2,4-トリメチルヘキサメチレンビス(2-カルバモイルオキシエチル)ジメタクリレート) 0.31g (5.2重量部)、ETMPTA-3EO(トリメチロールプロパントリアクリレート3モルエチレンオキシド変性化合物、共栄社化学株式会社製)0.37g (6.2重量部)、MDP(10-メタクリロイルオキシデシルジハイドロジェンホスフェート)0.37g (6.1重量部)、CQ(カンファーキノン:和光純薬工業株式会社製) 6.1mg (0.1重量部)、エチル4-(ジメチルアミノ)ベンゾエート (和光純薬工業株式会社製)0.018g(0.3重量部)、BHT(ジブチルヒドロキシトルエン:和光純薬工業株式会社製)2.0mg(0.03重量部)、2-ヒドロキシ-4-メトキシベンゾフェノン(和光純薬工業株式会社製)0.015g(0.25重量部)、バリウムアルミニウムボロシリケートガラスフィラー(GM27884、粒径1.5μm、1.6%シラン処理品、NEC SCHOTTコンポーネンツ株式会社製)3.8g(64重量部)を容器に入れ、均一になるまで50℃で撹拌し歯科材料として用いる組成物を得た。なお、実施例1Bの組成物は、例えば、レジンとしての性能を評価するのに適した組成である。
抜去した後冷凍保存した牛下顎前歯を注水下解凍し、歯根切断、抜髄処理した。これを直径25mm、深さ25mmのプラスチック製円筒容器に設置し、アクリル樹脂中に包埋した。この表面を#120、#400のエメリーペーパーを用いて湿式研磨し、唇面と平行になるようにエナメル質および象牙質平面を削り出した。
次に、これらの平面に圧縮空気を約1秒間吹き付けて乾燥した後、エナメル質あるいは象牙質の平面に直径2.38mmのプラスチック製モールド(ULTRADENT社製)を設置し、作製した組成物を2回に分けて充填した後、可視光照射装置(Translux 2Wave、ヘレウスクルツァー社製)を20秒照射し、硬化させた。その後、モールドを除去し、接着試料を作製した。試料を37℃温水中24時間保管した後、汎用試験機(精密万能材料試験機210X、株式会社INTESCO製)を用いて、牛歯のエナメル質あるいは象牙質面に平行、かつ表面に接して1.0mm/分のクロスヘッド速度で剪断負荷を掛け、牛歯表面に柱状に形成させた組成物が表面から分離する時の剪断負荷から、剪断接着強度を求めた。
得られた歯科材料として用いられる組成物の剪断試験の結果を表2Bに示す。
化合物1Bの代わりにHEMA(三菱レイヨン株式会社製、アクリエステルHO(登録商標))に変更した以外は、実施例1Bの操作に従い、歯科材料として用いられる組成物を得た。さらに、実施例1Bと同様の操作を行い、剪断試験の結果を得た。結果を表2Bに示す。
化合物1Bを添加しない以外は、実施例1Bの操作に従い、歯科材料として用いられる組成物を得た。さらに、実施例1Bと同様の操作を行い、剪断試験の結果を得た。結果を表2Bに示す。
製造例1Bで得られた化合物1B 0.40g (20重量部)、UDMA(2,2,4-トリメチルヘキサメチレンビス(2-カルバモイルオキシエチル)ジメタクリレート) 0.20g (10重量部)、TEGDMA(トリエチレングリコールジメタクリレート:新中村化学工業株式会社製NKエステル3G)0.20g (10重量部)、MDP(10-メタクリロイルオキシデシルジハイドロジェンホスフェート)0.26g (13重量部)、CQ(カンファーキノン:和光純薬工業株式会社製)0.020g (1.0重量部)、4-(ジメチルアミノ)安息香酸2-ブトキシエチル(東京化成工業株式会社製)0.020g (1.0重量部)、エタノール(超脱水:和光純薬工業株式会社製)0.60g(30重量部)、および蒸留水0.30g(15重量部)を容器に入れ、均一になるまで50℃で撹拌し歯科材料として用いる組成物を得た。なお、実施例2Bの組成物は、例えば、ボンディング材としての性能を評価するのに適した組成である。
抜去した後冷凍保存した牛下顎前歯を注水下解凍し、歯根切断、抜髄処理した。これを直径25mm、深さ25mmのプラスチック製円筒容器に設置し、アクリル樹脂中に包埋した。この表面を#120、#400のエメリーペーパーを用いて湿式研磨し、唇面と平行になるようにエナメル質を削り出した。
次に、この平面に圧縮空気を約1秒間吹き付けて乾燥した後、エナメル質の平面に作成した組成物を塗布し、弱ブローの圧縮空気を吹き付け、溶媒を除去した。この表面に可視光照射装置(Translux 2Wave、ヘレウスクルツァー社製)を用いて20秒光照射した。更にこの上に直径2.38mmのプラスチック製モールド(ULTRADENT社製)を設置し、歯科用コンポジットレジン(Venus Diamond、ヘレウスクルツァー社製)を充填し、可視光照射装置を用いて20秒光照射し、硬化させた。その後、モールドを除去し、接着試料を作成した。試料を37℃温水中24時間保管した後、汎用試験機(精密万能材料試験機210X、株式会社INTESCO製)を用いて、牛歯のエナメル質に平行、かつ表面に接して1.0mm/分のクロスヘッド速度で剪断負荷を掛け、牛歯表面に柱状に形成させた組成物が表面から分離する時の剪断負荷から、剪断接着強度を求めた。
歯科材料用組成物の剪断試験の結果を表3Bに示す。
化合物1Bの代わりに、上記製造例で得られた水酸基含有モノマー3B、4B、または6Bを用いたこと以外は、実施例2Bと同様の操作を行い、歯科材料として用いる組成物の調製を行った。ついで実施例2Bと同様の試験を行い、剪断試験の結果を得た。結果を表3Bに示す。
化合物1Bの代わりに、HEMA(三菱レイヨン株式会社製、アクリエステルHO(登録商標))を用いたこと以外は、実施例2Bと同様の操作を行い、歯科材料として用いる組成物の調製を行った。ついで実施例2Bと同様の試験を行い、剪断試験の結果を得た。結果を表3Bに示す。
牛歯エナメル質の代わりに牛歯象牙質を用い、表4Bに記載の化合物を使用したこと以外は、実施例2Bと同様の操作を行い、歯科材料として用いる組成物の調製を行った。次いで実施例2Bと同様の試験を行い、剪断試験の結果を得た。結果を表4Bに示す。
化合物1Bの代わりに、HEMA(三菱レイヨン株式会社製、アクリエステルHO(登録商標))を用いたこと以外は、実施例6Bと同様の操作を行い、歯科材料として用いる組成物の調製を行った。次いで実施例2と同様の試験を行い、剪断試験の結果を得た。結果を表4Bに示す。
Claims (44)
- 下記核部(X)と下記末端基(Y2A)とが直接または下記連結基(Z)を介して結合した下記一般式(8A)で示される化合物を含む歯科材料用多官能モノマー。
核部(X)は酸素原子または窒素原子を含有し、末端基(Y2A)または連結基(Z)と結合する原子が酸素原子または窒素原子である炭素数1~200の3価以上の多価有機基であり、
末端基(Y2A)は、下記一般式(9)で示される(メタ)アクリロイル基含有基(Y3)、(メタ)アクリロイル基、または炭素数1~20の炭化水素基であり、複数ある末端基(Y2A)は同一でも異なっていてもよく、ただし、一般式(8A)で示される化合物中のすべての末端基(Y2A)のうち、3以上は(メタ)アクリロイル基含有基(Y3)または(メタ)アクリロイル基でありかつ1以上は(メタ)アクリロイル基含有基(Y3)であり、
連結基(Z)は下記一般式(2)で示される2価の基であり、上記一般式(8A)で示される化合物中に連結基(Z)が複数含まれる場合には、連結基(Z)は同一でも異なっていてもよい。)
- 上記末端基(Y2A)が、(メタ)アクリロイル基含有基(Y3)または(メタ)アクリロイル基である請求項1に記載の歯科材料用多官能モノマー。
- 上記末端基(Y2A)が、(メタ)アクリロイル基含有基(Y3)である請求項1または2に記載の歯科材料用多官能モノマー。
- 上記連結基(Z)におけるn2a、n2b、n2c、およびn2dがそれぞれ0~20であり、n2a、n2b、n2c、およびn2dの合計が1~20である請求項1~3のいずれか1項に記載の歯科材料用多官能モノマー。
- 上記核部(X)が、3~12価の有機基である請求項1~6のいずれか1項に記載の歯科材料用多官能モノマー。
- 下記核部(X)と下記末端基(Y1A)とが直接または下記連結基(Z)を介して結合している下記一般式(1A)で示される化合物と、下記一般式(3)で示される(メタ)アクリロイル基含有イソシアネート化合物との、(下記一般式(3)で示される化合物に含まれるイソシアネート基の数)/(下記一般式(1A)で示される化合物に含まれる酸素原子および窒素原子と結合した活性プロトンの数)=1の条件での反応生成物である歯科材料用多官能モノマー。
核部(X)は酸素原子または窒素原子を含有し、末端基(Y1A)または連結基(Z)と結合する原子が酸素原子または窒素原子である炭素数1~200の3価以上の多価有機基であり、
末端基(Y1A)は、(メタ)アクリロイル基、炭素数1~20の1価の炭化水素基、または水素原子であり、複数あるY1Aは同一でも異なっていてもよく、ただし、上記一般式(1A)で示される化合物中に含まれる末端基(Y1A)のうち3以上は水素原子または(メタ)アクリロイル基であり、かつ1以上は水素原子であり、
連結基(Z)は下記一般式(2)で示される2価の基であり、上記一般式(1A)で示される化合物中に連結基(Z)が複数含まれる場合には、連結基(Z)は同一でも異なっていてもよい。)
- 上記末端基(Y1A)が水素原子である、請求項10に記載の歯科材料用多官能モノマー。
- 上記連結基(Z)におけるn2a、n2b、n2c、およびn2dがそれぞれ0~20であり、n2a、n2b、n2c、およびn2dの合計が1~20である請求項10または11に記載の歯科材料用多官能モノマー。
- 上記核部(X)が、3~12価の有機基である請求項10~14のいずれか1項に記載の歯科材料用多官能モノマー。
- 上記化合物(1A)が、下記一般式(6’a)~(6’k)で示される化合物からなる群より選択される少なくとも1つである請求項10~15のいずれか1項に記載の歯科材料用多官能モノマー。
上記一般式(6’i)および(6’j)中のn6'i-bおよびn6'j-bは、それぞれオキシエチレン、オキシプロピレンユニットの個数を示し、それぞれ1~100の範囲であり、それぞれのアームごとのユニットの個数は同じでも異なっていてもよく、上記一般式(6’k)中のn6'k-bおよびn6'k-cは、それぞれオキシエチレン、オキシプロピレンユニットの個数を示し、その和は1~100の範囲であり、それぞれのアームごとのユニットの個数の和は同じでも異なっていてもよい。) - 請求項1~17のいずれか1項に記載の歯科材料用多官能モノマーを含有する歯科材料用モノマー組成物。
- 復帰突然変異試験において陰性を示す、請求項18に記載の歯科材料用モノマー組成物。
- 請求項1~17のいずれか1項に記載の歯科材料用多官能モノマーを含有する歯科材料。
- 復帰突然変異試験において陰性を示す、請求項20に記載の歯科材料。
- 請求項20または21に記載の歯科材料を硬化させてなる硬化物。
- 請求項20または21に記載の歯科材料を含むキット。
- 下記核部(X)と下記末端基(Y2B)とが直接または下記連結基(Z)を介して結合した下記一般式(8B)で示される化合物を含む歯科材料用水酸基含有モノマー。
核部(X)は酸素原子または窒素原子を含有し、末端基(Y2B)または連結基(Z)と結合する原子が酸素原子または窒素原子である炭素数1~200の3価以上の多価有機基であり、
末端基(Y2B)は、下記一般式(9)で示される(メタ)アクリロイル基含有基(Y3)、(メタ)アクリロイル基、炭素数1~20の炭化水素基、または水素原子であり、複数ある末端基(Y2B)は同一でも異なっていてもよく、ただし、一般式(8B)で示される化合物中のすべての末端基(Y2B)のうち、1以上は(メタ)アクリロイル基含有基(Y3)でありかつ1以上は水素原子であり、
連結基(Z)は下記一般式(2)で示される2価の基であり、上記一般式(8B)で示される化合物中に連結基(Z)が複数含まれる場合には、連結基(Z)は同一でも異なっていてもよい。)
- 上記末端基(Y2B)が、(メタ)アクリロイル基含有基(Y3)または水素原子である請求項24に記載の歯科材料用水酸基含有モノマー。
- 上記連結基(Z)におけるn2a、n2b、n2c、およびn2dがそれぞれ0~20であり、n2a、n2b、n2c、およびn2dの合計が1~20である請求項24または25に記載の歯科材料用水酸基含有モノマー。
- 上記核部(X)が、3~12価の有機基である請求項24~28のいずれか1項に記載の歯科材料用水酸基含有モノマー。
- 下記核部(X)と下記末端基(Y1B)とが直接または下記連結基(Z)を介して結合している下記一般式(1B)で示される化合物と、下記一般式(3)で示される(メタ)アクリロイル基含有イソシアネート化合物との、1/(下記一般式(1B)で示される化合物に含まれる酸素原子および窒素原子と結合した活性プロトンの数)≦(下記一般式(3)で示される化合物に含まれるイソシアネート基の数)/(下記一般式(1B)で示される化合物に含まれる酸素原子および窒素原子と結合した活性プロトンの数)<1の条件での反応生成物である歯科材料用水酸基含有モノマー。
核部(X)は酸素原子または窒素原子を含有し、末端基(YI)または連結基(Z)と結合する原子が酸素原子または窒素原子である炭素数1~200の3価以上の多価有機基であり、
末端基(Y1B)は、(メタ)アクリロイル基、炭素数1~20の1価の炭化水素基、または水素原子であり、複数あるY1Bは同一でも異なっていてもよく、ただし、上記一般式(1B)で示される化合物中に含まれる末端基(Y1B)のうち2以上は水素原子であり、
連結基(Z)は下記一般式(2)で示される2価の基であり、上記一般式(1B)で示される化合物中に連結基(Z)が複数含まれる場合には、連結基(Z)は同一でも異なっていてもよい。)
- 上記末端基(Y1B)が水素原子である、請求項32に記載の歯科材料用水酸基含有モノマー。
- 上記連結基(Z)におけるn2a、n2b、n2c、およびn2dがそれぞれ0~20であり、n2a、n2b、n2c、およびn2dの合計が1~20である請求項32または33に記載の歯科材料用水酸基含有モノマー。
- 上記核部(X)が、3~12価の有機基である請求項32~36のいずれか1項に記載の歯科材料用水酸基含有モノマー。
- 上記化合物(1B)が、下記一般式(6’a)~(6’k)で示される化合物からなる群より選択される少なくとも1つである請求項32~37のいずれか1項に記載の歯科材料用水酸基含有モノマー。
上記一般式(6’i)および(6’j)中のn6'i-bおよびn6'j-bは、それぞれオキシエチレン、オキシプロピレンユニットの個数を示し、それぞれ1~100の範囲であり、それぞれのアームごとのユニットの個数は同じでも異なっていてもよく、上記一般式(6’k)中のn6'k-bおよびn6'k-cは、それぞれオキシエチレン、オキシプロピレンユニットの個数を示し、その和は1~100の範囲であり、それぞれのアームごとのユニットの個数の和は同じでも異なっていてもよい。) - 請求項24~39のいずれか1項に記載の歯科材料用水酸基含有モノマーを含有する歯科材料用モノマー組成物。
- 復帰突然変異試験において陰性を示す、請求項40に記載の歯科材料用モノマー組成物。
- 請求項24~39のいずれか1項に記載の歯科材料用水酸基含有モノマーを含有する歯科材料。
- 復帰突然変異試験において陰性を示す、請求項42に記載の歯科材料。
- 請求項42または43に記載の歯科材料を含むキット。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019510123A JP6836646B2 (ja) | 2017-03-31 | 2018-03-29 | 歯科材料用多官能モノマーおよび歯科材料用水酸基含有モノマー |
EP18777611.7A EP3603607B1 (en) | 2017-03-31 | 2018-03-29 | Multifunctional monomer for dental material, and hydroxyl group-containing monomer for dental material |
US16/485,612 US20190365610A1 (en) | 2017-03-31 | 2018-03-29 | Dental polyfunctional monomers and dental hydroxyl group-containing monomers |
US17/166,135 US11406571B2 (en) | 2017-03-31 | 2021-02-03 | Dental polyfunctional monomers and dental hydroxyl group-containing monomers |
US17/408,804 US11786444B2 (en) | 2017-03-31 | 2021-08-23 | Dental polyfunctional monomers and dental hydroxyl group-containing monomers |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017072678 | 2017-03-31 | ||
JP2017072677 | 2017-03-31 | ||
JP2017-072677 | 2017-03-31 | ||
JP2017-072678 | 2017-03-31 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/485,612 A-371-Of-International US20190365610A1 (en) | 2017-03-31 | 2018-03-29 | Dental polyfunctional monomers and dental hydroxyl group-containing monomers |
US17/166,135 Division US11406571B2 (en) | 2017-03-31 | 2021-02-03 | Dental polyfunctional monomers and dental hydroxyl group-containing monomers |
US17/408,804 Division US11786444B2 (en) | 2017-03-31 | 2021-08-23 | Dental polyfunctional monomers and dental hydroxyl group-containing monomers |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018181710A1 true WO2018181710A1 (ja) | 2018-10-04 |
Family
ID=63676458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2018/013236 WO2018181710A1 (ja) | 2017-03-31 | 2018-03-29 | 歯科材料用多官能モノマーおよび歯科材料用水酸基含有モノマー |
Country Status (4)
Country | Link |
---|---|
US (3) | US20190365610A1 (ja) |
EP (1) | EP3603607B1 (ja) |
JP (1) | JP6836646B2 (ja) |
WO (1) | WO2018181710A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4032522A4 (en) * | 2019-09-19 | 2023-09-20 | Kuraray Noritake Dental Inc. | CURTABLE COMPOSITION FOR DENTAL MEDICINE |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6836646B2 (ja) | 2017-03-31 | 2021-03-03 | 三井化学株式会社 | 歯科材料用多官能モノマーおよび歯科材料用水酸基含有モノマー |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000204069A (ja) | 1998-11-11 | 2000-07-25 | Tokuyama Corp | 重合性不飽和結合含有n―置換アミド化合物 |
EP1449650A2 (en) | 2003-02-21 | 2004-08-25 | Fuji Photo Film Co., Ltd. | Photosensitive composition and planographic printing plate precursor using the same |
US20050124721A1 (en) * | 2003-12-03 | 2005-06-09 | Arthur Samuel D. | Bulky monomers leading to resins exhibiting low polymerization shrinkage |
JP2008088251A (ja) * | 2006-09-29 | 2008-04-17 | Fujifilm Corp | 硬化性組成物、カラーフィルタ及びその製造方法 |
JP2010505895A (ja) | 2006-10-13 | 2010-02-25 | デンツプライ デトレイ ゲー.エム.ベー.ハー. | 歯科用接着剤組成物 |
JP2010150290A (ja) | 2002-06-26 | 2010-07-08 | Ivoclar Vivadent Ag | ヒドロキシアルキルアクリルアミドに基づく歯科材料 |
US20110207086A1 (en) * | 2008-10-22 | 2011-08-25 | Jie Yang | Dental composition comprising biphenyl di(meth)acrylate monomer comprising urethane moieties |
JP2013133290A (ja) | 2011-12-26 | 2013-07-08 | Tokuyama Dental Corp | トレハロース誘導体 |
JP2013544823A (ja) | 2010-11-23 | 2013-12-19 | デンツプライ インターナショナル インコーポレーテッド | 高強度歯科用材料 |
WO2015152221A1 (ja) | 2014-03-31 | 2015-10-08 | 三井化学株式会社 | 歯科材料用重合性モノマー |
CN105801795A (zh) * | 2016-04-15 | 2016-07-27 | 江苏利田科技股份有限公司 | 一种6官能度聚己内酯聚氨酯丙烯酸酯及其制备方法和应用 |
CN105859587A (zh) | 2016-04-15 | 2016-08-17 | 江苏利田科技股份有限公司 | 一种基于季戊四醇的4官能度聚氨酯丙烯酸酯及其制备方法和应用 |
CN105860026A (zh) | 2016-04-15 | 2016-08-17 | 江苏利田科技股份有限公司 | 一种基于双季戊四醇的6官能度聚氨酯丙烯酸酯及其制备方法和应用 |
CN105860028A (zh) * | 2016-04-15 | 2016-08-17 | 江苏利田科技股份有限公司 | 一种基于2,2-二羟甲基丙(丁)酸的3官能度聚氨酯丙烯酸酯及其制备方法和应用 |
CN105859585A (zh) | 2016-04-15 | 2016-08-17 | 江苏利田科技股份有限公司 | 一种基于甘油的3官能度聚氨酯丙烯酸酯及其制备方法和应用 |
CN105859584A (zh) | 2016-04-15 | 2016-08-17 | 江苏利田科技股份有限公司 | 一种基于三羟甲基乙(丙)烷的3官能度聚氨酯丙烯酸酯及其制备方法和应用 |
EP3603607A1 (en) | 2017-03-31 | 2020-02-05 | Mitsui Chemicals, Inc. | Multifunctional monomer for dental material, and hydroxyl group-containing monomer for dental material |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4233425A (en) | 1978-11-15 | 1980-11-11 | The Dow Chemical Company | Addition polymerizable polyethers having pendant ethylenically unsaturated urethane groups |
US4859780A (en) | 1988-02-26 | 1989-08-22 | Ciba-Geigy Corporation | Hydrophilic modifier monomers |
US6900251B2 (en) | 2002-06-26 | 2005-05-31 | Ivoclar Vivadent Ag | Dental materials based on acrylic-ester phosphonic acids |
TWI428691B (zh) | 2006-09-25 | 2014-03-01 | Fujifilm Corp | 硬化組成物、彩色濾光片及其製法 |
CN101663336B (zh) * | 2007-03-20 | 2012-10-10 | 可乐丽则武齿科株式会社 | 聚合性单体、聚合性组合物及牙科用材料 |
CN105884655B (zh) * | 2016-04-15 | 2017-11-21 | 江苏利田科技股份有限公司 | 一种基于双三羟甲基丙烷的4官能度聚氨酯丙烯酸酯及其制备方法和应用 |
CN105801829B (zh) * | 2016-04-15 | 2018-08-17 | 江苏利田科技股份有限公司 | 一种2官能度聚己内酯聚氨酯丙烯酸酯及其制备方法和应用 |
CN105859997A (zh) * | 2016-04-15 | 2016-08-17 | 江苏利田科技股份有限公司 | 一种3官能度聚己内酯聚氨酯丙烯酸酯及其制备方法和应用 |
CN105860027A (zh) * | 2016-04-15 | 2016-08-17 | 江苏利田科技股份有限公司 | 一种2官能度聚酯基聚氨酯丙烯酸酯及其制备方法和应用 |
CN105820063B (zh) * | 2016-04-15 | 2017-11-17 | 江苏利田科技股份有限公司 | 一种基于无水柠檬酸的4官能度聚氨酯丙烯酸酯及其制备方法和应用 |
CN105859586A (zh) * | 2016-04-15 | 2016-08-17 | 江苏利田科技股份有限公司 | 一种2官能度聚碳酸酯聚氨酯丙烯酸酯及其制备方法和应用 |
CN105859588B (zh) * | 2016-04-15 | 2018-08-10 | 江苏利田科技股份有限公司 | 一种4官能度聚己内酯聚氨酯丙烯酸酯及其制备方法和应用 |
CN105801807A (zh) * | 2016-04-15 | 2016-07-27 | 江苏利田科技股份有限公司 | 一种2官能度聚醚聚氨酯丙烯酸酯及其制备方法和应用 |
-
2018
- 2018-03-29 JP JP2019510123A patent/JP6836646B2/ja active Active
- 2018-03-29 US US16/485,612 patent/US20190365610A1/en not_active Abandoned
- 2018-03-29 WO PCT/JP2018/013236 patent/WO2018181710A1/ja active Application Filing
- 2018-03-29 EP EP18777611.7A patent/EP3603607B1/en active Active
-
2021
- 2021-02-03 US US17/166,135 patent/US11406571B2/en active Active
- 2021-08-23 US US17/408,804 patent/US11786444B2/en active Active
Patent Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000204069A (ja) | 1998-11-11 | 2000-07-25 | Tokuyama Corp | 重合性不飽和結合含有n―置換アミド化合物 |
JP2010150290A (ja) | 2002-06-26 | 2010-07-08 | Ivoclar Vivadent Ag | ヒドロキシアルキルアクリルアミドに基づく歯科材料 |
EP1449650A2 (en) | 2003-02-21 | 2004-08-25 | Fuji Photo Film Co., Ltd. | Photosensitive composition and planographic printing plate precursor using the same |
US20050124721A1 (en) * | 2003-12-03 | 2005-06-09 | Arthur Samuel D. | Bulky monomers leading to resins exhibiting low polymerization shrinkage |
JP2008088251A (ja) * | 2006-09-29 | 2008-04-17 | Fujifilm Corp | 硬化性組成物、カラーフィルタ及びその製造方法 |
JP2010505895A (ja) | 2006-10-13 | 2010-02-25 | デンツプライ デトレイ ゲー.エム.ベー.ハー. | 歯科用接着剤組成物 |
US20110207086A1 (en) * | 2008-10-22 | 2011-08-25 | Jie Yang | Dental composition comprising biphenyl di(meth)acrylate monomer comprising urethane moieties |
JP2013544823A (ja) | 2010-11-23 | 2013-12-19 | デンツプライ インターナショナル インコーポレーテッド | 高強度歯科用材料 |
JP2013133290A (ja) | 2011-12-26 | 2013-07-08 | Tokuyama Dental Corp | トレハロース誘導体 |
WO2015152221A1 (ja) | 2014-03-31 | 2015-10-08 | 三井化学株式会社 | 歯科材料用重合性モノマー |
WO2015152220A1 (ja) | 2014-03-31 | 2015-10-08 | 三井化学株式会社 | 歯科材料用重合性モノマー組成物 |
CN105801795A (zh) * | 2016-04-15 | 2016-07-27 | 江苏利田科技股份有限公司 | 一种6官能度聚己内酯聚氨酯丙烯酸酯及其制备方法和应用 |
CN105859587A (zh) | 2016-04-15 | 2016-08-17 | 江苏利田科技股份有限公司 | 一种基于季戊四醇的4官能度聚氨酯丙烯酸酯及其制备方法和应用 |
CN105860026A (zh) | 2016-04-15 | 2016-08-17 | 江苏利田科技股份有限公司 | 一种基于双季戊四醇的6官能度聚氨酯丙烯酸酯及其制备方法和应用 |
CN105860028A (zh) * | 2016-04-15 | 2016-08-17 | 江苏利田科技股份有限公司 | 一种基于2,2-二羟甲基丙(丁)酸的3官能度聚氨酯丙烯酸酯及其制备方法和应用 |
CN105859585A (zh) | 2016-04-15 | 2016-08-17 | 江苏利田科技股份有限公司 | 一种基于甘油的3官能度聚氨酯丙烯酸酯及其制备方法和应用 |
CN105859584A (zh) | 2016-04-15 | 2016-08-17 | 江苏利田科技股份有限公司 | 一种基于三羟甲基乙(丙)烷的3官能度聚氨酯丙烯酸酯及其制备方法和应用 |
EP3603607A1 (en) | 2017-03-31 | 2020-02-05 | Mitsui Chemicals, Inc. | Multifunctional monomer for dental material, and hydroxyl group-containing monomer for dental material |
Non-Patent Citations (2)
Title |
---|
CYNTHIA J.E. FLOYD ET AL.: "Network structure of Bis-GMA- and UDMA-based resin systems", DENTAL MATERIALS, vol. 22, 2006, pages 1143 - 1149 |
YOSHIHIRO NISHITANI ET AL.: "Effects of resin hydrophilicity on dentin bonds", ADHESIVE DENTISTRY, vol. 26, 2008, pages 92 - 98 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4032522A4 (en) * | 2019-09-19 | 2023-09-20 | Kuraray Noritake Dental Inc. | CURTABLE COMPOSITION FOR DENTAL MEDICINE |
JP7464615B2 (ja) | 2019-09-19 | 2024-04-09 | クラレノリタケデンタル株式会社 | 歯科用硬化性組成物 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2018181710A1 (ja) | 2020-01-16 |
US20190365610A1 (en) | 2019-12-05 |
EP3603607A4 (en) | 2021-01-13 |
US11406571B2 (en) | 2022-08-09 |
EP3603607A1 (en) | 2020-02-05 |
US11786444B2 (en) | 2023-10-17 |
JP6836646B2 (ja) | 2021-03-03 |
EP3603607B1 (en) | 2023-09-20 |
US20210161771A1 (en) | 2021-06-03 |
US20210378919A1 (en) | 2021-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3135270B1 (en) | Polymerizable monomer for dental material | |
JP2018177821A (ja) | 歯科材料用重合性モノマー、組成物、接着性歯科材料、及びキット | |
JP6734990B2 (ja) | 歯科材料用接着性モノマー | |
WO2012157566A1 (ja) | 歯科材料、歯科材料組成物、歯科修復材料および硬化物 | |
JPWO2012157568A1 (ja) | 新規な化合物、該化合物を含む組成物および硬化物 | |
US11786444B2 (en) | Dental polyfunctional monomers and dental hydroxyl group-containing monomers | |
EP3604318B1 (en) | Phosphorus-containing compound | |
JP7286674B2 (ja) | (メタ)アクリレート、モノマー組成物、成形体、歯科材料用組成物、及び歯科材料 | |
JP7429559B2 (ja) | (メタ)アクリレート化合物、モノマー組成物、成形体、歯科材料用組成物、歯科材料及び(メタ)アクリレート化合物の製造方法 | |
JP7044885B2 (ja) | 重合開始剤、硬化性組成物、歯科材料および硬化性組成物の調製用キット | |
WO2022209973A1 (ja) | 歯科材料用組成物、歯科材料及び抗菌用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18777611 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2019510123 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2018777611 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2018777611 Country of ref document: EP Effective date: 20191031 |